0001677576--12-312023Q3false6000006000002797283028039830P3Y6000000.50http://fasb.org/us-gaap/2023#OtherLiabilities0001677576us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001677576us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001677576us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001677576us-gaap:CommonStockMember2023-07-012023-09-300001677576iipr:AtMarketOfferingsMember2023-01-012023-09-300001677576us-gaap:CommonStockMember2023-01-012023-09-300001677576us-gaap:CommonStockMember2022-07-012022-09-300001677576us-gaap:CommonStockMember2022-01-012022-09-300001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2023-09-300001677576us-gaap:AdditionalPaidInCapitalMember2023-09-300001677576iipr:DividendInExcessOfEarningMember2023-09-300001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2023-06-300001677576us-gaap:AdditionalPaidInCapitalMember2023-06-300001677576iipr:DividendInExcessOfEarningMember2023-06-3000016775762023-06-300001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2022-12-310001677576us-gaap:AdditionalPaidInCapitalMember2022-12-310001677576iipr:DividendInExcessOfEarningMember2022-12-310001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2022-09-300001677576us-gaap:AdditionalPaidInCapitalMember2022-09-300001677576iipr:DividendInExcessOfEarningMember2022-09-300001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2022-06-300001677576us-gaap:AdditionalPaidInCapitalMember2022-06-300001677576iipr:DividendInExcessOfEarningMember2022-06-3000016775762022-06-300001677576us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2021-12-310001677576srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2021-12-310001677576srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberiipr:DividendInExcessOfEarningMember2021-12-310001677576us-gaap:AdditionalPaidInCapitalMember2021-12-310001677576srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2021-12-310001677576iipr:DividendInExcessOfEarningMember2021-12-310001677576us-gaap:CommonStockMember2023-09-300001677576us-gaap:CommonStockMember2023-06-300001677576us-gaap:CommonStockMember2022-12-310001677576us-gaap:CommonStockMember2022-09-300001677576us-gaap:CommonStockMember2022-06-300001677576us-gaap:CommonStockMember2021-12-310001677576srt:MaximumMemberiipr:TwoThousandSixteenPlanMember2023-09-300001677576iipr:TwoThousandSixteenPlanMember2023-01-012023-09-300001677576us-gaap:RestrictedStockUnitsRSUMember2023-06-300001677576us-gaap:RestrictedStockMember2023-06-300001677576us-gaap:RestrictedStockUnitsRSUMember2023-03-310001677576us-gaap:RestrictedStockMember2023-03-310001677576us-gaap:RestrictedStockUnitsRSUMember2022-12-310001677576us-gaap:RestrictedStockMember2022-12-310001677576us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001677576us-gaap:RestrictedStockMember2023-04-012023-06-300001677576us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001677576us-gaap:PerformanceSharesMember2022-01-012022-01-310001677576us-gaap:PerformanceSharesMember2021-01-012021-01-310001677576us-gaap:RestrictedStockMember2023-07-012023-09-300001677576us-gaap:RestrictedStockMember2023-01-012023-03-310001677576us-gaap:LandMember2023-09-300001677576iipr:KingsGardenLawsuitMemberiipr:KingsGardenLeasesInSouthernCaliforniaMemberus-gaap:ScenarioAdjustmentMemberus-gaap:ConstructionInProgressMember2023-09-300001677576srt:MinimumMemberiipr:OfficeEquipmentAndFurnitureAndFixturesMember2023-09-300001677576srt:MaximumMemberiipr:OfficeEquipmentAndFurnitureAndFixturesMember2023-09-300001677576us-gaap:BuildingAndBuildingImprovementsMember2023-09-300001677576iipr:KingsGardenLawsuitMember2023-01-012023-09-300001677576us-gaap:SeriesAPreferredStockMember2023-09-300001677576us-gaap:SeriesAPreferredStockMember2022-12-310001677576us-gaap:SeriesAPreferredStockMember2022-01-012022-12-310001677576us-gaap:SubsequentEventMember2023-10-132023-10-1300016775762023-07-142023-07-1400016775762023-04-142023-04-140001677576iipr:CommitmentsRelatedToTenantImprovementAllowancesMember2023-09-300001677576iipr:CommitmentsRelatedToConstructionLoanMember2023-09-300001677576us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001677576us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-300001677576us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001677576us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001677576iipr:DerivativeActionLawsuitMember2023-09-300001677576iipr:AmendedClassActionLawsuitMember2023-09-300001677576iipr:ParallelPennsylvaniaLitigationMember2023-10-312023-10-310001677576us-gaap:SubsequentEventMember2023-10-230001677576us-gaap:SubsequentEventMember2023-11-0200016775762021-11-3000016775762018-12-310001677576us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:UnsecuredDebtMember2023-09-300001677576us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:SeniorNotesMember2023-09-300001677576us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:UnsecuredDebtMember2022-12-310001677576us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:SeniorNotesMember2022-12-310001677576us-gaap:AboveMarketLeasesMember2023-09-300001677576us-gaap:LeasesAcquiredInPlaceMember2022-12-310001677576us-gaap:AboveMarketLeasesMember2022-12-310001677576us-gaap:PerformanceSharesMember2023-09-300001677576us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001677576us-gaap:RestrictedStockMember2023-01-012023-09-300001677576us-gaap:RestrictedStockUnitsRSUMember2023-09-300001677576us-gaap:RestrictedStockMember2023-09-300001677576iipr:DividendInExcessOfEarningMember2023-07-012023-09-300001677576iipr:DividendInExcessOfEarningMember2023-01-012023-09-300001677576iipr:DividendInExcessOfEarningMember2022-07-012022-09-300001677576iipr:DividendInExcessOfEarningMember2022-01-012022-09-300001677576iipr:RedeemedPriorToFebruary252026Memberus-gaap:UnsecuredDebtMember2023-01-012023-09-300001677576iipr:RedeemedOnOrAfterFebruary252026Memberus-gaap:UnsecuredDebtMember2023-01-012023-09-300001677576us-gaap:UnsecuredDebtMember2023-09-300001677576us-gaap:SeniorNotesMember2023-09-300001677576us-gaap:UnsecuredDebtMember2022-12-310001677576us-gaap:SeniorNotesMember2022-12-310001677576us-gaap:SeniorNotesMemberus-gaap:CommonStockMember2023-09-300001677576srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001677576us-gaap:SeniorNotesMemberus-gaap:CommonStockMember2023-01-012023-09-300001677576iipr:KingsGardenLawsuitMemberiipr:KingsGardenLeasesInSouthernCaliforniaMember2023-09-300001677576iipr:KingsGardenLawsuitMemberiipr:KingsGardenLeasesInSouthernCaliforniaMember2022-12-310001677576iipr:ParallelPennsylvaniaLitigationMemberiipr:ShParentInc.ParallelMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-3000016775762023-09-152023-09-1500016775762023-06-152023-06-1500016775762023-03-152023-03-150001677576srt:MaximumMember2023-09-3000016775762022-09-3000016775762021-12-310001677576us-gaap:LeasesAcquiredInPlaceMember2023-07-012023-09-300001677576us-gaap:AboveMarketLeasesMember2023-07-012023-09-300001677576us-gaap:AboveMarketLeasesMember2023-01-012023-09-300001677576us-gaap:LeasesAcquiredInPlaceMember2022-07-012022-09-300001677576us-gaap:AboveMarketLeasesMember2022-07-012022-09-300001677576us-gaap:LeasesAcquiredInPlaceMember2022-01-012022-09-300001677576us-gaap:AboveMarketLeasesMember2022-01-012022-09-300001677576us-gaap:PerformanceSharesMember2023-07-012023-09-300001677576us-gaap:PerformanceSharesMember2023-01-012023-09-300001677576us-gaap:PerformanceSharesMember2022-07-012022-09-300001677576us-gaap:PerformanceSharesMember2022-01-012022-09-300001677576us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-3000016775762022-07-012022-09-300001677576us-gaap:LeasesAcquiredInPlaceMember2023-01-012023-09-300001677576iipr:GoodnessGrowthHoldingsInc.Memberiipr:NewYorkPropertiesMemberus-gaap:SubsequentEventMember2023-10-012023-10-310001677576iipr:PharmacannInc.Memberiipr:NewYorkPropertiesMember2023-02-012023-02-280001677576iipr:GoodnessGrowthHoldingsInc.Memberiipr:NewYorkPropertiesMember2023-02-012023-02-280001677576iipr:AscendWellnessHoldingsLlcMemberiipr:NewJerseyPropertiesMember2023-02-012023-02-280001677576iipr:GoodnessGrowthHoldingsInc.Memberiipr:NewYorkPropertiesMemberus-gaap:SubsequentEventMember2023-10-310001677576iipr:PharmacannInc.Memberiipr:NewYorkPropertiesMember2023-02-280001677576iipr:GoodnessGrowthHoldingsInc.Memberiipr:NewYorkPropertiesMember2023-02-280001677576iipr:AscendWellnessHoldingsLlcMemberiipr:NewJerseyPropertiesMember2023-02-280001677576iipr:ParallelTexasLitigationMemberiipr:ShParentInc.ParallelMemberstpr:TX2023-01-012023-09-300001677576iipr:ParallelPennsylvaniaLitigationMemberiipr:ShParentInc.ParallelMemberstpr:PA2023-01-012023-09-300001677576iipr:KingsGardenLawsuitMember2023-07-012023-09-300001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMember2023-03-310001677576iipr:SusquehannaStreetMember2023-01-012023-09-300001677576iipr:BoltonfieldStreetMember2023-01-012023-09-300001677576iipr:SusquehannaStreetMember2023-09-300001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMemberus-gaap:LandMember2023-09-300001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMemberus-gaap:BuildingAndBuildingImprovementsMember2023-09-300001677576iipr:IipOperatingPartnershipLpMember2023-09-300001677576us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-09-300001677576us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-09-300001677576iipr:AtMarketOfferingsMember2023-01-012023-01-310001677576iipr:KingsGardenInc.Member2023-09-300001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMember2023-03-012023-03-310001677576iipr:ParallelTexasLitigationMemberiipr:ShParentInc.ParallelMemberstpr:TX2023-09-300001677576iipr:ParallelPennsylvaniaLitigationMemberiipr:ShParentInc.ParallelMemberstpr:PA2023-09-300001677576iipr:KingsGardenLawsuitMember2023-08-162023-08-1600016775762022-01-012022-06-300001677576iipr:TrulieveCannabisCorpMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001677576iipr:PharmaCannLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001677576iipr:GreenThumbIndustriesInc.Memberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001677576iipr:CuraleafHoldingsIncMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001677576iipr:AscendWellnessHoldingsLlcMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001677576iipr:ShParentInc.ParallelMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001677576iipr:PharmaCannLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001677576iipr:GreenThumbIndustriesInc.Memberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001677576iipr:CuraleafHoldingsIncMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001677576iipr:AscendWellnessHoldingsLlcMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-09-300001677576iipr:TrulieveCannabisCorpMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001677576iipr:ShParentInc.ParallelMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001677576iipr:PharmaCannLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001677576iipr:GreenThumbIndustriesInc.Memberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001677576iipr:AscendWellnessHoldingsLlcMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-300001677576iipr:TrulieveCannabisCorpMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001677576iipr:ShParentInc.ParallelMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001677576iipr:PharmaCannLLCMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001677576iipr:KingsGardenInc.Memberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001677576iipr:AscendWellnessHoldingsLlcMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-09-300001677576iipr:KingsGardenLawsuitMember2023-08-040001677576iipr:KingsGardenLawsuitMember2022-07-310001677576iipr:KingsGardenLawsuitMember2023-09-300001677576srt:MaximumMemberiipr:AtMarketOfferingsMember2023-01-310001677576iipr:MeasurementInputExpectedMarketYieldMember2023-09-300001677576iipr:MeasurementInputExpectedMarketYieldMember2022-12-310001677576iipr:GreenPeakMichiganLitigationMember2023-09-300001677576iipr:KingsGardenLawsuitMember2023-08-042023-08-040001677576iipr:FourFrontVenturesCorp.Member2023-07-012023-07-310001677576iipr:TemescalMaMemberiipr:MassachusettsPropertiesMember2023-03-012023-03-310001677576iipr:CalyxPeakMoMemberiipr:MissouriPropertyMember2023-01-012023-01-310001677576iipr:HolisticIndustriesInc.Memberiipr:MichiganPropertiesMember2023-01-012023-01-310001677576iipr:HolisticIndustriesInc.Memberiipr:CaliforniaPropertyMember2023-01-012023-01-310001677576iipr:HolisticIndustriesInc.Memberiipr:CaliforniaMarylandMassachusettsMichiganPennsylvaniaPropertiesMember2023-01-012023-01-310001677576us-gaap:UnsecuredDebtMember2021-05-250001677576us-gaap:LeasesAcquiredInPlaceMember2023-09-300001677576srt:MinimumMemberus-gaap:UnsecuredDebtMember2021-05-252021-05-250001677576srt:MaximumMemberus-gaap:UnsecuredDebtMember2021-05-252021-05-250001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMember2023-01-012023-03-3100016775762022-12-3100016775762021-06-300001677576iipr:CannabisCultivationAndProcessingFacilityCaliforniaMember2023-02-280001677576stpr:NYiipr:NetRealEstateHeldForInvestmentMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300001677576iipr:NetRealEstateHeldForInvestmentMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-09-300001677576iipr:NetRealEstateHeldForInvestmentMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-3100016775762023-09-300001677576us-gaap:UnsecuredDebtMember2023-07-012023-09-300001677576us-gaap:SeniorNotesMember2023-07-012023-09-300001677576us-gaap:UnsecuredDebtMember2023-01-012023-09-300001677576us-gaap:SeniorNotesMember2023-01-012023-09-300001677576us-gaap:UnsecuredDebtMember2022-07-012022-09-300001677576us-gaap:SeniorNotesMember2022-07-012022-09-300001677576us-gaap:UnsecuredDebtMember2022-01-012022-09-300001677576us-gaap:SeniorNotesMember2022-01-012022-09-300001677576iipr:BoltonfieldStreetMember2023-09-300001677576iipr:MedicalInvestorHoldingsLlcVerticalMemberiipr:CaliforniaPropertyMember2023-09-3000016775762022-01-012022-09-3000016775762023-07-012023-09-300001677576us-gaap:SeriesAPreferredStockMember2023-01-012023-09-300001677576us-gaap:CommonStockMember2023-01-012023-09-3000016775762023-11-0200016775762023-01-012023-09-30iipr:segmentxbrli:sharesiso4217:USDxbrli:pureiipr:propertyiipr:tenantiipr:itemiipr:leaseiso4217:USDxbrli:sharesutr:sqft

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ TO _________

Commission file number: 001-37949

Innovative Industrial Properties, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Maryland

81-2963381

(State or other jurisdiction of incorporation or

(I.R.S. Employer Identification No.) 

organization) 

1389 Center Drive, Suite 200

Park City, UT 84098

(858) 997-3332

(Address of principal executive offices)

(Registrant’s telephone number)

Not Applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbols (s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

IIPR

 

New York Stock Exchange

Series A Preferred Stock, par value $0.001 per share

 

IIPR-PA

 

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes      No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

 

 

 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 2, 2023 there were 28,039,830 shares of common stock outstanding.

INNOVATIVE INDUSTRIAL PROPERTIES, INC.

FORM 10-Q – QUARTERLY REPORT

SEPTEMBER 30, 2023

TABLE OF CONTENTS

PART I

Item 1.

Financial Statements (Unaudited)

3

 

Condensed Consolidated Balance Sheets

3

 

Condensed Consolidated Statements of Income

4

 

Condensed Consolidated Statements of Stockholders’ Equity

5

 

Condensed Consolidated Statements of Cash Flows

6

 

Notes to the Condensed Consolidated Financial Statements

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

26

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

40

Item 4.

Controls and Procedures

40

PART II

Item 1.

Legal Proceedings

42

Item 1A.

Risk Factors

42

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

43

Item 4.

Mine Safety Disclosures

43

Item 5.

Other Information

43

Item 6.

Exhibits

44

2

PART I

ITEM 1. FINANCIAL STATEMENTS

Innovative Industrial Properties, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share and per share amounts)

    

September 30, 

    

December 31, 

Assets

2023

2022

Real estate, at cost:

Land

$

142,524

$

139,953

Buildings and improvements

 

2,100,662

 

2,010,628

Construction in progress

 

107,772

 

54,106

Total real estate, at cost

 

2,350,958

 

2,204,687

Less accumulated depreciation

 

(186,121)

 

(138,405)

Net real estate held for investment

 

2,164,837

 

2,066,282

Construction loan receivable

21,556

18,021

Cash and cash equivalents

 

117,034

 

87,122

Restricted cash

1,450

1,450

Investments

 

41,885

 

200,935

Right of use office lease asset

1,453

1,739

In-place lease intangible assets, net

8,460

9,105

Other assets, net

 

32,748

 

30,182

Total assets

$

2,389,423

$

2,414,836

Liabilities and stockholders’ equity

Liabilities:

Exchangeable Senior Notes, net

$

4,423

$

6,380

Notes due 2026, net

296,107

295,115

Building improvements and construction funding payable

12,724

29,376

Accounts payable and accrued expenses

 

13,631

 

10,615

Dividends payable

 

51,079

 

50,840

Rent received in advance and tenant security deposits

 

59,120

 

58,716

Other liabilities

 

3,670

 

1,901

Total liabilities

 

440,754

 

452,943

Commitments and contingencies (Notes 6 and 11)

 

  

 

  

Stockholders’ equity:

 

  

 

  

Preferred stock, par value $0.001 per share, 50,000,000 shares authorized: 9.00% Series A cumulative redeemable preferred stock, $15,000 liquidation preference ($25.00 per share), 600,000 shares issued and outstanding at September 30, 2023 and December 31, 2022

 

14,009

 

14,009

Common stock, par value $0.001 per share, 50,000,000 shares authorized: 28,039,830 and 27,972,830 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

 

28

 

28

Additional paid-in capital

 

2,081,291

 

2,065,248

Dividends in excess of earnings

 

(146,659)

 

(117,392)

Total stockholders’ equity

 

1,948,669

 

1,961,893

Total liabilities and stockholders’ equity

$

2,389,423

$

2,414,836

See the accompanying notes to the condensed consolidated financial statements.

3

Innovative Industrial Properties, Inc.

Condensed Consolidated Statements of Income

(Unaudited)

(In thousands, except share and per share amounts)

    

For the Three Months Ended

    

For the Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Revenues:

  

  

  

 

  

Rental (including tenant reimbursements)

$

77,286

$

70,345

$

228,734

$

204,454

Other

 

540

 

538

 

1,616

 

1,444

Total revenues

 

77,826

 

70,883

 

230,350

 

205,898

Expenses:

Property expenses

 

6,318

2,823

17,700

7,232

General and administrative expense

 

10,981

10,804

31,924

28,288

Depreciation and amortization expense

 

16,678

15,900

50,096

45,001

Total expenses

 

33,977

 

29,527

 

99,720

 

80,521

Income from operations

 

43,849

 

41,356

 

130,630

 

125,377

Interest and other income

 

2,075

773

6,625

1,411

Interest expense

(4,330)

(4,513)

(13,322)

(13,783)

Gain (loss) on exchange of Exchangeable Senior Notes

 

22

(125)

Net income

 

41,594

 

37,616

 

123,955

 

112,880

Preferred stock dividends

 

(338)

(338)

(1,014)

(1,014)

Net income attributable to common stockholders

$

41,256

$

37,278

$

122,941

$

111,866

Net income attributable to common stockholders per share (Note 8):

 

 

 

 

Basic

$

1.46

$

1.33

$

4.36

$

4.10

Diluted

$

1.45

$

1.32

$

4.32

$

4.06

Weighted-average shares outstanding:

 

 

 

 

Basic

 

27,983,004

 

27,938,568

 

27,971,544

 

27,144,953

Diluted

 

28,265,605

 

28,157,934

 

28,248,054

 

27,496,151

See accompanying notes to the condensed consolidated financial statements.

4

Innovative Industrial Properties, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

(In thousands, except share amounts)

Three Months Ended September 30, 2023

Three Months Ended September 30, 2022

Series A

Shares of

Additional

Dividends in

Total

Series A

Shares of

Additional

Dividends in

Total

Preferred

Common

Common

Paid-In-

Excess of

Stockholders’

Preferred

Common

Common

Paid-In

Excess of

Stockholders’

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Equity

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Equity

Balances at beginning of period

$

14,009

 

28,040,054

$

28

$

2,076,357

$

(137,174)

$

1,953,220

$

14,009

27,973,429

$

28

$

2,056,568

$

(94,833)

$

1,975,772

Net income

41,594

41,594

37,616

37,616

Forfeitures of unvested restricted stock, net of issuance

(224)

Exchange of Exchangeable Senior Notes

265

17

17

Payment of common stock offering costs

(28)

(28)

Preferred stock dividends

(338)

(338)

(338)

(338)

Common stock dividends

(50,741)

(50,741)

(50,503)

(50,503)

Stock-based compensation

4,934

4,934

4,379

4,379

Balances at end of period

$

14,009

 

28,039,830

$

28

$

2,081,291

$

(146,659)

$

1,948,669

$

14,009

27,973,694

$

28

$

2,060,936

$

(108,058)

$

1,966,915

Nine Months Ended September 30, 2023

Nine Months Ended September 30, 2022

Series A

Shares of

Additional

Dividends in

Total

Series A

Shares of

Additional

Dividends in

Total

Preferred

Common

Common

Paid-In

Excess of

Stockholders’

Preferred

Common

Common

Paid-In

Excess of

Stockholders’

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Equity

    

Stock

    

Stock

    

Stock

    

Capital

    

Earnings

    

Equity

Balances at beginning of period

$

14,009

 

27,972,830

$

28

$

2,065,248

$

(117,392)

$

1,961,893

$

14,009

25,612,541

$

26

$

1,672,882

$

(75,218)

$

1,611,699

Adjustment to opening balance upon adoption of ASU 2020-06 (Note 2)

(1,340)

728

(612)

Net income

123,955

123,955

112,880

112,880

Issuance of unvested restricted stock, net of forfeitures

34,800

(568)

(568)

15,174

(2,441)

(2,441)

Exchange of Exchangeable Senior Notes

32,200

1,964

1,964

413,166

26,682

26,682

Net proceeds from sale of common stock

1,932,813

2

351,958

351,960

Preferred stock dividends

(1,014)

(1,014)

(1,014)

(1,014)

Common stock dividends

(152,208)

(152,208)

(145,434)

(145,434)

Stock-based compensation

14,647

14,647

13,195

13,195

Balances at end of period

$

14,009

 

28,039,830

$

28

$

2,081,291

$

(146,659)

$

1,948,669

$

14,009

27,973,694

$

28

$

2,060,936

$

(108,058)

$

1,966,915

See accompanying notes to the condensed consolidated financial statements.

5

Innovative Industrial Properties, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

For the Nine Months Ended

September 30, 

    

2023

    

2022

Cash flows from operating activities

Net income

$

123,955

$

112,880

Adjustments to reconcile net income to net cash provided by operating activities

Depreciation and amortization

 

50,096

 

45,001

Loss (gain) on exchange of Exchangeable Senior Notes

(22)

125

Other non-cash adjustments

83

158

Stock-based compensation

 

14,647

 

13,195

Amortization of discounts on investments

 

(2,894)

 

(1,068)

Amortization of debt discount and issuance costs

 

1,021

 

1,017

Changes in assets and liabilities

Other assets, net

 

(2,905)

 

(6,555)

Accounts payable, accrued expenses and other liabilities

 

5,077

 

5,339

Rent received in advance and tenant security deposits

 

404

 

8,683

Net cash provided by (used in) operating activities

 

189,462

 

178,775

Cash flows from investing activities

Purchases of investments in real estate

 

(34,906)

 

(150,090)

Funding of draws for improvements and construction

 

(129,502)

 

(316,469)

Funding of construction loan and other investments

(3,535)

(21,360)

Deposits in escrow for acquisitions

 

 

(100)

Purchases of short-term investments

 

(91,772)

 

(278,717)

Maturities of short-term investments

 

253,716

 

365,000

Net cash provided by (used in) investing activities

 

(5,999)

 

(401,736)

Cash flows from financing activities

Issuance of common stock, net of offering costs

 

 

351,960

Dividends paid to common stockholders

 

(151,969)

 

(133,440)

Dividends paid to preferred stockholders

 

(1,014)

 

(1,014)

Taxes paid related to net share settlement of equity awards

 

(568)

 

(2,441)

Net cash provided by (used in) financing activities

 

(153,551)

 

215,065

Net increase (decrease) in cash, cash equivalents and restricted cash

 

29,912

 

(7,896)

Cash, cash equivalents and restricted cash, beginning of period

 

88,572

 

86,419

Cash, cash equivalents and restricted cash, end of period

$

118,484

$

78,523

Supplemental disclosure of cash flow information:

Cash paid during the period for interest, net of interest capitalized

$

8,253

$

8,997

Supplemental disclosure of non-cash investing and financing activities:

Accrual for current-period additions to real estate

$

10,520

$

35,195

Deposits applied for acquisitions

250

25

Accrual for common and preferred stock dividends declared

 

51,079

 

50,841

Exchange of Exchangeable Senior Notes for common stock

1,964

26,682

Operating lease liability for obtaining right of use asset

1,017

See accompanying notes to the condensed consolidated financial statements.

6

Innovative Industrial Properties, Inc.

Notes to the Condensed Consolidated Financial Statements

September 30, 2023

(Unaudited)

1. Organization

As used herein, the terms “we”, “us”, “our” or the “Company” refer to Innovative Industrial Properties, Inc., a Maryland corporation, and any of our subsidiaries, including IIP Operating Partnership, LP, a Delaware limited partnership (our “Operating Partnership”).

We are an internally-managed real estate investment trust (“REIT”) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. We have acquired and intend to continue to acquire our properties through sale-leaseback transactions and third-party purchases. We have leased and expect to continue to lease our properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, real estate taxes and insurance.

We were incorporated in Maryland on June 15, 2016. We conduct our business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which our properties are owned by our Operating Partnership, directly or through subsidiaries. We are the sole general partner of our Operating Partnership and own, directly or through subsidiaries, 100% of the limited partnership interests in our Operating Partnership.

2. Summary of Significant Accounting Policies and Procedures

Basis of Presentation. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm’s review.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2023.

Reclassification. We have combined $705.3 million of “Tenant improvements” as of December 31, 2022, which represented building improvements in which we are considered to be the accounting owner, with “Building and improvements” in our consolidated balance sheets to conform to the current period presentation as of September 30, 2023. There was no change to “Total real estate, at cost”.

Federal Income Taxes. We believe that we have operated our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Under the REIT operating structure, we are permitted to deduct dividends paid to our stockholders in determining our taxable income. Assuming our dividends equal or exceed our taxable net income, we generally will not be required to pay federal corporate income taxes on such income. The income taxes recorded on our condensed consolidated statements of income represent amounts paid for city and state income and franchise taxes and are included in general and administrative expenses in the accompanying condensed consolidated statements of income.

Use of Estimates. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions. The most significant estimates and assumptions made include determination of lease accounting, fair value of acquisition of real estate properties and valuation of stock-based compensation.

7

Reportable Segment. We are engaged in the business of providing real estate for the regulated cannabis industry. Our properties are similar in that they are leased to the state-licensed operators on a long-term triple-net basis, consist of improvements that are reusable and have similar economic characteristics. Our chief operating decision maker reviews financial information for our entire consolidated operations when making decisions related to assessing our operating performance. We have aggregated the properties into one reportable segment as the properties share similar long-term economic characteristics and have other similarities, including the fact that they are operated using consistent business strategies. The financial information disclosed herein represents all of the financial information related to our one reportable segment.

Acquisition of Real Estate Properties. Our investment in real estate is recorded at historical cost, less accumulated depreciation. Upon acquisition of a property, the tangible and intangible assets acquired and liabilities assumed are initially measured based upon their relative fair values. We estimate the fair value of land by reviewing comparable sales within the same submarket and/or region. We estimate the fair value of buildings and improvements as if the property was vacant, taking into consideration current replacement costs and other relevant market rate information and may engage third-party valuation specialists. Acquisition costs are capitalized as incurred. All of our acquisitions to date were recorded as asset acquisitions.

The fair value of acquired in-place leases is derived based on our assessment of estimated lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased. The amounts recorded for acquired in-place leases are reflected as in-place lease intangible assets, net on our condensed consolidated balance sheets and are amortized on a straight-line basis as a component of depreciation and amortization expense over the remaining term of the applicable leases.

The fair value of the above-market component of an acquired in-place operating lease is based upon the present value (calculated using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining non-cancellable lease term and (ii) our estimate of the rents that would be paid using fair market rental rates and rent escalations at the date of acquisition measured over the remaining non-cancellable term of the lease. The amount recorded for one above-market operating lease is included in other assets, net on our condensed consolidated balance sheets and is amortized on a straight-line basis as a reduction of rental revenues over the remaining term of the applicable lease.

Sale of Real Estate. When a real estate asset is sold, we evaluate the provisions of ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”) to determine whether the asset is within the scope of ASC 610-20, including an evaluation of whether the asset being sold is a nonfinancial asset and whether the buyer has gained control of an asset within the scope of ASC 610-20. In assessing whether the buyer has gained control of the asset, we must determine whether the contract criteria in ASC 606, Revenue from Contracts with Customers (Topic 606) have been met, including 1) the parties to the contract have approved the contract and the contract has commercial substance, 2) we can identify each party’s rights regarding the asset to be transferred, 3) we can identify the payment terms for the asset to be transferred, and 4) it is probable that we will collect substantially all of the consideration to which we will be entitled in exchange for the asset to be transferred. If all of the contract criteria have been met, the carrying amount of the applicable asset is derecognized with a corresponding gain or loss from the sale recognized in our consolidated statements of income. If the contract criteria are not all met, the asset transferred is not derecognized and we continue to report the asset in our condensed consolidated balance sheet. See Note 6 “Investments in Real Estate - Property Disposition” for further information.

Cost Capitalization and Depreciation. We capitalize costs associated with development and redevelopment activities and improvements when we are considered to be the accounting owner of the resulting assets. The development and redevelopment activities may be funded by us pursuant to the lease. We are generally considered the accounting owner for such improvements that are attached to or built into the premises, which are required under the lease to be surrendered to us upon the expiration or earlier termination of the lease. Typically, such improvements include, but are not limited to, ground up development, and enhanced HVAC, plumbing, electrical and other building systems.

Amounts capitalized are depreciated over estimated useful lives determined by management. We depreciate buildings and improvements based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. For the three months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $16.5 million and $15.7 million, respectively, and for the nine months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $49.5 million and $44.4 million, respectively. Depreciation expense relating to our real estate held for investment is included in depreciation and amortization expense in our condensed consolidated statements of income. We depreciate office equipment and furniture and fixtures over estimated useful lives ranging from three to seven years. We depreciate the leasehold improvements at our corporate office over the shorter of the estimated useful lives or the remaining lease term. Depreciation expense relating to our corporate assets is included in general and administrative expense in our condensed consolidated statements of income.

8

Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. Project costs that are clearly associated with the acquisition and development or redevelopment of a real estate project, for which we are the accounting owner, are capitalized as a cost of that project. Expenditures that meet one or more of the following criteria generally qualify for capitalization:

the expenditure provides benefit in future periods; and
the expenditure extends the useful life of the asset beyond our original estimates.

We define redevelopment properties as existing properties for which we expect to spend significant development and construction costs that are not reimbursements to tenants for improvements at the properties. When existing properties are determined to be redevelopment properties, the net carrying value of the buildings and improvements are transferred to construction in progress while the redevelopment activities are in process. During the nine months ended September 30, 2023, we reclassified the net carrying value of the buildings and improvements totaling approximately $51.2 million to construction in progress relating to an existing property that was placed into redevelopment. Costs capitalized to construction in progress related to redevelopment properties are transferred to buildings and improvements at historical cost of the properties as the redevelopment project or phases of projects are placed in service.

Provision for Impairment. On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties.

Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the nine months ended September 30, 2023 and 2022.

Revenue Recognition. Our leases are triple-net leases, an arrangement under which the tenant maintains the property while paying us rent. We account for our current leases as operating leases and record revenue for each of our properties on a cash basis due to the uncertain regulatory environment in the United States pertaining to the regulated cannabis industry, the limited operating history of certain tenants and the resulting uncertainty of collectability of lease payments from each tenant over the duration of the lease term. Contractually obligated reimbursements from tenants for recoverable real estate taxes, insurance and operating expenses are included in rental revenues in the period when such costs are reimbursed by the tenants. Contractually obligated real estate taxes that are paid directly by the tenant to the tax authorities are not reflected in our condensed consolidated financial statements.

For the three months ended September 30, 2023, rental revenue recognized included the application of approximately $2.2 million of security deposits for rent with three tenants in connection with lease amendments. For the nine months ended September 30, 2023, rental revenue recognized included the application of approximately $3.1 million of security deposits applied for rent with two tenants who were in default under their respective lease agreements and approximately $4.9 million of security deposits for rent with three tenants in connection with lease amendments.

Construction Loan. In June 2021, we executed a construction loan agreement with a developer, pursuant to which we agreed to lend up to $18.5 million for the development of a regulated cannabis cultivation and processing facility in California. We have an option to purchase the property, and may execute a negotiated lease with an affiliate of the developer or with another third party, if we determine to exercise our purchase option. In February 2023, we amended the construction loan to provide for, among other things: (1) the additional capital commitment of the borrower into the project of $1.0 million; (2) our agreement to fund an additional $4.5 million into the project; (3) an increase in the interest rate effective April 1, 2023; (4) an extension of the loan term to December 31, 2023; and (5) the provision of additional collateral from the borrower for the loan. Interest on the loan continued to accrue through March 31, 2023, with monthly payment of interest having commenced April 1, 2023. As of September 30, 2023, we had funded approximately $21.6 million of the $23.0 million total commitment.

9

Cash and Cash Equivalents. We consider all highly-liquid investments with original maturities of three months or less to be cash equivalents, which is comprised of short-term money market funds, obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of less than or equal to three months.

Restricted Cash. Restricted cash relates to cash held in escrow accounts for future draws for improvements for tenants in accordance with certain lease agreements.

Investments. Investments consist of obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of greater than three months. Investments are classified as held-to-maturity and stated at amortized cost.

Exchangeable Notes. In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models, and convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature, will no longer be allocated between debt and equity components. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. We adopted ASU 2020-06 on January 1, 2022 and recognized a cumulative-effect adjustment of approximately $728,000 to the opening balance of retained earnings and derecognized approximately $1.3 million of the remaining equity component relating to the outstanding principal balance of our Exchangeable Senior Notes (as defined below) at the date of adoption.

Deferred Financing Costs. The deferred financing costs that are included as a reduction in the net book value of the related liability on our condensed consolidated balance sheets reflect issuance and other costs related to our debt obligations. These costs are amortized as non-cash interest expense using the effective interest method over the life of the related obligations.

Stock-Based Compensation. Stock-based compensation for equity awards is based on the grant date fair value of the equity awards and is recognized over the requisite service or performance period. If awards are forfeited prior to vesting, we reverse any previously recognized expense related to such awards in the period during which the forfeiture occurs and reclassify any non-forfeitable dividends and dividend equivalents previously paid on these awards from retained earnings to compensation expense. Forfeitures are recognized as incurred. Certain equity awards are subject to vesting based upon the satisfaction of various market conditions. Forfeiture of share awards with market-based restrictions does not result in a reversal of previously recognized share-based compensation expense.

Lease Accounting. We elected the practical expedient not to separate certain non-lease components from the lease component if the timing and pattern of transfer are the same for the non-lease component and associated lease component, and the lease component would be classified as an operating lease if accounted for separately. We also elected the short-term lease exception for lessees for leases that are less than 12 months. As lessee, we recognized a liability to account for our future obligations and a corresponding right-of-use asset related to our corporate office lease. The lease liability was initially measured based on the present value of the future lease payments discounted using the estimated incremental borrowing rate of 7.25%, which was the interest rate that we estimate we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. In November 2021, we amended the lease to extend the term from April 2025 to January 2027 in connection with an expansion of the leased space which did not commence until February 2022. As a result of the lease amendment, we re-measured the lease liability relating to the existing lease space and measured the lease liability to the expansion space based on the present value of the respective future lease payments (excluding the extension option that we are not reasonably certain to exercise), discounted using the estimated incremental borrowing rate of 5.5%, which was the interest rate at that time that we estimate we would have had to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period.

The right-of-use asset is measured based on the corresponding lease liability. We did not incur any initial direct leasing costs or exchange any other consideration with the landlord prior to the commencement of the lease. Subsequently, the right-of-use asset is amortized on a straight-line basis during the lease term. For both the three months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $121,000, and for the nine months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $364,000 and $344,000, respectively, which are included in general and administrative expenses in our condensed consolidated statements of income. For the nine months ended September 30, 2023 and 2022, amounts paid and classified as operating activities in our condensed consolidated statements of cash flows for the office lease were approximately $372,000 and $282,000, respectively.

10

As lessor, for each of our real estate transactions involving the leaseback of the related property to the seller or affiliates of the seller, we determine whether these transactions qualify as sale and leaseback transactions under the accounting guidance. For these transactions, we consider various inputs and assumptions including, but not necessarily limited to, lease terms, renewal options, discount rates, and other rights and provisions in the purchase and sale agreement, lease and other documentation to determine whether control has been transferred to the Company or remains with the lessee. A transaction involving a sale leaseback will be treated as a purchase of a real estate property if it is considered to transfer control of the underlying asset from the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control and will be classified as a sales-type lease if control of the underlying asset is transferred to the lessee. Otherwise, the lease is treated as an operating lease. These criteria also include estimates and assumptions regarding the fair value of the leased facilities, minimum lease payments, the economic useful life of the facilities, the existence of a purchase option, and certain other terms in the lease agreements. The lease accounting guidance requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant’s option. Substantially all of our leases continue to be classified as operating leases and we continue to record revenue for each of our properties on a cash basis. Our tenant reimbursable revenue and property expenses continue to be presented on a gross basis as rental revenues and as property expenses, respectively, on our condensed consolidated statements of income. Property taxes paid directly by the lessee to a third party continue to be excluded from our condensed consolidated financial statements.

Lease amendments are evaluated to determine if the modification grants the lessee an additional right-of-use not included in the original lease and if the lease payments increase commensurate with the standalone price of the additional right-of-use, adjusted for the circumstances of the particular contract. If both conditions are present, the lease amendment is accounted for as a new lease that is separate from the original lease.

Our leases generally contain options to extend the lease terms at the prevailing market rate or at the expiring rental rate at the time of expiration. Certain of our leases provide the lessee with a right of first refusal or right of first offer in the event we market the leased property for sale.

Concentration of Credit Risk. As of September 30, 2023, we owned 108 properties located in 19 states and leased to 29 tenants. The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates.

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2023 and 2022, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

15

%

Ascend Wellness Holdings, Inc. ("Ascend")

4

10

%

Green Thumb Industries, Inc. ("GTI")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

 

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

GTI

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

11

For the Three Months Ended

September 30, 2022

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

14

%

Parallel

4

10

%

Ascend

4

10

%

GTI

3

8

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2022

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

14

%

Parallel

4

10

%

Ascend

 

4

9

%

Kings Garden Inc. ("Kings Garden")(2)

6

7

%

Trulieve

 

6

7

%

(1)Commencing in November 2022, Parallel defaulted on its obligations to pay rent at one of our Pennsylvania properties. In February 2023, Parallel defaulted on its obligations to pay rent at one of our Texas properties, and we regained possession of that property in March 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information. Excluding security deposits applied for payment of rent for Parallel at one property in Pennsylvania and one property in Texas of approximately $1.8 million and $395,000, respectively, Parallel would have represented 6% of our total rental revenues for the nine months ended September 30, 2023.
(2)In July 2022, Kings Garden defaulted on its obligations to pay rent at all of the properties it leases with us, and pursuant to a confidential, conditional settlement agreement executed on September 11, 2022 between us and Kings Garden, we terminated the leases for two properties and regained possession of those properties, which continued to be in development or redevelopment as of September 30, 2023. Kings Garden paid the stipulated rent during its period of occupancy for the remaining four properties through September 20, 2023, and we regained possession of those properties in September 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

As of September 30, 2023, our largest property was located in New York and accounted for approximately 5.4% of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment as of September 30, 2023. As of December 31, 2022, none of our properties individually represented more than 5% of our net real estate held for investment.

We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.

3. Common Stock

In January 2023, we terminated the previously existing “at-the-market” offering program and entered into new equity distribution agreements with four sales agents, pursuant to which we may offer and sell from time to time through an “at-the-market” offering program (the “ATM Program”) up to $500.0 million in shares of our common stock. As of September 30, 2023, we had not sold any shares of common stock under the ATM Program.

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchange by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes.

12

4. Preferred Stock

As of September 30, 2023, the Company was authorized to issue up to 50,000,000 shares of preferred stock, par value $0.001 per share, and there were 600,000 shares issued and outstanding of 9.00% Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”). The Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus all accrued and unpaid dividends on such Series A Preferred Stock up to, but excluding the redemption date. Holders of the Series A Preferred Stock generally have no voting rights except for limited voting rights if the Company fails to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.

5. Dividends

The following table describes the dividends declared by the Company during the nine months ended September 30, 2023:

    

    

Amount

    

    

Dividend

    

Dividend

Declaration Date

Security Class

Per Share

Period Covered

Paid Date

Amount

 

(In thousands)

March 15, 2023

Common stock

$

1.80

January 1, 2023 to March 31, 2023

April 14, 2023

$

50,725

March 15, 2023

Series A preferred stock

$

0.5625

January 15, 2023 to April 14, 2023

April 14, 2023

$

338

June 15, 2023

Common stock

$

1.80

April 1, 2023 to June 30, 2023

July 14, 2023

$

50,742

June 15, 2023

Series A preferred stock

$

0.5625

April 15, 2023 to July 14, 2023

July 14, 2023

$

338

September 15, 2023

Common stock

$

1.80

July 1, 2023 to September 30, 2023

October 13, 2023

$

50,742

September 15, 2023

Series A preferred stock

$

0.5625

July 15, 2023 to October 14, 2023

October 13, 2023

$

338

6. Investments in Real Estate

Acquisitions

The Company acquired the following properties during the nine months ended September 30, 2023 (dollars in thousands):

Rentable 

 Square

 Purchase

Transaction

Property

    

Market

    

Closing Date

    

Feet(1)

    

 Price

    

 Costs

    

Total

Susquehanna Street

 

Pennsylvania

February 15, 2023

 

58,000

$

15,000

$

26

$

15,026

Boltonfield Street

 

Ohio

March 3, 2023

 

157,000

 

20,100

 

29

 

20,129

(2)

Total

 

215,000

$

35,100

$

55

$

35,155

(3)

(1)Includes expected rentable square feet at completion of construction of certain properties.
(2)The tenant is expected to complete improvements at the property, for which we agreed to provide funding of up to $21.9 million.
(3)Approximately $2.6 million was allocated to land and approximately $32.6 million was allocated to building and improvements.

Acquired In-Place Lease Intangible Assets

In-place lease intangible assets and related accumulated amortization as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

In-place lease intangible assets

$

9,979

$

9,979

Accumulated amortization

 

 

(1,519)

 

(874)

In-place lease intangible assets, net

$

8,460

$

9,105

Amortization of in-place lease intangible assets classified in depreciation and amortization expense in our condensed consolidated statements of income was approximately $215,000 for both the three months ended September 30, 2023 and 2022, respectively, and was approximately $645,000 and $626,000 for the nine months ended September 30, 2023 and 2022, respectively. The weighted-average remaining amortization period of the acquired in-place leases was approximately 9.8 years, and the estimated annual amortization of the value of the acquired in-place leases as of September 30, 2023 is as follows (in thousands):

13

Year

    

Amount

2023 (three months ending December 31)

$

215

2024

 

860

2025

 

860

2026

 

860

2027

 

860

Thereafter

 

4,805

Total

$

8,460

Above-Market Lease

The above-market lease and related accumulated amortization included in other assets, net on our condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

Above-market lease

$

1,054

$

1,054

Accumulated amortization

 

 

(164)

 

(95)

Above-market lease, net

$

890

$

959

The above-market lease is amortized on a straight-line basis as a reduction to rental revenues over the remaining lease term of approximately 9.5 years. For the three months ended September 30, 2023 and 2022, the amortization of the above-market lease was approximately $23,000 in each period. For the nine months ended September 30, 2023 and 2022, the amortization of the above-market lease was approximately $69,000 in each period.

Additional Improvement Allowances

In February 2023, we amended our lease with a subsidiary of Ascend at one of our New Jersey properties, increasing the improvement allowance under the lease by $15.0 million to a total of approximately $19.6 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with Ascend to include cross-default provisions applicable to each lease.

In February 2023, we amended our lease and development agreement with PharmaCann at one of our New York properties, increasing the construction funding by $15.0 million to a total of approximately $93.5 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with PharmaCann to include cross-default provisions applicable to each lease.

In February 2023, we amended our lease with a subsidiary of Goodness Growth Holdings Inc. (“Goodness Growth”) at one of our New York properties, increasing the improvement allowance under the lease by $4.0 million to a total of approximately $53.4 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with Goodness Growth to include cross-default provisions applicable to each lease.

Lease Amendments

In January 2023, we entered into lease amendments with Holistic Industries Inc. (“Holistic”) at our properties located in California, Maryland, Massachusetts, Michigan and Pennsylvania, which (1) included cross-default provisions applicable to each lease; (2) extended the term of each lease; and (3) provided that 100% of the base rent shall be applied from the security deposits held by us for (a) the nine months ending September 30, 2023 with respect to the Michigan property and (b) the eight months ending September 30, 2023 with respect to the California property, with pro rata monthly payback of the security deposits over the twelve-month period starting January 2024.

In January 2023, we executed a lease amendment with Calyx Peak, Inc. at our Missouri property, which (1) extended the term of the lease; and (2) provided for 100% base rent deferral through March 31, 2023, with pro rata monthly payback of the deferred rent over the twelve-month period starting April 2023.

In March 2023, we executed a lease amendment with Temescal Wellness of Massachusetts, LLC (“Temescal”) at our Massachusetts property, which (1) provided for temporary reduced base rent from April 2023 through January 2024 to be partially

14

paid through application of security deposits, with pro rata payback of those security deposits over twelve months starting in February 2024; (2) extended the lease term; and (3) increased base rent for the remainder of the term of the lease.

In July 2023, we amended our lease with a subsidiary of 4Front Ventures Corp. (“4Front”) at one of our Illinois properties, pursuant to which, among other things, we agreed to apply a portion of the security deposit that we hold under the lease to pay one-half of the monthly installments of base rent due from the tenant, commencing on August 1, 2023 and continuing through November 30, 2023, which the tenant is then required to repay over a 12-month period commencing on January 1, 2024.

New Lease

In June 2023, we executed a new long-term lease with a tenant at our property located at 68860 Perez Road in Cathedral City, California that was previously leased to Kings Garden, which is under construction as of September 30, 2023.

Capitalized Costs

During the nine months ended September 30, 2023, we capitalized costs of approximately $111.1 million and funded approximately $129.5 million relating to improvements and construction activities at our properties.

Property Disposition

In March 2023, we sold the portfolio of four properties in California previously leased to affiliates of Medical Investor Holdings, LLC (“Vertical”) for $16.2 million (excluding transaction costs) and provided a secured loan for $16.1 million to the buyer of the properties. The loan matures on February 29, 2028 with two options to extend the maturity for twelve months, conditional in each instance on the payment of an extension fee and at least $500,000 of the principal balance. The loan is interest only and payments are payable monthly in advance. The transaction did not qualify for recognition as a completed sale under GAAP since not all of the criteria were met. Accordingly, we have not derecognized the assets transferred on our condensed consolidated balance sheets. All consideration received, as well as any future payments, from the buyer will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until such time the criteria for recognition as a sale have been met. As of September 30, 2023, we received interest payments of approximately $939,000. In addition, as we have not met all of the held-for-sale criteria, land and building and improvements with a gross carrying value of approximately $3.4 million and approximately $13.9 million, respectively, and accumulated depreciation of approximately $1.5 million as of September 30, 2023, remain on the condensed consolidated balance sheet, and the buildings and improvements continue to be depreciated.

Future Contractual Minimum Rent

Future contractual minimum rent (including base rent and property management fees) under the operating leases as of September 30, 2023 for future periods is summarized as follows (in thousands):

Year

    

Contractual Minimum Rent

2023 (three months ending December 31)

$

71,899

2024

296,878

2025

 

305,612

2026

 

314,670

2027

 

324,001

Thereafter

 

4,167,626

Total

$

5,480,686

7. Debt

Exchangeable Senior Notes

As of September 30, 2023, our Operating Partnership had outstanding approximately $4.4 million principal amount of 3.75% Exchangeable Senior Notes due 2024 (the “Exchangeable Senior Notes”). The Exchangeable Senior Notes are senior unsecured obligations of our Operating Partnership, are fully and unconditionally guaranteed by us and our Operating Partnership’s subsidiaries and are exchangeable for cash, shares of our common stock, or a combination of cash and shares of our common stock, at our Operating Partnership’s option, at any time prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date. The exchange rate for the Exchangeable Senior Notes at September 30, 2023 was 17.06090 shares of our common stock per $1,000 principal amount of Notes and the exchange price at September 30, 2023 was approximately $58.61 per

15

share of our common stock. The exchange rate and exchange price are subject to adjustment in certain circumstances. The Exchangeable Senior Notes will pay interest semiannually at a rate of 3.75% per annum and will mature on February 21, 2024, unless earlier exchanged or repurchased in accordance with their terms. Our Operating Partnership will not have the right to redeem the Exchangeable Senior Notes prior to maturity, but may be required to repurchase the Exchangeable Senior Notes from holders under certain circumstances. At September 30, 2023, the if-exchanged value of the Exchangeable Senior Notes exceeded the principal amount by approximately $1.3 million.

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchanges by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes. For the nine months ended September 30, 2023, we recognized a gain on the exchange totaling approximately $22,000, resulting from the difference between the fair value and carrying value of the debt as of the date of the exchange. The issuance of the shares pursuant to the exchanges resulted in a net non-cash increase to our additional paid-in capital account of approximately $2.0 million for the nine months ended September 30, 2023.

During the three and nine months ended September 30, 2022, we issued 265 and 413,166 shares, respectively, of our common stock upon exchanges by holders of approximately $17,000 and $26.9 million, respectively, of outstanding principal amount of our Exchangeable Senior Notes. For the nine months ended September 30, 2022, we recognized a loss on the exchanges totaling approximately $125,000, resulting from the difference between the fair value and carrying value of the debt as of the date of the exchange. The issuance of the shares pursuant to the exchanges resulted in a non-cash increase to our additional paid-in capital account of approximately $17,000 and $26.7 million for the three and nine months ended September 30, 2022, respectively.

The following table details our interest expense related to the Exchangeable Senior Notes (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

Cash coupon

  

$

41

  

$

60

  

$

140

  

$

391

Amortization of issuance cost

  

9

  

12

  

29

  

83

Capitalized interest

(2)

(2)

Total interest expense

  

$

48

  

$

72

  

$

167

  

$

474

The following table details the carrying value of our Exchangeable Senior Notes (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

4,436

  

$

6,436

Unamortized issuance cost

  

 

(13)

  

(56)

Carrying value

  

$

4,423

  

$

6,380

Accrued interest payable for the Exchangeable Senior Notes as of September 30, 2023 and December 31, 2022 was approximately $7,000 and $70,000, respectively, and is included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

16

Notes due 2026

On May 25, 2021, our Operating Partnership issued $300.0 million aggregate principal amount of its 5.50% Senior Notes due 2026 (the “Notes due 2026”). The Notes due 2026 are senior unsecured obligations of our Operating Partnership, are fully and unconditionally guaranteed by us and our Operating Partnership’s subsidiaries and rank equally in right of payment with all of the Operating Partnership’s existing and future senior unsecured indebtedness, including the Exchangeable Senior Notes. However, the Notes due 2026 are effectively subordinated to any of the Company’s, the Operating Partnership’s and the Operating Partnership’s subsidiaries’ future secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes due 2026 will pay interest semiannually at a rate of 5.50% per year and will mature on May 25, 2026. The terms of the Notes due 2026 are governed by an indenture, dated May 25, 2021, among the Operating Partnership, as issuer, the Company and the Operating Partnership’s subsidiaries, as guarantors, Argent Institutional Trust Company, as trustee (as successor-in-interest to GLAS Trust Company LLC), and Securities Transfer Corporation, as registrar (as successor-in-interest to GLAS Trust Company LLC). The terms of the indenture provide that if the debt rating on the Notes due 2026 is downgraded or withdrawn entirely, interest on the Notes due 2026 will increase to a range of 6.0% to 6.5% based on such debt rating.

In connection with the issuance of the Notes due 2026, we recorded approximately $6.8 million of issuance costs, which are being amortized using the effective interest method and recognized as non-cash interest expense over the term of the Notes due 2026.

The following table details our interest expense related to the Notes due 2026 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

2022

    

2023

2022

Cash coupon

$

4,125

$

4,125

$

12,375

$

12,375

Amortization of issuance cost

 

335

316

992

934

Capitalized interest

 

(178)

(212)

Total interest expense

$

4,282

$

4,441

$

13,155

$

13,309

The following table details the carrying value of our Notes due 2026 (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

300,000

  

$

300,000

Unamortized issuance cost

  

 

(3,893)

  

(4,885)

Carrying value

  

$

296,107

  

$

295,115

The Operating Partnership may redeem some or all of the Notes due 2026 at its option at any time at the applicable redemption price. If the Notes due 2026 are redeemed prior to February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus a make-whole premium and accrued and unpaid interest thereon to, but excluding, the applicable redemption date. If the Notes due 2026 are redeemed on or after February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus accrued and unpaid interest thereon to, but excluding, the applicable redemption date.

The terms of the indenture for the Notes due 2026 require compliance with various financial covenants, including minimum level of debt service coverage and limits on the amount of total leverage and secured debt maintained by the Operating Partnership. Management believes that it was in compliance with those covenants as of September 30, 2023.

Accrued interest payable for the Notes due 2026 as of September 30, 2023 and December 31, 2022 was approximately $6.2 million and $2.1 million, respectively, and is included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

17

The following table summarizes the principal payments on our outstanding indebtedness as of September 30, 2023 (in thousands):

Payments Due

by Year

    

Amount

2023 (three months ending December 31)

$

2024

4,436

2025

2026

300,000

2027

Thereafter

Total

$

304,436

8. Net Income Per Share

Grants of restricted stock and restricted stock units (“RSUs”) of the Company in share-based payment transactions are considered participating securities prior to vesting and, therefore, are considered in computing basic earnings per share under the two-class method. The two-class method is an earnings allocation method for calculating earnings per share when a company’s capital structure includes either two or more classes of common stock or common stock and participating securities. Earnings per basic share under the two-class method is calculated based on dividends declared on common shares and other participating securities (“distributed earnings”) and the rights of participating securities in any undistributed earnings, which represents net income remaining after deduction of dividends accruing during the period. The undistributed earnings are allocated to all outstanding common shares and participating securities based on the relative percentage of each security to the total number of outstanding participating securities. Earnings per basic share represents the summation of the distributed and undistributed earnings per share class divided by the total number of shares.

Through September 30, 2023, all of the Company’s participating securities received dividends or dividend equivalents at an equal dividend rate per share or unit. As a result, distributions to participating securities for the three and nine months ended September 30, 2023 and 2022 have been included in net income attributable to common stockholders to calculate net income per basic and diluted share.

The 75,682 and 83,007 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the three and nine months ended September 30, 2023, respectively, and were included in the computation of diluted earnings per share. The 100,799 and 235,753 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the three and nine months ended September 30, 2022, respectively, and were included in the computation of diluted earnings per share.

For the three and nine months ended September 30, 2023 and 2022, the performance share units (“PSUs”) granted to certain employees were not included in dilutive securities as the performance thresholds for vesting of the PSUs were not met as measured as of the respective dates (see Note 10 for further discussion of PSUs).

18

Computations of net income per basic and diluted share (in thousands, except share and per share data) were as follows:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Net income

$

41,594

$

37,616

$

123,955

$

112,880

Preferred stock dividends

 

(338)

 

(338)

(1,014)

(1,014)

Distribution to participating securities

 

(372)

 

(213)

(1,106)

(622)

Net income attributable to common stockholders used to compute net income per share – basic

40,884

37,065

121,835

111,244

Dilutive effect of Exchangeable Senior Notes

50

72

169

474

Net income attributable to common stockholders used to compute net income per share – diluted

$

40,934

$

37,137

$

122,004

$

111,718

Weighted-average common shares outstanding:

Basic

 

27,983,004

 

27,938,568

27,971,544

27,144,953

Restricted stock and RSUs

206,919

118,567

193,503

115,445

Dilutive effect of Exchangeable Senior Notes

75,682

100,799

83,007

235,753

Diluted

 

28,265,605

 

28,157,934

28,248,054

27,496,151

Net income attributable to common stockholders per share:

Basic

$

1.46

$

1.33

$

4.36

$

4.10

Diluted

$

1.45

$

1.32

$

4.32

$

4.06

9. Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2—Includes other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs that are supported by little or no market activities, therefore requiring an entity to develop its own assumptions.

The following table presents the carrying value and approximate fair value of financial instruments at September 30, 2023 and December 31, 2022 (in thousands):

At September 30, 2023

At December 31, 2022

                                                                                                          

                                                                                                                         

                                                                                                

                                                                                                                                   

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Investments(1)

$

41,885

$

41,880

$

200,935

$

200,715

Investments as cash equivalents(2)

$

20,100

$

20,091

$

$

Exchangeable Senior Notes(3)

$

4,423

$

5,577

$

6,380

$

10,282

Notes due 2026(3)

$

296,107

$

268,611

$

295,115

$

264,234

Construction Loan(4)

$

21,556

$

26,362

$

18,021

$

20,167

(1)Investments consisting of obligations of the U.S. government with an original maturity at the time of purchase of greater than three months are classified as held-to-maturity and valued using Level 1 inputs.
(2)Investments as cash equivalents consisting of obligations of the U.S. government with an original maturity at the time of purchase of less than or equal to three months are classified as held-to-maturity and valued using Level 1 inputs.
(3)The fair value is determined based upon Level 2 inputs as the Exchangeable Senior Notes and Notes due 2026 were trading in the private market.
(4)The construction loan receivable is categorized as Level 3 and was valued using a yield analysis, which is typically performed for non-credit impaired loans. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. At September 30, 2023 and December 31, 2022, the expected market yield used to determine fair value was 25%. Changes in market yields may change the

19

fair value of the construction loan. Generally, an increase in market yields may result in a decrease in the fair value of the construction loan. Due to the inherent uncertainty of determining the fair value of a loan that does not have a readily available market value, the fair value of the construction loan may fluctuate from period to period. Additionally, the fair value of the construction loan may differ significantly from the value that would have been used had a readily available market existed for such loan and may differ materially from the value that the Company may ultimately realize.

The carrying amounts of cash equivalents, accounts payable, accrued expenses and other liabilities approximate their fair values.

10. Common Stock Incentive Plan

Our board of directors adopted our 2016 Omnibus Incentive Plan (the “2016 Plan”) to enable us to motivate, attract and retain the services of directors, employees and consultants considered essential to our long-term success. The 2016 Plan offers our directors, employees and consultants an opportunity to own our stock or rights that will reflect our growth, development and financial success. Under the terms of the 2016 Plan, the aggregate number of shares of our common stock subject to options, restricted stock, stock appreciation rights, restricted stock units and other awards, will be no more than 1,000,000 shares. Any equity awards that lapse, expire, terminate, are canceled or are forfeited (including forfeitures in connection with satisfaction of tax withholdings obligations of the recipient) are re-credited to the 2016 Plan’s reserve for future issuance. The 2016 Plan automatically terminates on the date which is ten years following the effective date of the 2016 Plan.

A summary of the restricted stock activity under the 2016 Plan and related information for the nine months ended September 30, 2023 is included in the table below:

    

    

Weighted-

Unvested

Average

Restricted

Grant Date Fair

Stock

Value

Balance at December 31, 2022

 

34,026

$

181.08

Granted

 

35,565

$

110.88

Vested

 

(9,154)

$

187.00

Forfeited(1)

 

(5,596)

$

115.01

Balance at March 31, 2023

 

54,841

$

141.31

Granted

5,055

$

71.23

Vested

(2,811)

$

128.11

Balance at June 30, 2023

57,085

$

135.75

Granted

150

$

80.49

Vested

(150)

$

80.49

Forfeited(1)

(374)

$

135.84

Balance at September 30, 2023

56,711

$

135.75

(1)Shares that were forfeited to cover the employees’ tax withholding obligation upon vesting or employees’ cessation of employment.

The remaining unrecognized compensation cost of approximately $5.2 million for restricted stock awards is expected to be recognized over a weighted-average amortization period of approximately 1.8 years as of September 30, 2023. The fair value of restricted stock that vested during the nine months ended September 30, 2023 was approximately $1.7 million.

20

The following table summarizes our RSU activity for the nine months ended September 30, 2023. RSUs are issued as part of the Innovative Industrial Properties, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows a select group of management and our non-employee directors to defer receiving certain of their cash and equity-based compensation. RSUs are subject to vesting conditions of the Deferred Compensation Plan and have the same economic rights as shares of restricted stock under the 2016 Plan:

    

    

Weighted-Average

Restricted

Grant Date Fair

Stock Units

Value

Balance at December 31, 2022

83,677

$

144.30

Granted

61,785

$

103.60

Balance at March 31, 2023

145,462

$

127.01

Granted

4,494

$

71.23

Balance at June 30, 2023

149,956

$

125.34

Granted

$

-

Balance at September 30, 2023

149,956

$

125.34

The remaining unrecognized compensation cost of approximately $7.3 million for RSU awards is expected to be recognized over an amortization period of approximately 1.9 years as of September 30, 2023.

In January 2021 and 2022, we issued 70,795 and 102,641 “target” PSUs, respectively, to a select group of officers, which vest and are settled in shares of common stock based on the Company’s total stockholder return over a performance period of approximately three years from the grant date.

Stock-based compensation for market-based PSU awards is based on the grant date fair value of the equity awards and is recognized over the applicable Performance Period. For both the three and nine months ended September 30, 2023 and 2022, we recognized stock-based compensation expense of approximately $2.7 million and $8.0 million, respectively, relating to PSU awards. As of September 30, 2023, the remaining unrecognized compensation cost of approximately $9.3 million relating to PSU awards is expected to be recognized over the remaining Performance Period of approximately 1.2 years.

As measured as of September 30, 2023, the performance thresholds for the vesting of the PSUs were not met for any of the applicable awards.

11. Commitments and Contingencies

Office Lease. The future contractual lease payments for our office lease and the reconciliation to the office lease liability reflected in other liabilities in our condensed consolidated balance sheet as of September 30, 2023 is presented in the table below (in thousands):

Year

    

Amount

2023 (three months ending December 31)

$

124

2024

 

511

2025

 

526

2026

 

543

2027

 

45

Total future contractual lease payments

 

1,749

Effect of discounting

 

(166)

Office lease liability

$

1,583

Improvement Allowances. As of September 30, 2023, we had approximately $17.2 million of commitments related to improvement allowances, which generally may be requested by the tenants at any time up until a date that is near the expiration of the initial term of the applicable lease.

Construction Loan. As of September 30, 2023, we had approximately $1.4 million of commitments related to our construction loan for the development of a regulated cannabis cultivation and processing facility in California. The developer is required to complete construction by December 31, 2023, subject to extension in certain circumstances.

21

Environmental Matters. We follow the policy of monitoring our properties, both targeted acquisition and existing properties, for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liabilities that would have a material adverse effect on our financial condition, results of operations and cash flow, or that we believe would require disclosure or the recording of a loss contingency.

Litigation.

Class Action Lawsuit

On April 25, 2022, a federal securities class action lawsuit was filed against the Company and certain of its officers. The case was named Michael V. Malozzi, individually and on behalf of others similarly situated v. Innovative Industrial Properties, Inc., Paul Smithers, Catherine Hastings and Andy Bui, Case No. 2-22-cv-02359, and was filed in the U.S. District Court for the District of New Jersey. The lawsuit was purportedly brought on behalf of purchasers of our common stock and alleges that we and certain of our officers made false or misleading statements regarding our business in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), SEC Rule 10b-5, and Section 20(a) of the Exchange Act. According to the filed complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between May 7, 2020 and April 13, 2022.

On September 29, 2022, an Amended Class Action Complaint was filed under the same Case Number, adding as defendants Alan D. Gold and Benjamin C. Regin, and asserting causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. On December 1, 2022, defendants moved to dismiss the Amended Class Action Complaint; on January 25, 2023, plaintiff responded to defendants’ motion to dismiss the Amended Class Action Complaint; and on March 6, 2023 defendants replied to plaintiff’s response. On September 19, 2023, the court granted defendants’ motion to dismiss the Amended Class Action Complaint without prejudice. On October 19, 2023, a Second Amended Class Action complaint was filed under the same Case Number, and asserted causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Second Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. It is possible that similar lawsuits may yet be filed in the same or other courts that name the same or additional defendants. We intend to defend the lawsuit vigorously. However, at this time, we cannot predict the probable outcome of this action, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements.

Derivative Action Lawsuit

On July 26, 2022, a derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named John Rice, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, and Innovative Industrial Properties, Inc., and was filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets against the directors and certain officers of the Company.  The plaintiffs are seeking declaratory relief, direction to reform and improve corporate governance and internal procedures, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On September 6, 2022, the defendants in this action filed a Consent Motion to Stay the Proceedings, which was granted on October 11, 2022. On September 28, 2022, a second derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Karen Drover, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, Defendants, and Innovative Industrial Properties Inc., Nominal Defendant, Case Number 24-C-22-004243, and filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, and seeks actions to reform and improve the Company, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On October 19, 2022, the parties to both cases filed a Joint Motion to Consolidate Related Shareholder Derivative Actions and to Appoint Lead and Liaison Counsel for plaintiffs, which was granted on December 16, 2022, along with a stay in the lawsuit pending a ruling on the defendants’ motion to dismiss the federal class action lawsuit described above. On April 17, 2023, a third derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Ross Weintraub, derivatively on behalf of Innovative Industrial Properties, Inc. v. Alan Gold, Paul Smithers, Catherine Hastings, Ben Regin, Andy Bui, Tracie Hager, Gary Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-00737-GLR, and filed in the United States District Court for the District of Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty and violations of Section 14(a) of the Exchange Act, and seeks an undetermined amount of damages, equitable relief, and attorneys’ fees and costs. Defendants in this

22

action filed a Consent Motion to Stay the Proceeding, which was granted on April 17, 2023. On June 5, 2023, a fourth derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Franco DeBlasio, on behalf of Gerich Melenth Nin (GMN) LP, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Alan D. Gold, Tracie J. Hager, Benjamin C. Regin, Andy Bui, Gary A. Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-01513-GLR, and filed in the United States District Court for the District of Maryland. The Company intends to vigorously defend each of these lawsuits. However, at this time, the Company cannot predict the probable outcome of these actions, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements. On July 19, 2023, the United States Court for the District of Maryland consolidated Case Nos. 1:23-cv-00737-GLR and 1:23-cv-01513-GLR with case number 1:23-cv-00737-GLR as the lead case, and kept the stay in place.

Kings Garden Lawsuit

In July 2022, one of our tenants, Kings Garden Inc., defaulted on its obligations to pay base rent and property management fees under each of its six leases with our indirect, wholly owned subsidiary, IIP-CA 2 LP, and defaulted on its obligations to reimburse us for certain insurance premiums at the properties incurred by us that are payable by Kings Garden as operating expenses under such leases.

On July 25, 2022, IIP-CA 2 LP filed a lawsuit against Kings Garden. The case was named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation, and JM Endeavors, Inc., a California corporation, and was filed in the Superior Court of the State of California. The lawsuit asserts claims for breach of contract, declaratory relief, and injunctive relief. On August 2, 2022, the case was amended to be named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation,  JM Endeavors, Inc., a California corporation, Michael King, an individual, Gary LaSalle, an individual, Charles Kieley, an individual, and Laurie Kibby, an individual, and to include claims relating to construction at two projects as of June 30, 2022 for breach of implied covenant of good faith and fair dealing, fraud, negligent misrepresentation, conversion, theft by false pretenses, money had and received, and violations of the Racketeer Influenced and Corrupt Organization Act (18 U.S.C. Section 1962(c)). The amount related to these project costs reported in construction in progress as of September 30, 2023 and December 31, 2022 was approximately $28.9 million and $33.2 million, respectively.

On September 11, 2022, the parties to the lawsuit entered into a confidential, conditional settlement agreement pertaining to matters related to the lawsuit. Pursuant to the conditional settlement agreement, as of September 30, 2023, the Company has received a total of approximately $19.8 million in partial settlement payments from Kings Garden, which has been accounted for as a reduction to net real estate held for investment on our condensed consolidated balance sheets. During the three months ended September 30, 2023, we received approximately $4.2 million in additional payments from Kings Garden (reflected in the total amount above) and are investigating the remaining additional costs paid of approximately $750,000 related to one construction project to determine whether these are overpayments. Although there is at least a reasonable possibility that a loss may have been incurred in connection with the default by Kings Garden and the related construction project related to these potential overpayments, as of September 30, 2023, we are unable to make such an estimate.

Additionally, on August 16, 2023, we filed suit against Orr Construction, the general contractor for certain amounts on one construction project undertaken by Kings Garden, named IIP-CA 2 LP v. Orr Builders, asserting claims for fraud, negligent misrepresentation, intentional interference with economic relationship, intentional interference with contract, conspiracy, violation of California unfair competition law, money had and received, and unjust enrichment. The Company contends that the lawsuit arose out of representations made to the Company by Orr Construction while investigating payments made for one construction project, relating to the lawsuit named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation, and JM Endeavors, Inc., a California corporation, filed in the Superior Court of the State of California, which was ultimately settled. Although there is at least a reasonable possibility that a loss may have been incurred in connection with amounts paid by us and work performed by Orr Construction for that construction project, as of September 30, 2023, we are unable to make such an estimate.

On February 14, 2023, Kings Garden filed an Arbitration Demand related to the interpretation of the confidential, conditional settlement agreement between the parties that concerns certain terms governing (along with the relevant lease) the assignment of one of the Kings Garden leases. The Company filed a Response to Kings Garden’s Arbitration Demand, Affirmative Defenses and Counter-Claim on March 1, 2023 (the “Counter-Claim”). Kings Garden filed an answer to the Counter-Claim on March 15, 2023. In July 2023, the Company filed a motion for leave to amend its Counter-Claims. On August 4, 2023, the Company accepted an offer of judgment extended by Kings Garden under California Code of Civil Procedure Section 998, pursuant to which Kings Garden (i) vacated the remaining four properties it previously occupied in September 2023, paying the stipulated rent during its period of occupancy through September 20, 2023, and (ii) agreed to pay the Company damages and attorneys’ fees totaling approximately $6.0

23

million, including interest on the then-outstanding amount, on a fully amortizing schedule of approximately $193,000 per month over a three-year period. The offer of judgment included a mutual release.

Parallel Pennsylvania Litigation

On February 6, 2023, IIP-PA 8 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Goodblend Pennsylvania LLC, as tenant, and Parallel, as guarantor, in the Court of Common Pleas of Allegheny County, Pennsylvania, regarding the lease and related guaranty for one of the Company’s properties located in Pennsylvania. The lawsuit asserts claims for breach of contract by the tenant and guarantor and ejectment. Goodblend Pennsylvania LLC and Parallel filed preliminary objections to the lawsuit on March 3, 2023.  IIP-PA 8 LLC filed its response to Goodblend Pennsylvania LLC’s and Parallel’s preliminary objections on March 23, 2023. The Court issued an Order on June 13, 2023 denying Goodblend Pennsylvania LLC’s and Parallel’s preliminary objections and directing Goodblend Pennsylvania LLC and Parallel to file an answer to the complaint. On October 25, 2023, a consent order was executed by the Court which awarded possession of the property to IIP-PA 8 LLC on October 31, 2023 and damages in favor of IIP-PA 8 LLC in the amount of approximately $15.5 million.

Parallel Texas Litigation

On February 11, 2023, a subsidiary of Parallel defaulted on its obligations to pay rent under the lease at one of our properties in Texas that is under development. On February 23, 2023, IIP-TX 1 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Surterra San Marcos, LLC, as tenant, in the Justice Court of Hays County, Texas, regarding the lease, asserting claim for possession. In March 2023, a judgment for possession was entered in favor of IIP-TX 1 LLC, as well as monthly rental amounts due, and we regained possession of the property. On March 13, 2023, IIP-TX 1 LLC filed a subsequent lawsuit against Surterra San Marcos, LLC, Parallel and Sunstream Opportunities LP (“SAF Entity 1”) in the District Court of Hays County, Texas, regarding the same lease, asserting claims against Surterra San Marcos, LLC, Parallel and SAF Entity 1 for breach of contract, tortious interference with contract, unjust enrichment, fraud and fraudulent inducement, intentional failure to disclose and misrepresentations and conversion, and also requested the granting of a temporary injunction and the appointment of a receiver over the license(s) pertaining to the property’s operations as a regulated cannabis facility. The parties exchanged initial disclosures in September 2023, and are in the discovery phase.

Green Peak Michigan Litigation

On February 2, 2023, IIP-MI 1 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Green Peak Industries, Inc. (“Green Peak”), as tenant, in 56-A District Court of the State of Michigan, regarding the lease for one of the Company’s properties located in Michigan, asserting claim for possession. On February 22, 2023, IIP-MI 1 LLC filed a subsequent lawsuit against Green Peak and Tropics LP (“SAF Entity 2”) in the Circuit Court of Eaton County, Michigan, regarding the same lease, asserting claims against Green Peak for breach of contract, unjust enrichment, and innocent misrepresentation, against SAF Entity 2 for tortious interference with contract, and against both Green Peak and SAF Entity 2 for civil conspiracy (the “Circuit Court Action”). On March 3, 2023, a stipulated order appointing a receiver over substantially all of Green Peak’s assets was entered in the Circuit Court of Ingham County, Michigan (the “Receivership Case”), pursuant to which the Company re-gained possession of one of the Company’s cultivation and processing properties, which is under redevelopment as of September 30, 2023, and two retail properties. As a result of the Receivership Case the claims asserted against Green Peak in the Circuit Court Action were stayed by order of the court and the claims against SAF Entity 2 were suspended by agreement of the parties pending the outcome of the Receivership Case. On September 28, 2023, a stipulation and order was entered in the Receivership Case, pursuant to which the Company is expected to re-gain possession of another retail property in Michigan on November 30, 2023, with the receiver paying contractually due rent through the last date of occupancy. On October 3, 2023, the court approved the sale of substantially all of Green Peak’s remaining assets in receivership to an affiliate of Green Peak’s senior secured lender, with the order approving the sale entered October 12, 2023. The leases for the remaining properties are expected to be assumed by the purchaser in connection with the closing of the sale.

We may, from time to time, be a party to other legal proceedings, which arise in the ordinary course of our business. Although the results of these proceedings, claims, inquiries, and investigations cannot be predicted with certainty, we do not believe that the final outcome of these matters is reasonably likely to have a material adverse effect on our business, financial condition, or results of operations. Regardless of final outcomes, however, any such proceedings, claims, inquiries, and investigations may nonetheless impose a significant burden on management and employees and may come with significant defense costs or unfavorable preliminary and interim rulings.

24

12. Subsequent Events

On October 23, 2023, our Operating Partnership entered into a loan and security agreement (the “Loan Agreement”) with a federally regulated commercial bank, as lender and as agent for lenders that become party thereto from time to time. The Loan Agreement matures on October 23, 2026, and provides $30.0 million in aggregate commitments for secured revolving loans, the availability of which is based on a borrowing base consisting of real properties owned by subsidiaries (the “Subsidiary Guarantors”) of the Operating Partnership that satisfy eligibility criteria set forth in the Loan Agreement. The obligations of the Operating Partnership under the Loan Agreement are guaranteed by the Company and the Subsidiary Guarantors, and are secured by (i) operating accounts of the Operating Partnership into which lease payments under the real property included in the borrowing base are paid, (ii) the equity interest of the Subsidiary Guarantors, (iii) the real estate included in the borrowing base and the leases and rents thereunder, and (iv) all personal property of the Subsidiary Guarantors. Borrowings under the Loan Agreement bear interest at a variable rate based on the greater of the prime rate and an applicable margin based on deposits with the participating bank(s) and a stipulated interest rate. The Loan Agreement is subject to certain liquidity and operating covenants and includes customary representations and warranties, affirmative and negative covenants and events of default. The Loan Agreement also allows the Operating Partnership, subject to the satisfaction of certain conditions, to request additional revolving incremental loan commitments up to a specified amount. There were no amounts outstanding under the Loan Agreement as of November 2, 2023.

In October 2023, we amended our lease with a subsidiary of Goodness Growth at one of our New York properties, increasing the improvement allowance under the lease by $14.0 million to a total of approximately $67.4 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. In connection with the lease amendment, the tenant prepaid rent for the three month period commencing on November 1, 2023 and ending January 31, 2024.

25

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this report. We make statements in this report that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, statements pertaining to our capital resources, portfolio performance and results of operations contain forward-looking statements. Likewise, our statements regarding anticipated growth in our funds from operations and anticipated market and regulatory conditions, our strategic direction, demographics, results of operations, plans and objectives are forward-looking statements. Forward-looking statements involve numerous risks and uncertainties, and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise, and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates” or “anticipates” or the negative of these words and phrases or similar words or phrases. You can also identify forward-looking statements by discussions of strategy, plans or intentions. The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: rates of default on leases for our assets; concentration of our portfolio of assets and limited number of tenants; the estimated growth in and evolving market dynamics of the regulated cannabis market; the demand for regulated cannabis facilities; inflation dynamics; our ability to improve our internal control over financial reporting, including our inability to remediate the identified material weakness, and the costs and the time associated with such efforts; the impact of pandemics on us, our business, our tenants, or the economy generally; war and other hostilities, including the conflicts in Ukraine and Israel; our business and investment strategy; our projected operating results; actions and initiatives of the U.S. or state governments and changes to government policies and the execution and impact of these actions, initiatives and policies, including the fact that cannabis remains illegal under federal law; availability of suitable investment opportunities in the regulated cannabis industry; our understanding of our competition and our potential tenants’ alternative financing sources; the expected medical-use or adult-use cannabis legalization in certain states; shifts in public opinion regarding regulated cannabis; the potential impact on us from litigation matters, including rising liability and insurance costs; the additional risks that may be associated with certain of our tenants cultivating, processing and/or dispensing adult-use cannabis in our facilities; the state of the U.S. economy generally or in specific geographic areas; economic trends and economic recoveries; our ability to access equity or debt capital; financing rates for our target assets; our level of indebtedness, which could reduce funds available for other business purposes and reduce our operational flexibility; covenants in our debt instruments, which may limit our flexibility and adversely affect our financial condition; our ability to maintain our investment grade credit rating; changes in the values of our assets; our expected portfolio of assets; our expected investments; interest rate mismatches between our assets and our borrowings used to fund such investments; changes in interest rates and the market value of our assets; the degree to which any interest rate or other hedging strategies may or may not protect us from interest rate volatility; the impact of and changes in governmental regulations, tax law and rates, accounting guidance and similar matters; our ability to maintain our qualification as a REIT; our ability to maintain our exemption from registration under the Investment Company Act of 1940; availability of qualified personnel; and market trends in our industry, interest rates, real estate values, the securities markets or the general economy.

The risks included here are not exhaustive, and additional factors could adversely affect our business and financial performance, including factors and risks included in other sections of this report. In addition, we discussed a number of material risks in our Annual Report on Form 10-K for the year ended December 31, 2022, in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, and in Part II, Item 1A below. Those risks continue to be relevant to our performance and financial condition. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on our Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Any forward-looking statement made by us speaks only of the date on which we make it. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company’s filings and reports.

The purpose of this Management’s Discussion and Analysis (“MD&A”) is to provide an understanding of the Company’s consolidated financial condition, results of operations and cash flows. MD&A is provided as a supplement to, and should be read in conjunction with, the Company’s condensed consolidated financial statements and accompanying notes.

26

Overview

As used herein, the terms “we”, “us”, “our” or the “Company” refer to Innovative Industrial Properties, Inc., a Maryland corporation, and any of our subsidiaries, including IIP Operating Partnership, LP, a Delaware limited partnership (the “Operating Partnership”).

We are an internally-managed REIT focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. We have leased and expect to continue to lease our properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, real estate taxes and insurance.

We were incorporated in Maryland on June 15, 2016. We conduct our business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which our properties are owned by our Operating Partnership, directly or through subsidiaries. We are the sole general partner of our Operating Partnership and own, directly or through subsidiaries, 100% of the limited partnership interests in our Operating Partnership. As of September 30, 2023, we had 21 full-time employees.

As of September 30, 2023, we owned 108 properties comprising approximately 8.9 million square feet (including approximately 1.4 million rentable square feet under development/redevelopment) in 19 states. As of September 30, 2023, we had invested approximately $2.4 billion in the aggregate (consisting of purchase price and funding of draws for construction funding and improvements submitted by tenants, if any, but excluding transaction costs) and had committed an additional approximately $29.5 million to fund draws to certain tenants for construction and improvements at our properties. Of the approximately $29.5 million committed to fund draws to certain tenants for construction and improvements at our properties, approximately $12.3 million was incurred but not funded as of September 30, 2023. These statistics do not include a $23.0 million loan commitment from us to a developer for construction of a regulated cannabis cultivation and processing facility in California, of which we have funded approximately $21.6 million as of September 30, 2023.

Of these 108 properties, we include 103 properties in our operating portfolio, which were 98.5% leased to state-licensed cannabis operators as of September 30, 2023, with a weighted-average remaining lease term of approximately 14.9 years. Rent collection for our operating portfolio (calculated as base rent and property management fees collected as a percentage of contractually due base rent and property management fees, including an aggregate of approximately $2.2 million of security deposits applied for payment of rent for our leases with three tenants) was approximately 97% for the three months ended September 30, 2023. Rent collection for our operating portfolio (calculated as base rent and property management fees collected as a percentage of contractually due base rent and property management fees, including an aggregate of approximately $8.0 million of security deposits applied for payment of rent for our leases with five tenants) was approximately 97% for the nine months ended September 30, 2023. As of September 30, 2023, we had fully applied approximately $909,000 of security deposit for payment of rent for one of our former leases with Green Peak and fully applied approximately $2.2 million of security deposits for payment of rent for a former lease with Parallel in Texas and a lease with Parallel in Pennsylvania. Kings Garden paid the stipulated rent during its period of occupancy through September 20, 2023 for the four properties it occupied, and we regained possession of those properties in September 2023.

We do not include in our operating portfolio the following properties (all of which were under development/redevelopment as of September 30, 2023, and together are expected to comprise approximately 715,000 rentable square feet upon completion of development/redevelopment):

Inland Center Drive in San Bernardino, California;
Perez Road in Cathedral City, California (pre-leased);
63795 19th Avenue in Palm Springs, California;
Leah Avenue in San Marcos, Texas; and
Davis Highway in Windsor, Michigan.

Factors Impacting Our Operating Results

Our results of operations are affected by a number of factors and depend on the rental revenues we receive from the properties that we acquire, the timing of lease expirations, general market conditions, the regulatory environment in the regulated cannabis industry, and the competitive environment for real estate assets that support the regulated cannabis industry.

27

Rental Revenues

We receive income primarily from rental revenues generated by the properties that we acquire. The amount of rental revenues depends upon a number of factors, including:

our ability to enter into leases with increasing or market value rents for the properties that we acquire; and
rent collection, which primarily relates to each of our tenant’s financial condition and ability to make rent payments to us on time.

The properties that we acquire consist of real estate assets that support the regulated cannabis industry. Most states where we own properties issue licenses for cannabis operations for a limited period. If one or more of our tenants are unable to renew or otherwise maintain their licenses or other state and local authorizations necessary to continue its cannabis operations, such tenants may default on their lease payments to us. Furthermore, changes in federal law and current favorable state or local laws in the cannabis industry may impair our ability to renew or re-lease properties and the ability of our tenants to fulfill their lease obligations and could materially and adversely affect our ability to maintain or increase rental rates for our properties.

Conditions in Our Markets

Positive or negative changes in regulatory, economic or other conditions, drought, and natural disasters in the markets where we acquire properties may affect our overall financial performance.

The success of our tenants in operating their businesses and their ability to pay rent continues to be significantly influenced by many challenges including the impact of inflation, labor shortages, supply chain constraints on their cost of doing business, and the U.S. consumer financial health. Additionally, market dynamics and the regulatory regime in the states where they operate create challenges that may impact our tenants’ businesses and/or decrease future demand for regulated cannabis cultivation and production facilities. The potential impact of current economic challenges on the Company’s financial condition, results of operations, and cash flows is subject to change and continues to depend on the extent and duration of these risks and uncertainties.

Market Dynamics in Regulated Cannabis State Programs

States vary significantly in their market dynamics, driven by many factors, including, but not limited to, regulatory frameworks, enforcement policies with respect to illicit, unlicensed cannabis operations, taxation and licensing structures. For example, in California, according to Global Go Analytics, the illicit market for cannabis remains a much larger portion of overall sales in the state, and state and local authorities have assessed significant taxes on regulated cannabis products, both of which have had the impact of significantly limiting the growth and profitability for operators in the state’s regulated cannabis market.

Many states continue to experience significant declines in unit pricing for regulated cannabis products, with that decline more pronounced in certain states than in others, which compresses operating margins for operators. As a result, certain regulated cannabis operators have announced that they are consolidating operations or shuttering certain operations to reduce costs, which if prolonged, could have a material negative impact on operators’ demand for regulated cannabis facilities, including our existing tenants.

Inflation and Supply Chain Constraints

The U.S. economy is experiencing a sustained increase in inflation rates, which we believe is negatively impacting our tenants. This inflation has increased costs for labor and production inputs for regulated cannabis operators, in addition to increasing costs of construction for development and redevelopment projects. Ongoing labor shortages and global supply chain issues also continue to adversely impact costs and timing for completion of these development and redevelopment projects, which are resulting in cost overruns and delays in commencing operations on certain of our tenants’ projects. Sustained inflation has also negatively impacted the level of spending of consumers, including for the purchase of regulated cannabis products.

Reduced Capital Availability for Tenants and the Company

For the past several months, financial markets have been volatile, reflecting heightened geopolitical risks and material tightening of financial conditions since the U.S. Federal Reserve began increasing interest rates in the spring of 2022 and continued uncertainty regarding monetary policy. Driven in part by overall macroeconomic conditions and substantially increased cost of capital, both capital availability and mergers and acquisitions activity have significantly declined for regulated cannabis operators.

28

Capital raising activities by U.S. REITs have also experienced steep declines, including significantly reduced capital availability for our company.

Significant Tenants and Concentrations of Risk

As of September 30, 2023, we owned 108 properties located in 19 states leased to 29 tenants. Many of our tenants are tenants at multiple properties. We seek to manage our portfolio-level risk through geographic diversification and by minimizing dependence on any single property or tenant. At September 30, 2023, our largest property was located in New York and accounted for approximately 5.4% of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment at September 30, 2023. See Note 2 “Summary of Significant Accounting Policies and Procedures” in the notes to our condensed consolidated financial statements for further information regarding the tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2023.

In July 2022, Kings Garden, a tenant of ours at six properties that we own in southern California, defaulted on its obligations to pay rent. In November 2022, Parallel defaulted on its obligations to pay rent at one of our properties in Pennsylvania, and Green Peak defaulted on its obligations to pay rent at one of our properties in Michigan. In February 2023, Parallel also defaulted on its obligations to pay rent at one of our properties in Texas. In March 2023, Green Peak was placed into receivership.

See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements included in this report for more information regarding Kings Garden, Parallel and Green Peak.

Competitive Environment

We face competition from a diverse mix of market participants, including but not limited to, other companies with similar business models, independent investors, hedge funds, lenders and other real estate investors, as well as potential tenants (cannabis operators themselves), all of whom may compete with us in our efforts to acquire real estate zoned for regulated cannabis operations. Competition from others may diminish our opportunities to acquire a desired property on favorable terms or at all. In addition, this competition may put pressure on us to reduce the rental rates below those that we expect to charge for the properties that we acquire, which would adversely affect our financial results.

Operating Expenses

Our operating expenses include general and administrative expenses, including personnel costs, stock-based compensation, and legal, accounting and other expenses related to corporate governance, public reporting and compliance with the various provisions of U.S. securities laws. Our operating expenses also include costs that we incur for properties that are not leased, including taxes, insurance, maintenance, security, utilities and other property-specific costs. We generally structure our leases so that the tenant is responsible for taxes, maintenance, insurance and structural repairs with respect to the premises throughout the lease term. Increases or decreases in such operating expenses will impact our overall financial performance.

Our Qualification as a REIT

We have been organized and operate our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Shares of our common stock and Series A Preferred Stock are subject to restrictions on ownership and transfer that are intended, among other purposes, to assist us in qualifying and maintaining our qualification as a REIT. In order for us to qualify as a REIT under the Code, the relevant sections of our charter provide that, subject to certain exceptions, no person or entity may own, or be deemed to own, by virtue of the applicable constructive ownership provisions of the Code, more than 9.8% (in value or number of shares, whichever is more restrictive) of the aggregate of our outstanding shares of stock or Series A Preferred Stock or more than 9.8% (in value or number of shares, whichever is more restrictive) of our outstanding common stock or any class or series of our outstanding preferred stock.

Results of Operations

Investments in Real Estate

See Note 6 “Investment in Real Estate” in the notes to the condensed consolidated financial statements for information regarding our investments in real estate activity and property portfolio activity during the nine months ended September 30, 2023. In March 2023, we sold the portfolio of four properties in California previously leased to affiliates of Vertical for $16.2 million (excluding transaction costs) with a secured loan for $16.1 million with the buyer of the properties. The transaction did not qualify for recognition as a completed sale since not all of the criteria were met. Accordingly, we have not derecognized the assets transferred. All

29

consideration received, as well as any future payments, from the buyer is recognized as a deposit liability and is included in other liabilities on our condensed consolidated balance sheet until such time the criteria for recognition as a sale have been met. In addition, as we have not met all of the held-for-sale criteria, land and building and improvements with a gross carrying value of approximately $3.4 million and approximately $13.9 million, respectively, and accumulated depreciation of approximately $1.5 million as of September 30, 2023, remain on the condensed consolidated balance sheet, and the buildings and improvements continue to be depreciated. During the three and nine months ended September 30, 2023, we received cash interest payments of approximately $402,000 and $939,000, respectively, which has been recorded as a liability as of September 30, 2023.

Comparison of the Three and Nine Months Ended September 30, 2023 and 2022

The following table sets forth the results of our operations (in thousands):

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Revenues:

Rental (including tenant reimbursements)

$

77,286

$

70,345

$

228,734

$

204,454

Other

 

540

 

538

 

1,616

 

1,444

Total revenues

 

77,826

 

70,883

 

230,350

 

205,898

Expenses:

Property expenses

 

6,318

 

2,823

 

17,700

 

7,232

General and administrative expense

 

10,981

 

10,804

 

31,924

 

28,288

Depreciation and amortization expense

 

16,678

 

15,900

 

50,096

 

45,001

Total expenses

 

33,977

 

29,527

 

99,720

 

80,521

Income from operations

 

43,849

 

41,356

 

130,630

 

125,377

Interest and other income

 

2,075

 

773

 

6,625

 

1,411

Interest expense

(4,330)

(4,513)

(13,322)

(13,783)

Gain (loss) on exchange of Exchangeable Senior Notes

 

 

 

22

 

(125)

Net income

 

41,594

 

37,616

 

123,955

 

112,880

Preferred stock dividends

 

(338)

 

(338)

 

(1,014)

 

(1,014)

Net income attributable to common stockholders

$

41,256

$

37,278

$

122,941

$

111,866

Revenues.

Rental Revenues. Rental revenues for the three months ended September 30, 2023 increased by approximately $7.0 million, or 10%, to approximately $77.3 million, compared to approximately $70.3 million for the three months ended September 30, 2022. Of that increase, approximately $3.5 million was related to tenant reimbursements for property insurance premiums and property taxes, which increased to approximately $6.2 million for the three months ended September 30, 2023, compared to approximately $2.7 million for the three months ended September 30, 2022. The increase in tenant reimbursements was primarily due to reimbursements for property taxes starting in January 2023. Prior to 2023, real estate taxes required to be paid by the tenant under our leases were paid directly by the tenant to the tax authorities and were therefore not reflected in our condensed consolidated financial statements. The remaining increase in rental revenues was generated by properties we acquired in prior periods, including contractual rent escalations and amendments to leases for additional improvement allowances and construction funding at existing properties that resulted in adjustments to rent. Rental revenues for the three months ended September 30, 2023 included the partial application of approximately $1.3 million of security deposits for payment of rent for two of our leases with Holistic in accordance with lease amendments executed with Holistic in January 2023, the partial application of approximately $191,000 of security deposits for payment of rent for one lease with Temescal in accordance with a lease amendment we executed with Temescal in March 2023 and the partial application of approximately $766,000 of security deposit for payment of rent for one lease with 4Front in accordance with a lease amendment we executed with 4Front in July 2023 (see Note 6 “Investment in Real Estate” in the notes to the condensed consolidated financial statements for more information).

Rental revenues during the three months ended September 30, 2023 were negatively impacted by non-collection of rent during the quarter from properties in our operating portfolio totaling approximately $2.2 million, primarily related to contractual base rents and property management fees from Parallel at one of our Pennsylvania properties. We regained possession of that property in October 2023. Kings Garden paid the stipulated rent through September 20, 2023 for the four properties it continued to occupy, including approximately $1.7 million in rent during the three months ended September 30, 2023, and we regained possession of those properties in September 2023.

30

Rental revenues for the nine months ended September 30, 2023 increased by approximately $24.2 million, or 12%, to approximately $228.7 million, compared to approximately $204.5 million for the nine months ended September 30, 2022. Of that increase, approximately $9.7 million was related to tenant reimbursements for property insurance premiums and property taxes, which increased to approximately $16.8 million for the nine months ended September 30, 2023, compared to approximately $7.1 million for the nine months ended September 30, 2022. The increase in tenant reimbursements was primarily due to reimbursements for property taxes starting in January 2023, as described above. Approximately $3.4 million of the increase in rental revenues was related to rent on the properties acquired during the nine months ended September 30, 2023. The remaining increase in rental revenues was generated by properties we acquired in prior periods, including contractual rent escalations and amendments to leases for additional improvement allowances and construction funding at existing properties that resulted in adjustments to rent. Rental revenues for the nine months ended September 30, 2023 included the full application of approximately $909,000 of security deposit for payment of rent for one of our former leases with Green Peak, the full application of approximately $2.2 million of security deposits for payment of rent for a former lease with Parallel in Texas and an existing lease with Parallel in Pennsylvania, partial application of approximately $3.6 million of security deposits for payment of rent for two of our leases with Holistic in accordance with lease amendments executed with Holistic in January 2023, the partial application of approximately $491,000 of security deposit for payment of rent for one lease with Temescal in accordance with a lease amendment we executed with Temescal in March 2023, and partial application of approximately $766,000 of security deposit for payment of rent for one lease with 4Front in accordance with a lease amendment we executed with 4Front in July 2023 (see Note 6 “Investment in Real Estate” in the notes to the condensed consolidated financial statements for more information).

Rental revenues during the nine months ended September 30, 2023 were negatively impacted by non-collection of rent during the period from properties in our operating portfolio totaling approximately $5.8 million (including approximately $5.6 million of contractual base rents and property management fees and approximately $249,000 of tenant reimbursements for property insurance premiums and property taxes) from primarily three tenants: Green Peak, affiliates of Vertical and Parallel.

Other Revenues. Other revenues for the three and nine months ended September 30, 2023 and 2022 consisted of interest revenue related to leases for property acquisitions that did not satisfy the requirements for sale-leaseback accounting.

Expenses.

Property Expenses. Property expenses for the three and nine months ended September 30, 2023 increased by approximately $3.5 million and approximately $10.5 million compared to the three and nine months ended September 30, 2022. The increase was primarily due to the recognition of property taxes incurred and paid or to be paid by us starting in January 2023, as described above. The increase was also due to new property acquisitions and additional investment in existing properties which resulted in higher property insurance premiums that we paid for our properties. Property expenses are generally reimbursable to us by the tenants under the terms of the leases.

General and Administrative Expense. General and administrative expense for the three months ended September 30, 2023 increased by approximately $177,000 to approximately $11.0 million, compared to approximately $10.8 million for the three months ended September 30, 2022. General and administrative expense for the nine months ended September 30, 2023 increased by approximately $3.6 million to approximately $31.9 million, compared to approximately $28.3 million for the nine months ended September 30, 2022. The increase in general and administrative expense was primarily due to approximately $2.5 million in litigation-related expense incurred during the nine months ended September 30, 2023 related to matters described in Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements included in this report, higher compensation to employees, the hiring of additional employees, higher public company costs and occupancy costs. Compensation expense for the three and nine months ended September 30, 2023 included approximately $4.9 million and $14.6 million, respectively, of non-cash stock-based compensation. Compensation expense for the three and nine months ended September 30, 2022 included approximately $4.4 million and $13.2 million, respectively, of non-cash stock-based compensation.

Depreciation and Amortization Expense. The increase in depreciation and amortization expense was related to depreciation on properties that we acquired and the placement into service of construction and improvements at certain of our properties.

Interest and Other Income. Interest and other income for the three months ended September 30, 2023 increased by approximately $1.3 million to approximately $2.1 million, compared to the three months ended September 30, 2022. Interest and other income for the nine months ended September 30, 2023 increased by approximately $5.2 million to approximately $6.6 million, compared to the nine months ended September 30, 2022. The increase in both periods was due to higher interest rates on our interest-bearing investments, as well as approximately $414,000 and $959,000 of interest received on our construction loan during the three and nine months ended September 30, 2023, respectively.

31

Interest Expense. Interest expense consists of interest on our Exchangeable Senior Notes and our Notes due 2026. Interest expense for the three months ended September 30, 2023 decreased by approximately $183,000 to approximately $4.3 million, compared to the three months ended September 30, 2022. Interest expense for the three months ended September 30, 2023 and 2022 included approximately $344,000 and $328,000, respectively, of non-cash interest expense. Interest expense for the nine months ended September 30, 2023 decreased by approximately $461,000 to approximately $13.3 million, compared to the nine months ended September 30, 2022 due to exchanges of approximately $26.9 million outstanding principal amount of our Exchangeable Senior Notes during the year ended December 31, 2022, and also due to the exchanges of $2.0 million outstanding principal amount of our Exchangeable Senior Notes and capitalization of approximately $214,000 of interest during the nine months ended September 30, 2023. Interest expense for the nine months ended September 30, 2023 and 2022 both included approximately $1.0 million of non-cash interest expense.

Cash Flows

Comparison of the Nine Months Ended September 30, 2023 and 2022 (in thousands)

Nine Months Ended September 30, 

    

2023

2022

    

Change

Net cash provided by (used in) operating activities

$

189,462

    

$

178,775

$

10,687

Net cash provided by (used in) investing activities

 

(5,999)

 

(401,736)

 

395,737

Net cash provided by (used in) financing activities

 

(153,551)

 

215,065

 

(368,616)

Ending cash, cash equivalents and restricted cash

 

118,484

 

78,523

 

39,961

Operating Activities

Cash flows provided by operating activities for the nine months ended September 30, 2023 and 2022 were approximately $189.5 million and $178.8 million, respectively. Cash flows provided by operating activities were generally from contractual rent from our properties, partially offset by our general and administrative expense, interest expense, property expenses in excess of tenant reimbursements and property expenses at properties that were not leased.

Investing Activities

Cash flows used in investing activities for the nine months ended September 30, 2023 were approximately $6.0 million, of which approximately $167.9 million related to investments in real estate and funding of draws for a portion of the improvement allowances, construction funding at our properties and other investments, partially offset by approximately $161.9 million related to net purchases and maturities of short-term investments. Cash flows used in investing activities for the nine months ended September 30, 2022 were approximately $401.7 million, of which approximately $488.0 million related to investments in real estate and funding of draws for a portion of the improvement allowances, construction funding at our properties and other investments, partially offset by approximately $86.3 million related to net maturities of short-term investments.

Financing Activities

Net cash used in financing activities of approximately $153.6 million during the nine months ended September 30, 2023 was the result of dividend payments of approximately $153.0 million to common and preferred stockholders and approximately $568,000 related to net share settlement of equity awards to pay the required withholding taxes upon vesting of restricted stock for certain employees.

Net cash provided by financing activities of approximately $215.1 million during the nine months ended September 30, 2022 was the result of approximately $352.0 million in net proceeds from the issuance of our common stock, partially offset by dividend payments of approximately $134.5 million to common and preferred stockholders and approximately $2.4 million related to net share settlement of equity awards to pay the required withholding taxes upon vesting of restricted stock for certain employees.

Liquidity and Capital Resources

Liquidity is a measure of our ability to meet potential cash requirements. We expect to use significant cash to acquire additional properties, develop and redevelop existing properties, pay dividends to our stockholders, fund our operations, service our Exchangeable Senior Notes and Notes due 2026, and meet other general business needs.

32

Sources and Uses of Cash

We derive substantially all of our revenues from the leasing of our properties and collecting rental income, which includes operating expense reimbursements, based on contractual arrangements with our tenants. This source of revenue represents our primary source of liquidity to fund our dividends, interest payments on our Exchangeable Senior Notes and Notes due 2026, general and administrative expenses, property development and redevelopment activities, property operating expenses and other expenses incurred related to managing our existing portfolio and investing in additional properties. Because substantially all our leases are triple net, our tenants are generally responsible for the maintenance, insurance and property taxes associated with the properties they lease from us. If a tenant defaults on one of our leases or the lease term expires with no tenant renewal, we would incur property costs not paid by the tenant during the time it takes to re-lease or sell the property.

As of September 30, 2023, we owned 108 properties. Of these properties, the 103 properties in our operating portfolio were 98.5% leased to state-licensed cannabis operators, with a weighted-average remaining lease term of approximately 14.9 years. Rent collection for our operating portfolio (calculated as base rent and property management fees collected as a percentage of contractually due base rent and property management fees, including an aggregate of approximately $2.2 million of security deposits applied for payment of rent for our leases with three tenants) was approximately 97% for the three months ended September 30, 2023. Rent collection for our operating portfolio (calculated as base rent and property management fees collected as a percentage of contractually due base rent and property management fees, including an aggregate of approximately $8.0 million of security deposits applied for payment of rent for five tenants) was approximately 97% for the nine months ended September 30, 2023. As of September 30, 2023, we had fully applied approximately $909,000 of security deposit for payment of rent for one of our former leases with Green Peak and fully applied approximately $2.2 million of security deposits for payment of rent for a former lease with Parallel in Texas and a lease with Parallel in Pennsylvania.

In July 2022, Kings Garden defaulted on its obligations to pay rent at all of the properties that Kings Garden leases from us. In September 2023, we regained possession of the four remaining properties that Kings Garden had occupied, where Kings Garden paid stipulated rent during its period of occupancy until September 20, 2023. In November 2022, Parallel defaulted on its obligations to pay rent at one of our properties in Pennsylvania, and we regained possession of that property in October 2023. Also in November 2022, Green Peak defaulted on its obligations to pay rent at one of our properties in Michigan. In March 2023, a receiver was appointed over substantially all of Green Peak’s assets, and we subsequently regained possession of one property that was under redevelopment as a regulated cannabis cultivation and processing facility and two retail properties in Michigan. In February 2023, Parallel also defaulted on its obligations to pay rent at one of our properties in Texas, and we regained possession of that property in March 2023.

See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements included in this report for more information regarding Kings Garden, Parallel and Green Peak.

We expect to incur some property-level operating costs from time to time in periods during which properties that become vacant are being remarketed or re-positioned. In addition, we may recognize an expense for certain property costs, such as insurance premiums and real estate taxes billed in arrears, if we believe the tenant is likely to vacate the property before making payment on those obligations or may be unable to pay such costs in a timely manner. Property costs are generally not significant to our operations, but the amount of property costs can vary quarter to quarter based on the number of property vacancies and whether we have any underperforming properties. We may advance certain property costs on behalf of our tenants but expect that the majority of these costs will be reimbursed by the tenant and do not anticipate that they will be significant to our operations. In addition, for properties that are not leased and are under development or redevelopment, we may make significant additional investments in these properties in order to get them ready for their intended use and to re-lease them.

To the extent additional resources are needed, we expect to fund our investment activity generally through equity or debt issuances either in the public or private markets. Where possible, we also may issue limited partnership interests in our Operating Partnership to acquire properties from existing owners seeking a tax-deferred transaction.

In May 2021, we received an investment grade rating from a ratings agency. We sought to obtain an investment grade rating to facilitate access to the investment grade unsecured debt market as part of our overall strategy to maximize our financial flexibility and manage our overall cost of capital. On May 25, 2021, our Operating Partnership issued $300.0 million aggregate principal amount of Notes due 2026. The Notes due 2026 are the Operating Partnership’s general unsecured and unsubordinated obligations, are fully and unconditionally guaranteed by us and all of the direct and indirect subsidiaries of the Operating Partnership, and rank equally in right of payment with all of the Operating Partnership’s existing and future senior unsecured indebtedness, including the Exchangeable Senior Notes. The terms of the Notes due 2026 are governed by an indenture, which requires compliance with various financial covenants including limits on the amount of total leverage and secured debt maintained by the Operating Partnership and which require the Operating Partnership to maintain minimum levels of debt service coverage. Management believes that it was in

33

compliance with those covenants as of September 30, 2023. Subject to the terms of the indenture, any new subsidiary of the Operating Partnership will also guarantee the Notes due 2026. In addition, the terms of the indenture provide that if the debt rating on the Notes due 2026 is downgraded or withdrawn entirely, interest on the Notes due 2026 will increase to a range of 6.0% to 6.5% based on such debt rating. 

During the nine months ended September 30, 2023, we issued 32,200 shares, respectively, of our common stock upon exchange by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes.

In January 2023, we terminated the previously existing “at-the-market” offering program and entered into new equity distribution agreements with four sales agents, pursuant to which we may offer and sell from time to time through an “at-the-market” offering program (the “ATM Program”) up to $500.0 million in shares of our common stock. As of September 30, 2023, we had not sold any shares of common stock under the ATM Program.

We have filed an automatic shelf registration statement, which may permit us, from time to time, to offer and sell common stock, preferred stock, warrants and other securities to the extent necessary or advisable to meet our liquidity needs.

On October 23, 2023, our Operating Partnership entered into a loan and security agreement (the “Loan Agreement”) with a federally regulated commercial bank, as lender and as agent for lenders that become party thereto from time to time. The Loan Agreement matures on October 23, 2026, and provides $30.0 million in aggregate commitments for secured revolving loans (the “Revolving Credit Facility”). The Loan Agreement also allows the Operating Partnership, subject to the satisfaction of certain conditions, to request additional revolving incremental loan commitments up to a specified amount. The Loan Agreement is subject to certain liquidity and operating covenants and includes customary representations and warranties, affirmative and negative covenants and events of default. There were no amounts outstanding under the Loan Agreement as of November 2, 2023. See Note 12 “Subsequent Events” to our condensed consolidated financial statements included in this report for more information.

We expect to meet our liquidity needs through cash and investments on hand, cash flows from operations, our Revolving Credit Facility and cash flow from sources discussed above. We believe that our liquidity and sources of capital are adequate to satisfy our cash requirements. We cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet our liquidity needs. Our investment guidelines also provide that our aggregate borrowings (secured and unsecured) will not exceed 50% of the cost of our tangible assets at the time of any new borrowing, subject to our board of directors’ discretion.

In recent months, financial markets have been volatile in general, which has also significantly reduced our access to capital. If this environment continues for a prolonged period of time or worsens, this would have a material adverse effect on our business, financial condition and results of operations, including our ability to continue to make acquisitions of new properties and fund investments for improvements at existing properties.

Dividends

The Company is required to pay dividends to its stockholders at least equal to 90% of its taxable income in order to qualify and maintain its qualification as a REIT. As a result of this distribution requirement, our Operating Partnership cannot rely on retained earnings to fund its ongoing operations to the same extent that other companies whose parent companies are not REITs can. Our ability to continue to pay dividends is dependent upon our ability to continue to generate cash flows, service any debt obligations we have, including our Exchangeable Senior Notes and Notes due 2026, and make accretive new investments.

The following table describes the dividends declared by the Company during the nine months ended September 30, 2023:

    

    

Amount

    

    

    

 

Declaration

Per

Dividend

 

Date

Security Class

Share

Period Covered

Paid Date

Dividend Amount

 

 

(In thousands)

March 15, 2023

Common stock

$

1.80

January 1, 2023 to March 31, 2023

April 14, 2023

$

50,725

March 15, 2023

Series A preferred stock

$

0.5625

January 15, 2023 to April 14, 2023

April 14, 2023

$

338

June 15, 2023

Common stock

$

1.80

April 1, 2023 to June 30, 2023

July 14, 2023

$

50,742

June 15, 2023

Series A preferred stock

$

0.5625

April 15, 2023 to July 14, 2023

July 14, 2023

$

338

September 15, 2023

Common stock

$

1.80

July 1, 2023 to September 30, 2023

October 13, 2023

$

50,742

September 15, 2023

Series A preferred stock

$

0.5625

July 15, 2023 to October 14, 2023

October 13, 2023

$

338

34

Contractual Obligations

The following table summarizes our contractual obligations as of September 30, 2023 (in thousands):

Payments Due

Exchangeable

    

    

    

by Year

    

Notes due 2026

Senior Notes

    

Interest

    

Office Rent

    

Total

2023 (three months ending December 31)

$

$

$

4,166

$

124

$

4,290

2024

 

4,436

 

16,523

 

511

 

21,470

2025

 

 

16,500

 

526

 

17,026

2026

300,000

 

 

6,646

 

543

 

307,189

2027

 

 

 

45

 

45

Total

$

300,000

$

4,436

$

43,835

$

1,749

$

350,020

Additionally, as of September 30, 2023, we had approximately $17.2 million outstanding in commitments related to improvement allowances, which generally may be requested by the tenants at any time up until a date that is near the expiration of the initial term of the applicable lease. As of September 30, 2023, we also had approximately $1.4 million outstanding in commitments to fund a construction loan, which the developer is required to complete by December 31, 2023, subject to extension in certain circumstances. The commitments discussed in this paragraph are excluded from the table of contractual obligations above, as improvement allowances generally may be requested by the tenants at any time up until a date that is near the expiration of the initial term of the applicable lease and construction loan funding generally may be requested by the borrower from time to time, subject to satisfaction of certain conditions.

Supplemental Guarantor Information

In March 2020, the SEC adopted amendments to Rule 3-10 of Regulation S-X and created Rule 13-01 to simplify disclosure requirements related to certain registered securities. The amendments became effective on January 4, 2021. Our Notes due 2026 and our Exchangeable Senior Notes are the unsecured senior obligations of our Operating Partnership and are fully and unconditionally guaranteed on an unsecured basis, jointly and severally, by us and all of our direct and indirect wholly-owned subsidiaries. Only the Notes due 2026 and the related guarantees are registered securities under the Securities Act. See Note 7 “Debt” to our condensed consolidated financial statements included in this report for a description of certain terms of our Notes due 2026.

The offer and sale of the Exchangeable Senior Notes and the related guarantees were not and will not be registered under the Securities Act or the securities laws of any other jurisdiction and instead were issued in reliance upon an exemption from such registration. Unless they are subsequently registered under the Securities Act, the Exchangeable Senior Notes and the related guarantees may be offered and sold only in transactions that are exempt from the registration requirements under the Securities Act and the applicable securities laws of any other jurisdiction.

As a result of the amendments to Rule 3-10 of Regulation S-X, subsidiary issuers of obligations guaranteed by the parent are not required to provide separate financial statements, provided that the subsidiary obligor is consolidated into the parent company’s consolidated financial statements, the parent guarantee is “full and unconditional” and, subject to certain exceptions as set forth below, the alternative disclosure required by Rule 13-01 of Regulation S-X is provided, which includes narrative disclosure and summarized financial information. Accordingly, separate consolidated financial statements of our Operating Partnership and the Subsidiary Guarantors have not been presented.

Furthermore, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, we have excluded the summarized financial information for the Operating Partnership and the Subsidiary Guarantors because the combined assets, liabilities, and results of operations of the Operating Partnership and the Subsidiary Guarantors are not materially different than the corresponding amounts in our condensed consolidated financial statements, and management believes such summarized financial information would be repetitive and would not provide incremental value to investors.

Non-GAAP Financial Information

In addition to the required GAAP presentations, we use certain non-GAAP performance measures as we believe these measures improve the understanding of our operational results. We continually evaluate the usefulness, relevance, limitations, and calculation of our reported non-GAAP performance measures to determine how best to provide relevant information to the public and thus such reported measures could change.

35

Funds from Operations, Normalized Funds from Operations and Adjusted Funds from Operations

Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT’s operating performance equal to net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, depreciation, amortization and impairment related to real estate properties, and after adjustments for unconsolidated partnerships and joint ventures.

Management believes that net income, as defined by GAAP, is the most appropriate earnings measurement. However, management believes FFO and FFO per share to be supplemental measures of a REIT’s performance because they provide an understanding of the operating performance of our properties without giving effect to certain significant non-cash items, primarily depreciation expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. We believe that by excluding the effect of depreciation, FFO and FFO per share can facilitate comparisons of operating performance between periods. We report FFO and FFO per share because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because FFO per share is consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. For these reasons, management has deemed it appropriate to disclose and discuss FFO and FFO per share.

We compute normalized funds from operations (“Normalized FFO”) by adjusting FFO, as defined by NAREIT, to exclude certain GAAP income and expense amounts that we believe are infrequent and unusual in nature and/or not related to our core real estate operations. Exclusion of these items from similar FFO-type metrics is common within the equity REIT industry, and management believes that presentation of Normalized FFO and Normalized FFO per share provides investors with a metric to assist in their evaluation of our operating performance across multiple periods and in comparison to the operating performance of other companies, because it removes the effect of unusual items that are not expected to impact our operating performance on an ongoing basis. Normalized FFO is used by management in evaluating the performance of our core business operations. Items included in calculating FFO that may be excluded in calculating Normalized FFO include certain transaction-related gains, losses, income or expense or other non-core amounts as they occur.

Management believes that adjusted funds from operations (“AFFO”) and AFFO per share are also appropriate supplemental measures of a REIT’s operating performance. We calculate AFFO by adjusting Normalized FFO for certain cash and non-cash items.

For the three and nine months ended September 30, 2023, FFO (diluted), Normalized FFO and AFFO, and FFO, Normalized FFO and AFFO per diluted share include the dilutive impact of the assumed full exchange of the Exchangeable Senior Notes for shares of common stock. As a result, for purposes of calculating FFO (diluted), cash and non-cash interest expense of the Exchangeable Senior Notes was added back to FFO, and the total diluted weighted-average common shares outstanding increased by 75,682 and 83,007 shares for the three and nine months ended September 30, 2023, respectively, which were the potentially issuable shares as if the Exchangeable Senior Notes were exchanged at the beginning of the period.

For the three and nine months ended September 30, 2022, FFO (diluted), Normalized FFO and AFFO, and FFO, Normalized FFO and AFFO per diluted share include the dilutive impact of the assumed full exchange of the Exchangeable Senior Notes for shares of common stock. As a result, for purposes of calculating FFO (diluted), cash and non-cash interest expense of the Exchangeable Senior Notes was added back to FFO, and the total diluted weighted-average common shares outstanding increased by 100,799 shares and 235,753 shares for the three and nine months ended September 30, 2022, respectively, which were the potentially issuable shares as if the Exchangeable Senior Notes were exchanged at the beginning of the period.

For the three and nine months ended September 30, 2023 and 2022, the performance share units (“PSUs”) granted to certain employees were not included in dilutive securities as the performance thresholds for vesting of the PSUs were not met as measured as of the respective periods.

Our computation of FFO, Normalized FFO, and AFFO may differ from the methodology for calculating FFO, Normalized FFO and AFFO utilized by other equity REITs and, accordingly, may not be comparable to such REITs. Further, FFO and AFFO do not represent cash flow available for management’s discretionary use. FFO, Normalized FFO and AFFO should not be considered as an alternative to net income (computed in accordance with GAAP) as an indicator of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to pay dividends or make distributions. FFO, Normalized FFO and AFFO should be considered only as supplements to net income computed in accordance with GAAP as measures of operations.

36

The table below is a reconciliation of net income attributable to common stockholders to FFO, Normalized FFO and AFFO for the three and nine months ended September 30, 2023 and 2022 (in thousands, except share and per share amounts):

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2023

2022

    

2023

2022

Net income attributable to common stockholders

$

41,256

    

$

37,278

    

$

122,941

    

$

111,866

Real estate depreciation and amortization

 

16,678

 

15,900

 

50,096

 

45,001

FFO attributable to common stockholders (basic)

 

57,934

 

53,178

 

173,037

 

156,867

Cash and non-cash interest expense on Exchangeable Senior Notes

50

72

169

474

FFO attributable to common stockholders (diluted)

57,984

53,250

173,206

157,341

Financing expense

14

118

Litigation-related expense

1,112

2,112

2,328

2,231

Loss (gain) on exchange of Exchangeable Senior Notes

(22)

125

Normalized FFO attributable to common stockholders (diluted)

59,096

55,376

175,512

159,815

Interest income on seller-financed note(1)

402

939

Stock-based compensation

 

4,934

 

4,379

 

14,647

 

13,195

Non-cash interest expense

 

335

 

316

 

992

 

934

Above-market lease amortization

23

23

69

69

AFFO attributable to common stockholders (diluted)

$

64,790

$

60,094

$

192,159

$

174,013

FFO per common share – diluted

$

2.05

$

1.89

$

6.13

$

5.72

Normalized FFO per common share – diluted

$

2.09

$

1.97

$

6.21

$

5.81

AFFO per common share – diluted

$

2.29

$

2.13

$

6.80

$

6.33

Weighted average common shares outstanding – basic

 

27,983,004

 

27,938,568

 

27,971,544

 

27,144,953

Restricted stock and RSUs

206,919

118,567

193,503

115,445

Dilutive effect of Exchangeable Senior Notes

75,682

100,799

83,007

235,753

Weighted average common shares outstanding – diluted

 

28,265,605

 

28,157,934

 

28,248,054

 

27,496,151

(1)Amount reflects the non-refundable interest paid on the seller-financed note issued to us by the buyer in connection with our disposition of a portfolio of four properties in southern California previously leased to affiliates of Vertical, which is recognized as a deposit liability and is included in other liabilities in our condensed consolidated balance sheet as of September 30, 2023, as the transaction did not qualify for recognition as a completed sale.

Critical Accounting Estimates

Our condensed consolidated financial statements have been prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ materially from those estimates and assumptions.

We continually evaluate the estimates and assumptions we use to prepare our consolidated financial statements. Our critical accounting estimates are defined as accounting estimates or assumptions made in accordance with GAAP, which involve a significant level of estimation uncertainty or subjectivity and have had or are reasonably likely to have a material impact on our financial condition or results of operations. The following critical accounting estimates discussion reflects what we believe are the most significant estimates and assumptions used in the preparation of our consolidated financial statements. This discussion of our critical accounting estimates is intended to supplement and should be read in conjunction with the more complete discussion of our accounting policies and procedures included in Note 2 “Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements” to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022.

37

Lease Accounting

We account for our leases under ASC 842 “Leases”, which requires significant estimates and judgments by management in its application. Upon lease inception or lease modification, we assess the lease classification of both the land and building components of the property. The determination of lease classification requires the calculation of the rate implicit in the lease, which is driven by significant estimates relating to the unguaranteed residual value of the assets at the end of the non-cancelable lease term.

Acquisition of Rental Property, Depreciation and Impairment

All of our acquisitions of rental properties to date were accounted for as asset acquisitions and not business combinations because substantially all of the fair value is concentrated in a single identifiable asset or group of similar identifiable assets (i.e., land, buildings, and related intangible assets). The accounting model for asset acquisitions requires that the acquisition consideration (including acquisition costs) be allocated to the individual assets acquired and liabilities assumed on a relative fair value basis.

We exercise judgement to determine key assumptions used in each valuation technique. For example, we are required to use judgment and make a number of assumptions, including those related to projected growth in rental rates and operating expenses, anticipated trends and market/economic conditions. The use of different assumptions can affect the amount of consideration allocated to the acquired depreciable/amortizable asset, which in turn can impact our net income due to the recognition of the related depreciation/amortization expense in our condensed consolidated statements of income.

We depreciate buildings and improvements where we are considered the owner for accounting purposes based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment.

The determination of whether we are or the tenant is the owner of improvements for accounting purposes is subject to significant judgment. In making that determination, we consider numerous factors and perform a detailed evaluation of each individual lease. No one factor is determinative in reaching a conclusion. The factors we evaluate include but are not limited to the following:

whether the lease agreement requires landlord approval of how the improvement allowance is spent prior to installation of the improvements;
whether the lease agreement requires the tenant to provide evidence to the landlord supporting the cost and what the improvement allowance was spent on prior to payment by the landlord for such improvements;
whether the improvements are unique to the tenant or reusable by other tenants;
whether the tenant is permitted to alter or remove the improvements without the consent of the landlord or without compensating the landlord for any lost utility or diminution in fair value; and
whether the ownership of the improvements remains with the landlord or remains with the tenant at the end of the lease term.

When we conclude that we are the owner of improvements for accounting purposes using the factors discussed above, we record the cost to construct the improvements as our capital asset.

We evaluate our real estate assets for potential impairment whenever events or changes in circumstances indicate that the carrying amount of a given asset may not be recoverable. We evaluate our real estate assets for impairment on a property-by-property basis. Indicators we use to determine whether an impairment evaluation is necessary include:

deterioration in rental rates for a specific property;
deterioration of a given rental submarket;
significant change in strategy or use of a specific property or any other event that could result in a decreased holding period, including classifying a property as held for sale, or significant development delay;
evidence of material physical damage to the property; and
default by a significant tenant when any of the other indicators above are present.

When we evaluate for potential impairment our real estate assets to be held and used, we first evaluate whether there are any indicators of impairment. If any impairment indicators are present for a specific real estate asset, we then perform an undiscounted cash flow analysis and compare the net carrying amount of the real estate asset to the real estate asset’s estimated undiscounted future cash flow over the anticipated holding period. If the estimated undiscounted future cash flow is less than the net carrying amount of the real estate asset, we perform an impairment loss calculation to determine if the fair value of the real estate asset is less than the net

38

carrying value of the real estate asset. Our impairment loss calculation compares the net carrying amount of the real estate asset to the real estate asset’s estimated fair value, which may be based on estimated discounted future cash flow calculations or third-party valuations or appraisals. We recognize an impairment loss if the amount of the asset’s net carrying amount exceeds the asset’s estimated fair value. If we recognize an impairment loss, the estimated fair value of the asset becomes its new cost basis. For a depreciable long-lived asset, the new cost basis would be depreciated (amortized) over the remaining useful life of that asset. If a real estate asset is designated as real estate held for sale, it is carried at the lower of the net carrying value or estimated fair value less costs to sell, and depreciation ceases.

Our undiscounted cash flow and fair value calculations contain uncertainties because they require management to make assumptions and to apply judgment to estimate future cash flow and property fair values, including determining our estimated holding period and selecting the discount or capitalization rate that reflects the risk inherent in future cash flow. Estimating projected cash flow is highly subjective as it requires assumptions related to future rental rates, tenant allowances, operating expenditures, property taxes, capital improvements, and occupancy levels. We are also required to make a number of assumptions relating to future economic and market events and prospective operating trends. Determining the appropriate capitalization rate also requires significant judgment and is typically based on many factors including the prevailing rate for the market or submarket, as well as the quality and location of the properties. Further, capitalization rates can fluctuate resulting from a variety of factors in the overall economy or within regional markets. If the actual net cash flow or actual market capitalization rates significantly differ from our estimates, the impairment evaluation for an individual asset could be materially affected.

For each property where such an indicator occurred, we completed an impairment evaluation. After completing this process, we determined that for each of the operating properties evaluated, undiscounted cash flows over the holding period were in excess of carrying value and, therefore, we did not record any impairment losses for these properties for the three and nine months ended September 30, 2023 and 2022.

Stock-Based Compensation

Compensation cost for all share-based awards requires an estimate of fair value on the grant date and compensation cost is recognized on a straight-line basis over the service vesting period, which represents the requisite service period. The grant date fair value for compensation programs that contain market conditions, like modifiers based on total stockholder return (a “market condition”), are performed using Monte Carlo simulation pricing models that require the input of assumptions, including judgments to estimate expected stock price volatility, risk-free interest rate, and discount for post vesting restriction. The expected share price volatility was based on the historical volatility of our shares of common stock over a period of approximately the applicable performance periods. The risk-free interest rate was based on the zero-coupon risk-free interest rate derived from the Treasury Constant Maturities yield curve on the applicable valuation date. The discount for the post vesting restriction was estimated using the Finnerty model.

Impact of Real Estate and Credit Markets

In the commercial real estate market, property prices generally continue to fluctuate. Likewise, during certain periods, the U.S. credit markets have experienced significant price volatility, dislocations, and liquidity disruptions, which may impact our access to and cost of capital. We continually monitor the commercial real estate and U.S. credit markets carefully and, if required, will make decisions to adjust our business strategy accordingly.

Interest Rate Risk

As of September 30, 2023, we had $300.0 million principal amount of Notes due 2026 and approximately $4.4 million principal amount of Exchangeable Senior Notes outstanding at fixed interest rates, and therefore, if interest rates decline, our required payments may exceed those based on current market rates. It is possible that a property we acquire in the future would be subject to a mortgage, which we may assume.

Impact of Inflation

The U.S. economy is experiencing a sustained increase in inflation rates. We enter into leases that generally provide for fixed increases in rent. During times when inflation is greater than the fixed increases in rent, as provided for in the leases, rent increases may not keep up with the rate of inflation.

Seasonality

Our business has not been, and we do not expect our business in the future to be, subject to material seasonal fluctuations.

39

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our Exchangeable Senior Notes bear interest at a fixed rate of 3.75% per annum until maturity and our Notes due 2026 bear interest at a fixed rate of 5.50% per annum until maturity, and collectively are the only debt we have outstanding.

Our investments in short-term money market funds, certificates of deposit and short-term investments in obligations of the U.S. government with an original maturity at the time of purchase of greater than three months are less sensitive to market fluctuations than a portfolio of long-term securities. Accordingly, we believe that a significant change in interest rates would not have a material effect on the condensed consolidated financial statements.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under supervision of the Audit Committee of the Board of Directors and with the participation of our principal executive and principal financial officers, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2023. Based on that evaluation, our principal executive and financial officers concluded that our disclosure controls and procedures were not effective as of September 30, 2023 because of a material weakness in our internal control over financial reporting as described below.

Notwithstanding this material weakness, the Company has concluded that no material misstatements exist in the consolidated financial statements as previously filed and included in this Quarterly Report on Form 10-Q and such financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2023 and the results of its operations and its cash flows for the three and nine-months period then ended, in conformity with GAAP.

Material Weakness in Internal Control over Financial Reporting

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

We have determined that we did not design and maintain effective internal control over financial reporting related to management’s review and approval of requests for funding disbursements for improvements at the Company’s properties. Specifically, management’s controls are not designed at an appropriate level of precision to prevent or detect a material misstatement in a timely manner.

This control deficiency did not result in a misstatement of the Company’s consolidated financial statements. However, this control deficiency could result in misstatements of interim or annual consolidated financial statements and disclosures that would result in a material misstatement that would not be prevented or detected in a timely manner. Therefore, management has concluded that this control deficiency constitutes a material weakness.

Remediation of Material Weakness

We are committed to the continuous improvement of our internal controls over financial reporting. We immediately commenced measures to remediate the identified material weakness. We have provided additional training to personnel regarding policies and procedures around construction projects and the necessary approvals of requests for funding disbursements in connection with qualifying property improvements at our properties. Our remediation efforts also include (1) enhancing the design of existing procedures and controls over the review and approval of funding requests for improvements; (2) providing additional training and developing tools to implement and monitor our policies and procedures; and (3) supplementing existing resources with the engagement of third-party construction consultants.

While we believe that the efforts taken to date for remediation are appropriate and reasonable steps to remediate the material weakness, the material weakness will not be remediated until the enhanced controls have been implemented for a sufficient period of time and management has concluded, through testing and monitoring, that the new and enhanced controls are designed and operating effectively. We may conclude that additional measures, including resources, are necessary to remediate the material weakness in our internal control over financial reporting, which may necessitate additional evaluation and implementation time. We may also modify certain of the remediation efforts described above.

40

Changes in Internal Control Over Financial Reporting

Other than the material weakness discussed above, there have been no changes in our system of internal control over financial reporting during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

41

PART II

ITEM 1. LEGAL PROCEEDINGS

For a description of our legal proceedings, see Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements, which is hereby incorporated by reference.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, and in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, which could materially affect our business, financial condition and/or results of operations. Except to the extent additional factual information disclosed elsewhere in this Quarterly Report on Form 10-Q relates to such risk factors, there have been no material changes to the risk factors described in the “Risk Factors” sections in our Annual Report on Form 10-K for the year ended December 31, 2022 and in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023. The risk factors set forth below update, and should be read together with, the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023. The risks as described in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or results of operations.

Laws and regulations affecting the regulated cannabis industry are constantly changing, which could materially adversely affect our operations, and we cannot predict the impact that future regulations may have on us.

Local, state and federal cannabis laws and regulations are broad in scope and subject to evolving interpretations, which could require us to incur substantial costs associated with compliance or alter our business plan. In addition, violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our operations. It is also possible that regulations may be enacted in the future that will be directly applicable to our business. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business.

In August 2023, the U.S. Department of Health and Human Services (“HHS”) recommended to the U.S. Drug Enforcement Administration (“DEA”) that cannabis be reclassified from a schedule I drug to a schedule III drug under the Controlled Substances Act. HHS based this recommendation on a Food and Drug Administration (“FDA”) review of cannabis’ classification pursuant to President Biden’s executive order in October 2022. The process for reclassification will require DEA approval and likely complex administrative rulemaking proceedings, and it remains unclear how long this process will take and the scope of any final decisions or rules. Further, the impact of such decisions or rules, if any are promulgated, on existing state-regulated cannabis programs remains unclear, including but not limited to FDA and other federal regulatory agency involvement, the impact of such a decision on potential federal legislative reform such as proposals to de-schedule cannabis and provide greater access to capital markets for state-regulated cannabis operators, and the potential entry into the cannabis markets of large, well-capitalized companies as a result of any re-scheduling.

Our tenants may be unable to renew or otherwise maintain their licenses or other requisite authorizations for their cannabis operations, which may result in such tenants not being able to operate their businesses and defaulting on their lease payments to us.

Most states where we own properties issue licenses for cannabis operations for a limited period. We rely on our tenants to renew or otherwise maintain the requisite state and local cannabis licenses and other authorizations on a continuous basis. If one or more of our tenants are unable to renew or otherwise maintain its licenses or other state and local authorizations necessary to continue its cannabis operations, such tenants may default on their lease payments to us.

Any such noncompliance by our tenants of state and local laws, rules and regulations may also subject us, as the owner of such properties, to potential penalties, fines or other liabilities.

Any lease payment defaults by a tenant or additional liability on us could adversely affect our cash flows and cause us to reduce the amount of distributions to stockholders. In the event of a default by a tenant, we may also experience delays in enforcing our rights as landlord and may incur substantial costs in protecting our investment and re-leasing our property as operators of cannabis

42

cultivation and production facilities are generally subject to extensive state licensing requirements, including required state and local authorizations for a new tenant to take over operations at a facility.

In July 2022, Kings Garden, a prior tenant of ours at six properties that we own in southern California, defaulted on its obligations to pay rent. As previously disclosed, for one property in San Bernardino, California, we are evaluating alternative non-cannabis uses for the property, due in part to changes in the zoning of the property that no longer allow for regulated cannabis cultivation and processing. As disclosed in our Current Report on Form 8-K filed with the Securities and Exchange Commission on September 27, 2023, we regained possession of the remaining four properties that Kings Garden previously occupied. Of those four properties, we are evaluating non-cannabis uses for two properties representing less than 1% of our invested capital at September 30, 2023, also due in part to changes in the zoning of the property that no longer allow for regulated cannabis cultivation and processing.

In November 2022, a subsidiary of Parallel defaulted on its obligations to pay rent at one of our properties in Pennsylvania, and we expect to regain possession of the property. The Pennsylvania regulated cannabis program issued a limited number of operator licenses, and as a result, we may encounter longer delays and other challenges in finding a suitable tenant, versus in states with more licensed operators. In October 2023, we regained possession of the property.

See Part I, Item 3. Legal Proceedings in our Annual Report on Form 10-K for the year ended December 31, 2022 and Note 11 “Commitments and Contingencies — Litigation” to our consolidated financial statements for more information.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchange by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes. Such shares of our common stock were issued in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

During the three months ended September 30, 2023, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading agreement,” as each term is defined in Item 408(a) of Regulation S-K.

43

ITEM 6. EXHIBITS

Exhibit
Number

    

Description of Exhibit 

 

31.1*

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*

Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101INS*

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH*

Inline XBRL Taxonomy Extension Schema Document.

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*

Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104*

Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).

*      Filed herewith.

44

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

INNOVATIVE INDUSTRIAL PROPERTIES, INC.

By:

/s/ Paul Smithers

Paul Smithers

 

President, Chief Executive Officer and Director

 

(Principal Executive Officer)

 

 

 

By:

/s/ David Smith

 

David Smith

 

Chief Financial Officer and Treasurer

 

(Principal Financial Officer)

 

Dated November 2, 2023

45

Exhibit 31.1

Innovative Industrial Properties, Inc.

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul Smithers, certify that:

1)    I have reviewed this Quarterly Report on Form 10-Q of Innovative Industrial Properties, Inc.;

2)    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)   Disclosed in this report, any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5)    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 2, 2023

/s/ Paul Smithers

Paul Smithers

Chief Executive Officer, President and Director


Exhibit 31.2

Innovative Industrial Properties, Inc.

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David Smith, certify that:

1)    I have reviewed this Quarterly Report on Form 10-Q of Innovative Industrial Properties, Inc.;

2)    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4)    The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)   Disclosed in this report, any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5)    The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 2, 2023

/s/ David Smith

David Smith

Chief Financial Officer and Treasurer


Exhibit 32.1

Innovative Industrial Properties, Inc.

Certification Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Innovative Industrial Properties, Inc. (the "Company") for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Paul Smithers, Chief Executive Officer, President and Director of the Company, and I, David Smith, Chief Financial Officer and Treasurer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1)    The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 2, 2023

/s/ Paul Smithers

Paul Smithers

Chief Executive Officer, President and Director

/s/ David Smith

David Smith

Chief Financial Officer and Treasurer


v3.23.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 02, 2023
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-37949  
Entity Registrant Name Innovative Industrial Properties, Inc.  
Entity Incorporation, State or Country Code MD  
Entity Tax Identification Number 81-2963381  
Entity Address, Address Line One 1389 Center Drive, Suite 200  
Entity Address, City or Town Park City  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84098  
City Area Code 858  
Local Phone Number 997-3332  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   28,039,830
Entity Central Index Key 0001677576  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Stock    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol IIPR  
Security Exchange Name NYSE  
Series A Preferred Stock    
Title of 12(b) Security Series A Preferred Stock, par value $0.001 per share  
Trading Symbol IIPR-PA  
Security Exchange Name NYSE  
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Real estate, at cost:    
Land $ 142,524 $ 139,953
Buildings and improvements 2,100,662 2,010,628
Construction in progress 107,772 54,106
Total real estate, at cost 2,350,958 2,204,687
Less accumulated depreciation (186,121) (138,405)
Net real estate held for investment 2,164,837 2,066,282
Construction loan receivable 21,556 18,021
Cash and cash equivalents 117,034 87,122
Restricted cash 1,450 1,450
Investments 41,885 200,935
Right of use office lease asset 1,453 1,739
In-place lease intangible assets, net 8,460 9,105
Other assets, net 32,748 30,182
Total assets 2,389,423 2,414,836
Liabilities:    
Exchangeable Senior Notes, net 4,423 6,380
Notes due 2026, net 296,107 295,115
Building improvements and construction funding payable 12,724 29,376
Accounts payable and accrued expenses 13,631 10,615
Dividends payable 51,079 50,840
Rent received in advance and tenant security deposits 59,120 58,716
Other liabilities 3,670 1,901
Total liabilities 440,754 452,943
Commitments and contingencies (Notes 6 and 11)
Stockholders' equity:    
Preferred stock, par value $0.001 per share, 50,000,000 shares authorized: 9.00% Series A cumulative redeemable preferred stock, $15,000 liquidation preference ($25.00 per share), 600,000 shares issued and outstanding at September 30, 2023 and December 31, 2022 14,009 14,009
Common stock, par value $0.001 per share, 50,000,000 shares authorized: 28,039,830 and 27,972,830 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 28 28
Additional paid-in capital 2,081,291 2,065,248
Dividends in excess of earnings (146,659) (117,392)
Total stockholders' equity 1,948,669 1,961,893
Total liabilities and stockholders' equity $ 2,389,423 $ 2,414,836
v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Preferred stock, Par Value (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Par Value (in dollars per share) $ 0.001 $ 0.001
Common Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Shares Issued 28,039,830 27,972,830
Common Stock, Shares Outstanding 28,039,830 27,972,830
Series A Preferred Stock    
Preferred stock, Par Value (in dollars per share) $ 0.001  
Preferred Stock, Dividend Rate, Percentage 9.00% 9.00%
Preferred Stock, Liquidation Preference, Value $ 15,000 $ 15,000
Preferred Stock, Liquidation Preference Per Share $ 25.00 $ 25.00
Preferred Stock, Shares Issued 600,000 600,000
Preferred Stock, Shares Outstanding 600,000 600,000
v3.23.3
Condensed Consolidated Statements of Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Rental (including tenant reimbursements) $ 77,286 $ 70,345 $ 228,734 $ 204,454
Other 540 538 1,616 1,444
Total revenues 77,826 70,883 230,350 205,898
Expenses:        
Property expenses 6,318 2,823 17,700 7,232
General and administrative expense 10,981 10,804 31,924 28,288
Depreciation and amortization expense 16,678 15,900 50,096 45,001
Total expenses 33,977 29,527 99,720 80,521
Income from operations 43,849 41,356 130,630 125,377
Interest and other income 2,075 773 6,625 1,411
Interest expense (4,330) (4,513) (13,322) (13,783)
Gain (loss) on exchange of Exchangeable Senior Notes     22 (125)
Net income 41,594 37,616 123,955 112,880
Preferred stock dividends (338) (338) (1,014) (1,014)
Net income attributable to common stockholders $ 41,256 $ 37,278 $ 122,941 $ 111,866
Net income attributable to common stockholders per share (Note 8):        
Basic (in dollars per share) $ 1.46 $ 1.33 $ 4.36 $ 4.10
Diluted (in dollars per share) $ 1.45 $ 1.32 $ 4.32 $ 4.06
Weighted-average shares outstanding:        
Basic (in shares) 27,983,004 27,938,568 27,971,544 27,144,953
Diluted (in shares) 28,265,605 28,157,934 28,248,054 27,496,151
v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In-Capital
Adjustment
Additional Paid-In-Capital
Dividends in Excess of Earnings
Adjustment
Dividends in Excess of Earnings
Adjustment
Total
Balances at beginning of period at Dec. 31, 2021 $ 14,009 $ 26 $ (1,340) $ 1,672,882 $ 728 $ (75,218) $ (612) $ 1,611,699
Balances at beginning of period (in shares) at Dec. 31, 2021   25,612,541            
Net Income (Loss)           112,880   112,880
Issuance of unvested restricted stock, net of forfeitures       (2,441)       (2,441)
Issuance of unvested restricted stock, net of forfeitures (in shares)   15,174            
Exchange of Exchangeable Senior Notes       26,682       26,682
Exchange of Exchangeable Senior Notes (in shares)   413,166            
Net proceeds from sale of common stock   $ 2   351,958       351,960
Net proceeds from sale of common stock (in shares)   1,932,813            
Preferred stock dividends           (1,014)   (1,014)
Common stock dividends           (145,434)   (145,434)
Stock-based compensation       13,195       13,195
Balances at end of period at Sep. 30, 2022 14,009 $ 28   2,060,936   (108,058)   1,966,915
Balances at end of period (in shares) at Sep. 30, 2022   27,973,694            
Balances at beginning of period at Jun. 30, 2022 14,009 $ 28   2,056,568   (94,833)   1,975,772
Balances at beginning of period (in shares) at Jun. 30, 2022   27,973,429            
Net Income (Loss)           37,616   37,616
Exchange of Exchangeable Senior Notes       17       17
Exchange of Exchangeable Senior Notes (in shares)   265            
Preferred stock dividends           (338)   (338)
Common stock dividends           (50,503)   (50,503)
Stock-based compensation       4,379       4,379
Payment of common stock offering costs       (28)       (28)
Balances at end of period at Sep. 30, 2022 14,009 $ 28   2,060,936   (108,058)   1,966,915
Balances at end of period (in shares) at Sep. 30, 2022   27,973,694            
Balances at beginning of period at Dec. 31, 2022 14,009 $ 28   2,065,248   (117,392)   1,961,893
Balances at beginning of period (in shares) at Dec. 31, 2022   27,972,830            
Net Income (Loss)           123,955   123,955
Issuance of unvested restricted stock, net of forfeitures       (568)       (568)
Issuance of unvested restricted stock, net of forfeitures (in shares)   34,800            
Exchange of Exchangeable Senior Notes       1,964       1,964
Exchange of Exchangeable Senior Notes (in shares)   32,200            
Preferred stock dividends           (1,014)   (1,014)
Common stock dividends           (152,208)   (152,208)
Stock-based compensation       14,647       14,647
Balances at end of period at Sep. 30, 2023 14,009 $ 28   2,081,291   (146,659)   1,948,669
Balances at end of period (in shares) at Sep. 30, 2023   28,039,830            
Balances at beginning of period at Jun. 30, 2023 14,009 $ 28   2,076,357   (137,174)   1,953,220
Balances at beginning of period (in shares) at Jun. 30, 2023   28,040,054            
Net Income (Loss)           41,594   41,594
Issuance of unvested restricted stock, net of forfeitures (in shares)   (224)            
Preferred stock dividends           (338)   (338)
Common stock dividends           (50,741)   (50,741)
Stock-based compensation       4,934       4,934
Balances at end of period at Sep. 30, 2023 $ 14,009 $ 28   $ 2,081,291   $ (146,659)   $ 1,948,669
Balances at end of period (in shares) at Sep. 30, 2023   28,039,830            
v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income $ 123,955 $ 112,880
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 50,096 45,001
Loss (gain) on exchange of Exchangeable Senior Notes (22) 125
Other non-cash adjustments 83 158
Stock-based compensation 14,647 13,195
Amortization of discounts on investments (2,894) (1,068)
Amortization of debt discount and issuance costs 1,021 1,017
Changes in assets and liabilities    
Other assets, net (2,905) (6,555)
Accounts payable, accrued expenses and other liabilities 5,077 5,339
Rent received in advance and tenant security deposits 404 8,683
Net cash provided by (used in) operating activities 189,462 178,775
Cash flows from investing activities    
Purchases of investments in real estate (34,906) (150,090)
Funding of draws for improvements and construction (129,502) (316,469)
Funding of construction loan and other investments (3,535) (21,360)
Deposits in escrow for acquisitions   (100)
Purchases of short-term investments (91,772) (278,717)
Maturities of short-term investments 253,716 365,000
Net cash provided by (used in) investing activities (5,999) (401,736)
Cash flows from financing activities    
Issuance of common stock, net of offering costs   351,960
Dividends paid to common stockholders (151,969) (133,440)
Dividends paid to preferred stockholders (1,014) (1,014)
Taxes paid related to net share settlement of equity awards (568) (2,441)
Net cash provided by (used in) financing activities (153,551) 215,065
Net increase (decrease) in cash, cash equivalents and restricted cash 29,912 (7,896)
Cash, cash equivalents and restricted cash, beginning of period 88,572 86,419
Cash, cash equivalents and restricted cash, end of period 118,484 78,523
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest, net of interest capitalized 8,253 8,997
Supplemental disclosure of non-cash investing and financing activities:    
Accrual for current-period additions to real estate 10,520 35,195
Deposits applied for acquisitions 250 25
Accrual for common and preferred stock dividends declared 51,079 50,841
Exchange of Exchangeable Senior Notes for common stock $ 1,964 26,682
Operating lease liability for obtaining right of use asset   $ 1,017
v3.23.3
Organization
9 Months Ended
Sep. 30, 2023
Organization  
Organization

1. Organization

As used herein, the terms “we”, “us”, “our” or the “Company” refer to Innovative Industrial Properties, Inc., a Maryland corporation, and any of our subsidiaries, including IIP Operating Partnership, LP, a Delaware limited partnership (our “Operating Partnership”).

We are an internally-managed real estate investment trust (“REIT”) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. We have acquired and intend to continue to acquire our properties through sale-leaseback transactions and third-party purchases. We have leased and expect to continue to lease our properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, real estate taxes and insurance.

We were incorporated in Maryland on June 15, 2016. We conduct our business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which our properties are owned by our Operating Partnership, directly or through subsidiaries. We are the sole general partner of our Operating Partnership and own, directly or through subsidiaries, 100% of the limited partnership interests in our Operating Partnership.

v3.23.3
Summary of Significant Accounting Policies and Procedures
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies and Procedures  
Summary of Significant Accounting Policies and Procedures

2. Summary of Significant Accounting Policies and Procedures

Basis of Presentation. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm’s review.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2023.

Reclassification. We have combined $705.3 million of “Tenant improvements” as of December 31, 2022, which represented building improvements in which we are considered to be the accounting owner, with “Building and improvements” in our consolidated balance sheets to conform to the current period presentation as of September 30, 2023. There was no change to “Total real estate, at cost”.

Federal Income Taxes. We believe that we have operated our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Under the REIT operating structure, we are permitted to deduct dividends paid to our stockholders in determining our taxable income. Assuming our dividends equal or exceed our taxable net income, we generally will not be required to pay federal corporate income taxes on such income. The income taxes recorded on our condensed consolidated statements of income represent amounts paid for city and state income and franchise taxes and are included in general and administrative expenses in the accompanying condensed consolidated statements of income.

Use of Estimates. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions. The most significant estimates and assumptions made include determination of lease accounting, fair value of acquisition of real estate properties and valuation of stock-based compensation.

Reportable Segment. We are engaged in the business of providing real estate for the regulated cannabis industry. Our properties are similar in that they are leased to the state-licensed operators on a long-term triple-net basis, consist of improvements that are reusable and have similar economic characteristics. Our chief operating decision maker reviews financial information for our entire consolidated operations when making decisions related to assessing our operating performance. We have aggregated the properties into one reportable segment as the properties share similar long-term economic characteristics and have other similarities, including the fact that they are operated using consistent business strategies. The financial information disclosed herein represents all of the financial information related to our one reportable segment.

Acquisition of Real Estate Properties. Our investment in real estate is recorded at historical cost, less accumulated depreciation. Upon acquisition of a property, the tangible and intangible assets acquired and liabilities assumed are initially measured based upon their relative fair values. We estimate the fair value of land by reviewing comparable sales within the same submarket and/or region. We estimate the fair value of buildings and improvements as if the property was vacant, taking into consideration current replacement costs and other relevant market rate information and may engage third-party valuation specialists. Acquisition costs are capitalized as incurred. All of our acquisitions to date were recorded as asset acquisitions.

The fair value of acquired in-place leases is derived based on our assessment of estimated lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased. The amounts recorded for acquired in-place leases are reflected as in-place lease intangible assets, net on our condensed consolidated balance sheets and are amortized on a straight-line basis as a component of depreciation and amortization expense over the remaining term of the applicable leases.

The fair value of the above-market component of an acquired in-place operating lease is based upon the present value (calculated using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining non-cancellable lease term and (ii) our estimate of the rents that would be paid using fair market rental rates and rent escalations at the date of acquisition measured over the remaining non-cancellable term of the lease. The amount recorded for one above-market operating lease is included in other assets, net on our condensed consolidated balance sheets and is amortized on a straight-line basis as a reduction of rental revenues over the remaining term of the applicable lease.

Sale of Real Estate. When a real estate asset is sold, we evaluate the provisions of ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”) to determine whether the asset is within the scope of ASC 610-20, including an evaluation of whether the asset being sold is a nonfinancial asset and whether the buyer has gained control of an asset within the scope of ASC 610-20. In assessing whether the buyer has gained control of the asset, we must determine whether the contract criteria in ASC 606, Revenue from Contracts with Customers (Topic 606) have been met, including 1) the parties to the contract have approved the contract and the contract has commercial substance, 2) we can identify each party’s rights regarding the asset to be transferred, 3) we can identify the payment terms for the asset to be transferred, and 4) it is probable that we will collect substantially all of the consideration to which we will be entitled in exchange for the asset to be transferred. If all of the contract criteria have been met, the carrying amount of the applicable asset is derecognized with a corresponding gain or loss from the sale recognized in our consolidated statements of income. If the contract criteria are not all met, the asset transferred is not derecognized and we continue to report the asset in our condensed consolidated balance sheet. See Note 6 “Investments in Real Estate - Property Disposition” for further information.

Cost Capitalization and Depreciation. We capitalize costs associated with development and redevelopment activities and improvements when we are considered to be the accounting owner of the resulting assets. The development and redevelopment activities may be funded by us pursuant to the lease. We are generally considered the accounting owner for such improvements that are attached to or built into the premises, which are required under the lease to be surrendered to us upon the expiration or earlier termination of the lease. Typically, such improvements include, but are not limited to, ground up development, and enhanced HVAC, plumbing, electrical and other building systems.

Amounts capitalized are depreciated over estimated useful lives determined by management. We depreciate buildings and improvements based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. For the three months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $16.5 million and $15.7 million, respectively, and for the nine months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $49.5 million and $44.4 million, respectively. Depreciation expense relating to our real estate held for investment is included in depreciation and amortization expense in our condensed consolidated statements of income. We depreciate office equipment and furniture and fixtures over estimated useful lives ranging from three to seven years. We depreciate the leasehold improvements at our corporate office over the shorter of the estimated useful lives or the remaining lease term. Depreciation expense relating to our corporate assets is included in general and administrative expense in our condensed consolidated statements of income.

Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. Project costs that are clearly associated with the acquisition and development or redevelopment of a real estate project, for which we are the accounting owner, are capitalized as a cost of that project. Expenditures that meet one or more of the following criteria generally qualify for capitalization:

the expenditure provides benefit in future periods; and
the expenditure extends the useful life of the asset beyond our original estimates.

We define redevelopment properties as existing properties for which we expect to spend significant development and construction costs that are not reimbursements to tenants for improvements at the properties. When existing properties are determined to be redevelopment properties, the net carrying value of the buildings and improvements are transferred to construction in progress while the redevelopment activities are in process. During the nine months ended September 30, 2023, we reclassified the net carrying value of the buildings and improvements totaling approximately $51.2 million to construction in progress relating to an existing property that was placed into redevelopment. Costs capitalized to construction in progress related to redevelopment properties are transferred to buildings and improvements at historical cost of the properties as the redevelopment project or phases of projects are placed in service.

Provision for Impairment. On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties.

Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the nine months ended September 30, 2023 and 2022.

Revenue Recognition. Our leases are triple-net leases, an arrangement under which the tenant maintains the property while paying us rent. We account for our current leases as operating leases and record revenue for each of our properties on a cash basis due to the uncertain regulatory environment in the United States pertaining to the regulated cannabis industry, the limited operating history of certain tenants and the resulting uncertainty of collectability of lease payments from each tenant over the duration of the lease term. Contractually obligated reimbursements from tenants for recoverable real estate taxes, insurance and operating expenses are included in rental revenues in the period when such costs are reimbursed by the tenants. Contractually obligated real estate taxes that are paid directly by the tenant to the tax authorities are not reflected in our condensed consolidated financial statements.

For the three months ended September 30, 2023, rental revenue recognized included the application of approximately $2.2 million of security deposits for rent with three tenants in connection with lease amendments. For the nine months ended September 30, 2023, rental revenue recognized included the application of approximately $3.1 million of security deposits applied for rent with two tenants who were in default under their respective lease agreements and approximately $4.9 million of security deposits for rent with three tenants in connection with lease amendments.

Construction Loan. In June 2021, we executed a construction loan agreement with a developer, pursuant to which we agreed to lend up to $18.5 million for the development of a regulated cannabis cultivation and processing facility in California. We have an option to purchase the property, and may execute a negotiated lease with an affiliate of the developer or with another third party, if we determine to exercise our purchase option. In February 2023, we amended the construction loan to provide for, among other things: (1) the additional capital commitment of the borrower into the project of $1.0 million; (2) our agreement to fund an additional $4.5 million into the project; (3) an increase in the interest rate effective April 1, 2023; (4) an extension of the loan term to December 31, 2023; and (5) the provision of additional collateral from the borrower for the loan. Interest on the loan continued to accrue through March 31, 2023, with monthly payment of interest having commenced April 1, 2023. As of September 30, 2023, we had funded approximately $21.6 million of the $23.0 million total commitment.

Cash and Cash Equivalents. We consider all highly-liquid investments with original maturities of three months or less to be cash equivalents, which is comprised of short-term money market funds, obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of less than or equal to three months.

Restricted Cash. Restricted cash relates to cash held in escrow accounts for future draws for improvements for tenants in accordance with certain lease agreements.

Investments. Investments consist of obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of greater than three months. Investments are classified as held-to-maturity and stated at amortized cost.

Exchangeable Notes. In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models, and convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature, will no longer be allocated between debt and equity components. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. We adopted ASU 2020-06 on January 1, 2022 and recognized a cumulative-effect adjustment of approximately $728,000 to the opening balance of retained earnings and derecognized approximately $1.3 million of the remaining equity component relating to the outstanding principal balance of our Exchangeable Senior Notes (as defined below) at the date of adoption.

Deferred Financing Costs. The deferred financing costs that are included as a reduction in the net book value of the related liability on our condensed consolidated balance sheets reflect issuance and other costs related to our debt obligations. These costs are amortized as non-cash interest expense using the effective interest method over the life of the related obligations.

Stock-Based Compensation. Stock-based compensation for equity awards is based on the grant date fair value of the equity awards and is recognized over the requisite service or performance period. If awards are forfeited prior to vesting, we reverse any previously recognized expense related to such awards in the period during which the forfeiture occurs and reclassify any non-forfeitable dividends and dividend equivalents previously paid on these awards from retained earnings to compensation expense. Forfeitures are recognized as incurred. Certain equity awards are subject to vesting based upon the satisfaction of various market conditions. Forfeiture of share awards with market-based restrictions does not result in a reversal of previously recognized share-based compensation expense.

Lease Accounting. We elected the practical expedient not to separate certain non-lease components from the lease component if the timing and pattern of transfer are the same for the non-lease component and associated lease component, and the lease component would be classified as an operating lease if accounted for separately. We also elected the short-term lease exception for lessees for leases that are less than 12 months. As lessee, we recognized a liability to account for our future obligations and a corresponding right-of-use asset related to our corporate office lease. The lease liability was initially measured based on the present value of the future lease payments discounted using the estimated incremental borrowing rate of 7.25%, which was the interest rate that we estimate we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. In November 2021, we amended the lease to extend the term from April 2025 to January 2027 in connection with an expansion of the leased space which did not commence until February 2022. As a result of the lease amendment, we re-measured the lease liability relating to the existing lease space and measured the lease liability to the expansion space based on the present value of the respective future lease payments (excluding the extension option that we are not reasonably certain to exercise), discounted using the estimated incremental borrowing rate of 5.5%, which was the interest rate at that time that we estimate we would have had to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period.

The right-of-use asset is measured based on the corresponding lease liability. We did not incur any initial direct leasing costs or exchange any other consideration with the landlord prior to the commencement of the lease. Subsequently, the right-of-use asset is amortized on a straight-line basis during the lease term. For both the three months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $121,000, and for the nine months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $364,000 and $344,000, respectively, which are included in general and administrative expenses in our condensed consolidated statements of income. For the nine months ended September 30, 2023 and 2022, amounts paid and classified as operating activities in our condensed consolidated statements of cash flows for the office lease were approximately $372,000 and $282,000, respectively.

As lessor, for each of our real estate transactions involving the leaseback of the related property to the seller or affiliates of the seller, we determine whether these transactions qualify as sale and leaseback transactions under the accounting guidance. For these transactions, we consider various inputs and assumptions including, but not necessarily limited to, lease terms, renewal options, discount rates, and other rights and provisions in the purchase and sale agreement, lease and other documentation to determine whether control has been transferred to the Company or remains with the lessee. A transaction involving a sale leaseback will be treated as a purchase of a real estate property if it is considered to transfer control of the underlying asset from the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control and will be classified as a sales-type lease if control of the underlying asset is transferred to the lessee. Otherwise, the lease is treated as an operating lease. These criteria also include estimates and assumptions regarding the fair value of the leased facilities, minimum lease payments, the economic useful life of the facilities, the existence of a purchase option, and certain other terms in the lease agreements. The lease accounting guidance requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant’s option. Substantially all of our leases continue to be classified as operating leases and we continue to record revenue for each of our properties on a cash basis. Our tenant reimbursable revenue and property expenses continue to be presented on a gross basis as rental revenues and as property expenses, respectively, on our condensed consolidated statements of income. Property taxes paid directly by the lessee to a third party continue to be excluded from our condensed consolidated financial statements.

Lease amendments are evaluated to determine if the modification grants the lessee an additional right-of-use not included in the original lease and if the lease payments increase commensurate with the standalone price of the additional right-of-use, adjusted for the circumstances of the particular contract. If both conditions are present, the lease amendment is accounted for as a new lease that is separate from the original lease.

Our leases generally contain options to extend the lease terms at the prevailing market rate or at the expiring rental rate at the time of expiration. Certain of our leases provide the lessee with a right of first refusal or right of first offer in the event we market the leased property for sale.

Concentration of Credit Risk. As of September 30, 2023, we owned 108 properties located in 19 states and leased to 29 tenants. The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates.

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2023 and 2022, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

15

%

Ascend Wellness Holdings, Inc. ("Ascend")

4

10

%

Green Thumb Industries, Inc. ("GTI")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

 

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

GTI

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

For the Three Months Ended

September 30, 2022

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

14

%

Parallel

4

10

%

Ascend

4

10

%

GTI

3

8

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2022

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

14

%

Parallel

4

10

%

Ascend

 

4

9

%

Kings Garden Inc. ("Kings Garden")(2)

6

7

%

Trulieve

 

6

7

%

(1)Commencing in November 2022, Parallel defaulted on its obligations to pay rent at one of our Pennsylvania properties. In February 2023, Parallel defaulted on its obligations to pay rent at one of our Texas properties, and we regained possession of that property in March 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information. Excluding security deposits applied for payment of rent for Parallel at one property in Pennsylvania and one property in Texas of approximately $1.8 million and $395,000, respectively, Parallel would have represented 6% of our total rental revenues for the nine months ended September 30, 2023.
(2)In July 2022, Kings Garden defaulted on its obligations to pay rent at all of the properties it leases with us, and pursuant to a confidential, conditional settlement agreement executed on September 11, 2022 between us and Kings Garden, we terminated the leases for two properties and regained possession of those properties, which continued to be in development or redevelopment as of September 30, 2023. Kings Garden paid the stipulated rent during its period of occupancy for the remaining four properties through September 20, 2023, and we regained possession of those properties in September 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

As of September 30, 2023, our largest property was located in New York and accounted for approximately 5.4% of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment as of September 30, 2023. As of December 31, 2022, none of our properties individually represented more than 5% of our net real estate held for investment.

We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.

v3.23.3
Common Stock
9 Months Ended
Sep. 30, 2023
Common Stock.  
Common Stock

3. Common Stock

In January 2023, we terminated the previously existing “at-the-market” offering program and entered into new equity distribution agreements with four sales agents, pursuant to which we may offer and sell from time to time through an “at-the-market” offering program (the “ATM Program”) up to $500.0 million in shares of our common stock. As of September 30, 2023, we had not sold any shares of common stock under the ATM Program.

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchange by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes.

v3.23.3
Preferred Stock
9 Months Ended
Sep. 30, 2023
Preferred Stock.  
Preferred Stock

4. Preferred Stock

As of September 30, 2023, the Company was authorized to issue up to 50,000,000 shares of preferred stock, par value $0.001 per share, and there were 600,000 shares issued and outstanding of 9.00% Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”). The Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus all accrued and unpaid dividends on such Series A Preferred Stock up to, but excluding the redemption date. Holders of the Series A Preferred Stock generally have no voting rights except for limited voting rights if the Company fails to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.

v3.23.3
Dividends
9 Months Ended
Sep. 30, 2023
Dividends  
Dividends

5. Dividends

The following table describes the dividends declared by the Company during the nine months ended September 30, 2023:

    

    

Amount

    

    

Dividend

    

Dividend

Declaration Date

Security Class

Per Share

Period Covered

Paid Date

Amount

 

(In thousands)

March 15, 2023

Common stock

$

1.80

January 1, 2023 to March 31, 2023

April 14, 2023

$

50,725

March 15, 2023

Series A preferred stock

$

0.5625

January 15, 2023 to April 14, 2023

April 14, 2023

$

338

June 15, 2023

Common stock

$

1.80

April 1, 2023 to June 30, 2023

July 14, 2023

$

50,742

June 15, 2023

Series A preferred stock

$

0.5625

April 15, 2023 to July 14, 2023

July 14, 2023

$

338

September 15, 2023

Common stock

$

1.80

July 1, 2023 to September 30, 2023

October 13, 2023

$

50,742

September 15, 2023

Series A preferred stock

$

0.5625

July 15, 2023 to October 14, 2023

October 13, 2023

$

338

v3.23.3
Investments in Real Estate
9 Months Ended
Sep. 30, 2023
Investments in Real Estate  
Investments in Real Estate

6. Investments in Real Estate

Acquisitions

The Company acquired the following properties during the nine months ended September 30, 2023 (dollars in thousands):

Rentable 

 Square

 Purchase

Transaction

Property

    

Market

    

Closing Date

    

Feet(1)

    

 Price

    

 Costs

    

Total

Susquehanna Street

 

Pennsylvania

February 15, 2023

 

58,000

$

15,000

$

26

$

15,026

Boltonfield Street

 

Ohio

March 3, 2023

 

157,000

 

20,100

 

29

 

20,129

(2)

Total

 

215,000

$

35,100

$

55

$

35,155

(3)

(1)Includes expected rentable square feet at completion of construction of certain properties.
(2)The tenant is expected to complete improvements at the property, for which we agreed to provide funding of up to $21.9 million.
(3)Approximately $2.6 million was allocated to land and approximately $32.6 million was allocated to building and improvements.

Acquired In-Place Lease Intangible Assets

In-place lease intangible assets and related accumulated amortization as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

In-place lease intangible assets

$

9,979

$

9,979

Accumulated amortization

 

 

(1,519)

 

(874)

In-place lease intangible assets, net

$

8,460

$

9,105

Amortization of in-place lease intangible assets classified in depreciation and amortization expense in our condensed consolidated statements of income was approximately $215,000 for both the three months ended September 30, 2023 and 2022, respectively, and was approximately $645,000 and $626,000 for the nine months ended September 30, 2023 and 2022, respectively. The weighted-average remaining amortization period of the acquired in-place leases was approximately 9.8 years, and the estimated annual amortization of the value of the acquired in-place leases as of September 30, 2023 is as follows (in thousands):

Year

    

Amount

2023 (three months ending December 31)

$

215

2024

 

860

2025

 

860

2026

 

860

2027

 

860

Thereafter

 

4,805

Total

$

8,460

Above-Market Lease

The above-market lease and related accumulated amortization included in other assets, net on our condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

Above-market lease

$

1,054

$

1,054

Accumulated amortization

 

 

(164)

 

(95)

Above-market lease, net

$

890

$

959

The above-market lease is amortized on a straight-line basis as a reduction to rental revenues over the remaining lease term of approximately 9.5 years. For the three months ended September 30, 2023 and 2022, the amortization of the above-market lease was approximately $23,000 in each period. For the nine months ended September 30, 2023 and 2022, the amortization of the above-market lease was approximately $69,000 in each period.

Additional Improvement Allowances

In February 2023, we amended our lease with a subsidiary of Ascend at one of our New Jersey properties, increasing the improvement allowance under the lease by $15.0 million to a total of approximately $19.6 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with Ascend to include cross-default provisions applicable to each lease.

In February 2023, we amended our lease and development agreement with PharmaCann at one of our New York properties, increasing the construction funding by $15.0 million to a total of approximately $93.5 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with PharmaCann to include cross-default provisions applicable to each lease.

In February 2023, we amended our lease with a subsidiary of Goodness Growth Holdings Inc. (“Goodness Growth”) at one of our New York properties, increasing the improvement allowance under the lease by $4.0 million to a total of approximately $53.4 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended each of our leases with Goodness Growth to include cross-default provisions applicable to each lease.

Lease Amendments

In January 2023, we entered into lease amendments with Holistic Industries Inc. (“Holistic”) at our properties located in California, Maryland, Massachusetts, Michigan and Pennsylvania, which (1) included cross-default provisions applicable to each lease; (2) extended the term of each lease; and (3) provided that 100% of the base rent shall be applied from the security deposits held by us for (a) the nine months ending September 30, 2023 with respect to the Michigan property and (b) the eight months ending September 30, 2023 with respect to the California property, with pro rata monthly payback of the security deposits over the twelve-month period starting January 2024.

In January 2023, we executed a lease amendment with Calyx Peak, Inc. at our Missouri property, which (1) extended the term of the lease; and (2) provided for 100% base rent deferral through March 31, 2023, with pro rata monthly payback of the deferred rent over the twelve-month period starting April 2023.

In March 2023, we executed a lease amendment with Temescal Wellness of Massachusetts, LLC (“Temescal”) at our Massachusetts property, which (1) provided for temporary reduced base rent from April 2023 through January 2024 to be partially

paid through application of security deposits, with pro rata payback of those security deposits over twelve months starting in February 2024; (2) extended the lease term; and (3) increased base rent for the remainder of the term of the lease.

In July 2023, we amended our lease with a subsidiary of 4Front Ventures Corp. (“4Front”) at one of our Illinois properties, pursuant to which, among other things, we agreed to apply a portion of the security deposit that we hold under the lease to pay one-half of the monthly installments of base rent due from the tenant, commencing on August 1, 2023 and continuing through November 30, 2023, which the tenant is then required to repay over a 12-month period commencing on January 1, 2024.

New Lease

In June 2023, we executed a new long-term lease with a tenant at our property located at 68860 Perez Road in Cathedral City, California that was previously leased to Kings Garden, which is under construction as of September 30, 2023.

Capitalized Costs

During the nine months ended September 30, 2023, we capitalized costs of approximately $111.1 million and funded approximately $129.5 million relating to improvements and construction activities at our properties.

Property Disposition

In March 2023, we sold the portfolio of four properties in California previously leased to affiliates of Medical Investor Holdings, LLC (“Vertical”) for $16.2 million (excluding transaction costs) and provided a secured loan for $16.1 million to the buyer of the properties. The loan matures on February 29, 2028 with two options to extend the maturity for twelve months, conditional in each instance on the payment of an extension fee and at least $500,000 of the principal balance. The loan is interest only and payments are payable monthly in advance. The transaction did not qualify for recognition as a completed sale under GAAP since not all of the criteria were met. Accordingly, we have not derecognized the assets transferred on our condensed consolidated balance sheets. All consideration received, as well as any future payments, from the buyer will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until such time the criteria for recognition as a sale have been met. As of September 30, 2023, we received interest payments of approximately $939,000. In addition, as we have not met all of the held-for-sale criteria, land and building and improvements with a gross carrying value of approximately $3.4 million and approximately $13.9 million, respectively, and accumulated depreciation of approximately $1.5 million as of September 30, 2023, remain on the condensed consolidated balance sheet, and the buildings and improvements continue to be depreciated.

Future Contractual Minimum Rent

Future contractual minimum rent (including base rent and property management fees) under the operating leases as of September 30, 2023 for future periods is summarized as follows (in thousands):

Year

    

Contractual Minimum Rent

2023 (three months ending December 31)

$

71,899

2024

296,878

2025

 

305,612

2026

 

314,670

2027

 

324,001

Thereafter

 

4,167,626

Total

$

5,480,686

v3.23.3
Debt
9 Months Ended
Sep. 30, 2023
Debt  
Debt

7. Debt

Exchangeable Senior Notes

As of September 30, 2023, our Operating Partnership had outstanding approximately $4.4 million principal amount of 3.75% Exchangeable Senior Notes due 2024 (the “Exchangeable Senior Notes”). The Exchangeable Senior Notes are senior unsecured obligations of our Operating Partnership, are fully and unconditionally guaranteed by us and our Operating Partnership’s subsidiaries and are exchangeable for cash, shares of our common stock, or a combination of cash and shares of our common stock, at our Operating Partnership’s option, at any time prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date. The exchange rate for the Exchangeable Senior Notes at September 30, 2023 was 17.06090 shares of our common stock per $1,000 principal amount of Notes and the exchange price at September 30, 2023 was approximately $58.61 per

share of our common stock. The exchange rate and exchange price are subject to adjustment in certain circumstances. The Exchangeable Senior Notes will pay interest semiannually at a rate of 3.75% per annum and will mature on February 21, 2024, unless earlier exchanged or repurchased in accordance with their terms. Our Operating Partnership will not have the right to redeem the Exchangeable Senior Notes prior to maturity, but may be required to repurchase the Exchangeable Senior Notes from holders under certain circumstances. At September 30, 2023, the if-exchanged value of the Exchangeable Senior Notes exceeded the principal amount by approximately $1.3 million.

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchanges by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes. For the nine months ended September 30, 2023, we recognized a gain on the exchange totaling approximately $22,000, resulting from the difference between the fair value and carrying value of the debt as of the date of the exchange. The issuance of the shares pursuant to the exchanges resulted in a net non-cash increase to our additional paid-in capital account of approximately $2.0 million for the nine months ended September 30, 2023.

During the three and nine months ended September 30, 2022, we issued 265 and 413,166 shares, respectively, of our common stock upon exchanges by holders of approximately $17,000 and $26.9 million, respectively, of outstanding principal amount of our Exchangeable Senior Notes. For the nine months ended September 30, 2022, we recognized a loss on the exchanges totaling approximately $125,000, resulting from the difference between the fair value and carrying value of the debt as of the date of the exchange. The issuance of the shares pursuant to the exchanges resulted in a non-cash increase to our additional paid-in capital account of approximately $17,000 and $26.7 million for the three and nine months ended September 30, 2022, respectively.

The following table details our interest expense related to the Exchangeable Senior Notes (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

Cash coupon

  

$

41

  

$

60

  

$

140

  

$

391

Amortization of issuance cost

  

9

  

12

  

29

  

83

Capitalized interest

(2)

(2)

Total interest expense

  

$

48

  

$

72

  

$

167

  

$

474

The following table details the carrying value of our Exchangeable Senior Notes (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

4,436

  

$

6,436

Unamortized issuance cost

  

 

(13)

  

(56)

Carrying value

  

$

4,423

  

$

6,380

Accrued interest payable for the Exchangeable Senior Notes as of September 30, 2023 and December 31, 2022 was approximately $7,000 and $70,000, respectively, and is included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

Notes due 2026

On May 25, 2021, our Operating Partnership issued $300.0 million aggregate principal amount of its 5.50% Senior Notes due 2026 (the “Notes due 2026”). The Notes due 2026 are senior unsecured obligations of our Operating Partnership, are fully and unconditionally guaranteed by us and our Operating Partnership’s subsidiaries and rank equally in right of payment with all of the Operating Partnership’s existing and future senior unsecured indebtedness, including the Exchangeable Senior Notes. However, the Notes due 2026 are effectively subordinated to any of the Company’s, the Operating Partnership’s and the Operating Partnership’s subsidiaries’ future secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes due 2026 will pay interest semiannually at a rate of 5.50% per year and will mature on May 25, 2026. The terms of the Notes due 2026 are governed by an indenture, dated May 25, 2021, among the Operating Partnership, as issuer, the Company and the Operating Partnership’s subsidiaries, as guarantors, Argent Institutional Trust Company, as trustee (as successor-in-interest to GLAS Trust Company LLC), and Securities Transfer Corporation, as registrar (as successor-in-interest to GLAS Trust Company LLC). The terms of the indenture provide that if the debt rating on the Notes due 2026 is downgraded or withdrawn entirely, interest on the Notes due 2026 will increase to a range of 6.0% to 6.5% based on such debt rating.

In connection with the issuance of the Notes due 2026, we recorded approximately $6.8 million of issuance costs, which are being amortized using the effective interest method and recognized as non-cash interest expense over the term of the Notes due 2026.

The following table details our interest expense related to the Notes due 2026 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

2022

    

2023

2022

Cash coupon

$

4,125

$

4,125

$

12,375

$

12,375

Amortization of issuance cost

 

335

316

992

934

Capitalized interest

 

(178)

(212)

Total interest expense

$

4,282

$

4,441

$

13,155

$

13,309

The following table details the carrying value of our Notes due 2026 (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

300,000

  

$

300,000

Unamortized issuance cost

  

 

(3,893)

  

(4,885)

Carrying value

  

$

296,107

  

$

295,115

The Operating Partnership may redeem some or all of the Notes due 2026 at its option at any time at the applicable redemption price. If the Notes due 2026 are redeemed prior to February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus a make-whole premium and accrued and unpaid interest thereon to, but excluding, the applicable redemption date. If the Notes due 2026 are redeemed on or after February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus accrued and unpaid interest thereon to, but excluding, the applicable redemption date.

The terms of the indenture for the Notes due 2026 require compliance with various financial covenants, including minimum level of debt service coverage and limits on the amount of total leverage and secured debt maintained by the Operating Partnership. Management believes that it was in compliance with those covenants as of September 30, 2023.

Accrued interest payable for the Notes due 2026 as of September 30, 2023 and December 31, 2022 was approximately $6.2 million and $2.1 million, respectively, and is included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

The following table summarizes the principal payments on our outstanding indebtedness as of September 30, 2023 (in thousands):

Payments Due

by Year

    

Amount

2023 (three months ending December 31)

$

2024

4,436

2025

2026

300,000

2027

Thereafter

Total

$

304,436

v3.23.3
Net Income Per Share
9 Months Ended
Sep. 30, 2023
Net Income Per Share  
Net Income Per Share

8. Net Income Per Share

Grants of restricted stock and restricted stock units (“RSUs”) of the Company in share-based payment transactions are considered participating securities prior to vesting and, therefore, are considered in computing basic earnings per share under the two-class method. The two-class method is an earnings allocation method for calculating earnings per share when a company’s capital structure includes either two or more classes of common stock or common stock and participating securities. Earnings per basic share under the two-class method is calculated based on dividends declared on common shares and other participating securities (“distributed earnings”) and the rights of participating securities in any undistributed earnings, which represents net income remaining after deduction of dividends accruing during the period. The undistributed earnings are allocated to all outstanding common shares and participating securities based on the relative percentage of each security to the total number of outstanding participating securities. Earnings per basic share represents the summation of the distributed and undistributed earnings per share class divided by the total number of shares.

Through September 30, 2023, all of the Company’s participating securities received dividends or dividend equivalents at an equal dividend rate per share or unit. As a result, distributions to participating securities for the three and nine months ended September 30, 2023 and 2022 have been included in net income attributable to common stockholders to calculate net income per basic and diluted share.

The 75,682 and 83,007 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the three and nine months ended September 30, 2023, respectively, and were included in the computation of diluted earnings per share. The 100,799 and 235,753 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the three and nine months ended September 30, 2022, respectively, and were included in the computation of diluted earnings per share.

For the three and nine months ended September 30, 2023 and 2022, the performance share units (“PSUs”) granted to certain employees were not included in dilutive securities as the performance thresholds for vesting of the PSUs were not met as measured as of the respective dates (see Note 10 for further discussion of PSUs).

Computations of net income per basic and diluted share (in thousands, except share and per share data) were as follows:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Net income

$

41,594

$

37,616

$

123,955

$

112,880

Preferred stock dividends

 

(338)

 

(338)

(1,014)

(1,014)

Distribution to participating securities

 

(372)

 

(213)

(1,106)

(622)

Net income attributable to common stockholders used to compute net income per share – basic

40,884

37,065

121,835

111,244

Dilutive effect of Exchangeable Senior Notes

50

72

169

474

Net income attributable to common stockholders used to compute net income per share – diluted

$

40,934

$

37,137

$

122,004

$

111,718

Weighted-average common shares outstanding:

Basic

 

27,983,004

 

27,938,568

27,971,544

27,144,953

Restricted stock and RSUs

206,919

118,567

193,503

115,445

Dilutive effect of Exchangeable Senior Notes

75,682

100,799

83,007

235,753

Diluted

 

28,265,605

 

28,157,934

28,248,054

27,496,151

Net income attributable to common stockholders per share:

Basic

$

1.46

$

1.33

$

4.36

$

4.10

Diluted

$

1.45

$

1.32

$

4.32

$

4.06

v3.23.3
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2023
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

9. Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2—Includes other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs that are supported by little or no market activities, therefore requiring an entity to develop its own assumptions.

The following table presents the carrying value and approximate fair value of financial instruments at September 30, 2023 and December 31, 2022 (in thousands):

At September 30, 2023

At December 31, 2022

                                                                                                          

                                                                                                                         

                                                                                                

                                                                                                                                   

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Investments(1)

$

41,885

$

41,880

$

200,935

$

200,715

Investments as cash equivalents(2)

$

20,100

$

20,091

$

$

Exchangeable Senior Notes(3)

$

4,423

$

5,577

$

6,380

$

10,282

Notes due 2026(3)

$

296,107

$

268,611

$

295,115

$

264,234

Construction Loan(4)

$

21,556

$

26,362

$

18,021

$

20,167

(1)Investments consisting of obligations of the U.S. government with an original maturity at the time of purchase of greater than three months are classified as held-to-maturity and valued using Level 1 inputs.
(2)Investments as cash equivalents consisting of obligations of the U.S. government with an original maturity at the time of purchase of less than or equal to three months are classified as held-to-maturity and valued using Level 1 inputs.
(3)The fair value is determined based upon Level 2 inputs as the Exchangeable Senior Notes and Notes due 2026 were trading in the private market.
(4)The construction loan receivable is categorized as Level 3 and was valued using a yield analysis, which is typically performed for non-credit impaired loans. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. At September 30, 2023 and December 31, 2022, the expected market yield used to determine fair value was 25%. Changes in market yields may change the
fair value of the construction loan. Generally, an increase in market yields may result in a decrease in the fair value of the construction loan. Due to the inherent uncertainty of determining the fair value of a loan that does not have a readily available market value, the fair value of the construction loan may fluctuate from period to period. Additionally, the fair value of the construction loan may differ significantly from the value that would have been used had a readily available market existed for such loan and may differ materially from the value that the Company may ultimately realize.

The carrying amounts of cash equivalents, accounts payable, accrued expenses and other liabilities approximate their fair values.

v3.23.3
Common Stock Incentive Plan
9 Months Ended
Sep. 30, 2023
Common Stock Incentive Plan  
Common Stock Incentive Plan

10. Common Stock Incentive Plan

Our board of directors adopted our 2016 Omnibus Incentive Plan (the “2016 Plan”) to enable us to motivate, attract and retain the services of directors, employees and consultants considered essential to our long-term success. The 2016 Plan offers our directors, employees and consultants an opportunity to own our stock or rights that will reflect our growth, development and financial success. Under the terms of the 2016 Plan, the aggregate number of shares of our common stock subject to options, restricted stock, stock appreciation rights, restricted stock units and other awards, will be no more than 1,000,000 shares. Any equity awards that lapse, expire, terminate, are canceled or are forfeited (including forfeitures in connection with satisfaction of tax withholdings obligations of the recipient) are re-credited to the 2016 Plan’s reserve for future issuance. The 2016 Plan automatically terminates on the date which is ten years following the effective date of the 2016 Plan.

A summary of the restricted stock activity under the 2016 Plan and related information for the nine months ended September 30, 2023 is included in the table below:

    

    

Weighted-

Unvested

Average

Restricted

Grant Date Fair

Stock

Value

Balance at December 31, 2022

 

34,026

$

181.08

Granted

 

35,565

$

110.88

Vested

 

(9,154)

$

187.00

Forfeited(1)

 

(5,596)

$

115.01

Balance at March 31, 2023

 

54,841

$

141.31

Granted

5,055

$

71.23

Vested

(2,811)

$

128.11

Balance at June 30, 2023

57,085

$

135.75

Granted

150

$

80.49

Vested

(150)

$

80.49

Forfeited(1)

(374)

$

135.84

Balance at September 30, 2023

56,711

$

135.75

(1)Shares that were forfeited to cover the employees’ tax withholding obligation upon vesting or employees’ cessation of employment.

The remaining unrecognized compensation cost of approximately $5.2 million for restricted stock awards is expected to be recognized over a weighted-average amortization period of approximately 1.8 years as of September 30, 2023. The fair value of restricted stock that vested during the nine months ended September 30, 2023 was approximately $1.7 million.

The following table summarizes our RSU activity for the nine months ended September 30, 2023. RSUs are issued as part of the Innovative Industrial Properties, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows a select group of management and our non-employee directors to defer receiving certain of their cash and equity-based compensation. RSUs are subject to vesting conditions of the Deferred Compensation Plan and have the same economic rights as shares of restricted stock under the 2016 Plan:

    

    

Weighted-Average

Restricted

Grant Date Fair

Stock Units

Value

Balance at December 31, 2022

83,677

$

144.30

Granted

61,785

$

103.60

Balance at March 31, 2023

145,462

$

127.01

Granted

4,494

$

71.23

Balance at June 30, 2023

149,956

$

125.34

Granted

$

-

Balance at September 30, 2023

149,956

$

125.34

The remaining unrecognized compensation cost of approximately $7.3 million for RSU awards is expected to be recognized over an amortization period of approximately 1.9 years as of September 30, 2023.

In January 2021 and 2022, we issued 70,795 and 102,641 “target” PSUs, respectively, to a select group of officers, which vest and are settled in shares of common stock based on the Company’s total stockholder return over a performance period of approximately three years from the grant date.

Stock-based compensation for market-based PSU awards is based on the grant date fair value of the equity awards and is recognized over the applicable Performance Period. For both the three and nine months ended September 30, 2023 and 2022, we recognized stock-based compensation expense of approximately $2.7 million and $8.0 million, respectively, relating to PSU awards. As of September 30, 2023, the remaining unrecognized compensation cost of approximately $9.3 million relating to PSU awards is expected to be recognized over the remaining Performance Period of approximately 1.2 years.

As measured as of September 30, 2023, the performance thresholds for the vesting of the PSUs were not met for any of the applicable awards.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies  
Commitments and Contingencies

11. Commitments and Contingencies

Office Lease. The future contractual lease payments for our office lease and the reconciliation to the office lease liability reflected in other liabilities in our condensed consolidated balance sheet as of September 30, 2023 is presented in the table below (in thousands):

Year

    

Amount

2023 (three months ending December 31)

$

124

2024

 

511

2025

 

526

2026

 

543

2027

 

45

Total future contractual lease payments

 

1,749

Effect of discounting

 

(166)

Office lease liability

$

1,583

Improvement Allowances. As of September 30, 2023, we had approximately $17.2 million of commitments related to improvement allowances, which generally may be requested by the tenants at any time up until a date that is near the expiration of the initial term of the applicable lease.

Construction Loan. As of September 30, 2023, we had approximately $1.4 million of commitments related to our construction loan for the development of a regulated cannabis cultivation and processing facility in California. The developer is required to complete construction by December 31, 2023, subject to extension in certain circumstances.

Environmental Matters. We follow the policy of monitoring our properties, both targeted acquisition and existing properties, for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liabilities that would have a material adverse effect on our financial condition, results of operations and cash flow, or that we believe would require disclosure or the recording of a loss contingency.

Litigation.

Class Action Lawsuit

On April 25, 2022, a federal securities class action lawsuit was filed against the Company and certain of its officers. The case was named Michael V. Malozzi, individually and on behalf of others similarly situated v. Innovative Industrial Properties, Inc., Paul Smithers, Catherine Hastings and Andy Bui, Case No. 2-22-cv-02359, and was filed in the U.S. District Court for the District of New Jersey. The lawsuit was purportedly brought on behalf of purchasers of our common stock and alleges that we and certain of our officers made false or misleading statements regarding our business in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), SEC Rule 10b-5, and Section 20(a) of the Exchange Act. According to the filed complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between May 7, 2020 and April 13, 2022.

On September 29, 2022, an Amended Class Action Complaint was filed under the same Case Number, adding as defendants Alan D. Gold and Benjamin C. Regin, and asserting causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. On December 1, 2022, defendants moved to dismiss the Amended Class Action Complaint; on January 25, 2023, plaintiff responded to defendants’ motion to dismiss the Amended Class Action Complaint; and on March 6, 2023 defendants replied to plaintiff’s response. On September 19, 2023, the court granted defendants’ motion to dismiss the Amended Class Action Complaint without prejudice. On October 19, 2023, a Second Amended Class Action complaint was filed under the same Case Number, and asserted causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Second Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. It is possible that similar lawsuits may yet be filed in the same or other courts that name the same or additional defendants. We intend to defend the lawsuit vigorously. However, at this time, we cannot predict the probable outcome of this action, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements.

Derivative Action Lawsuit

On July 26, 2022, a derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named John Rice, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, and Innovative Industrial Properties, Inc., and was filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets against the directors and certain officers of the Company.  The plaintiffs are seeking declaratory relief, direction to reform and improve corporate governance and internal procedures, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On September 6, 2022, the defendants in this action filed a Consent Motion to Stay the Proceedings, which was granted on October 11, 2022. On September 28, 2022, a second derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Karen Drover, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, Defendants, and Innovative Industrial Properties Inc., Nominal Defendant, Case Number 24-C-22-004243, and filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, and seeks actions to reform and improve the Company, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On October 19, 2022, the parties to both cases filed a Joint Motion to Consolidate Related Shareholder Derivative Actions and to Appoint Lead and Liaison Counsel for plaintiffs, which was granted on December 16, 2022, along with a stay in the lawsuit pending a ruling on the defendants’ motion to dismiss the federal class action lawsuit described above. On April 17, 2023, a third derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Ross Weintraub, derivatively on behalf of Innovative Industrial Properties, Inc. v. Alan Gold, Paul Smithers, Catherine Hastings, Ben Regin, Andy Bui, Tracie Hager, Gary Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-00737-GLR, and filed in the United States District Court for the District of Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty and violations of Section 14(a) of the Exchange Act, and seeks an undetermined amount of damages, equitable relief, and attorneys’ fees and costs. Defendants in this

action filed a Consent Motion to Stay the Proceeding, which was granted on April 17, 2023. On June 5, 2023, a fourth derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Franco DeBlasio, on behalf of Gerich Melenth Nin (GMN) LP, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Alan D. Gold, Tracie J. Hager, Benjamin C. Regin, Andy Bui, Gary A. Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-01513-GLR, and filed in the United States District Court for the District of Maryland. The Company intends to vigorously defend each of these lawsuits. However, at this time, the Company cannot predict the probable outcome of these actions, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements. On July 19, 2023, the United States Court for the District of Maryland consolidated Case Nos. 1:23-cv-00737-GLR and 1:23-cv-01513-GLR with case number 1:23-cv-00737-GLR as the lead case, and kept the stay in place.

Kings Garden Lawsuit

In July 2022, one of our tenants, Kings Garden Inc., defaulted on its obligations to pay base rent and property management fees under each of its six leases with our indirect, wholly owned subsidiary, IIP-CA 2 LP, and defaulted on its obligations to reimburse us for certain insurance premiums at the properties incurred by us that are payable by Kings Garden as operating expenses under such leases.

On July 25, 2022, IIP-CA 2 LP filed a lawsuit against Kings Garden. The case was named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation, and JM Endeavors, Inc., a California corporation, and was filed in the Superior Court of the State of California. The lawsuit asserts claims for breach of contract, declaratory relief, and injunctive relief. On August 2, 2022, the case was amended to be named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation,  JM Endeavors, Inc., a California corporation, Michael King, an individual, Gary LaSalle, an individual, Charles Kieley, an individual, and Laurie Kibby, an individual, and to include claims relating to construction at two projects as of June 30, 2022 for breach of implied covenant of good faith and fair dealing, fraud, negligent misrepresentation, conversion, theft by false pretenses, money had and received, and violations of the Racketeer Influenced and Corrupt Organization Act (18 U.S.C. Section 1962(c)). The amount related to these project costs reported in construction in progress as of September 30, 2023 and December 31, 2022 was approximately $28.9 million and $33.2 million, respectively.

On September 11, 2022, the parties to the lawsuit entered into a confidential, conditional settlement agreement pertaining to matters related to the lawsuit. Pursuant to the conditional settlement agreement, as of September 30, 2023, the Company has received a total of approximately $19.8 million in partial settlement payments from Kings Garden, which has been accounted for as a reduction to net real estate held for investment on our condensed consolidated balance sheets. During the three months ended September 30, 2023, we received approximately $4.2 million in additional payments from Kings Garden (reflected in the total amount above) and are investigating the remaining additional costs paid of approximately $750,000 related to one construction project to determine whether these are overpayments. Although there is at least a reasonable possibility that a loss may have been incurred in connection with the default by Kings Garden and the related construction project related to these potential overpayments, as of September 30, 2023, we are unable to make such an estimate.

Additionally, on August 16, 2023, we filed suit against Orr Construction, the general contractor for certain amounts on one construction project undertaken by Kings Garden, named IIP-CA 2 LP v. Orr Builders, asserting claims for fraud, negligent misrepresentation, intentional interference with economic relationship, intentional interference with contract, conspiracy, violation of California unfair competition law, money had and received, and unjust enrichment. The Company contends that the lawsuit arose out of representations made to the Company by Orr Construction while investigating payments made for one construction project, relating to the lawsuit named IIP-CA 2 LP, a Delaware limited partnership v. Kings Garden Inc., a Nevada corporation, CK Endeavors, Inc., a California corporation, and JM Endeavors, Inc., a California corporation, filed in the Superior Court of the State of California, which was ultimately settled. Although there is at least a reasonable possibility that a loss may have been incurred in connection with amounts paid by us and work performed by Orr Construction for that construction project, as of September 30, 2023, we are unable to make such an estimate.

On February 14, 2023, Kings Garden filed an Arbitration Demand related to the interpretation of the confidential, conditional settlement agreement between the parties that concerns certain terms governing (along with the relevant lease) the assignment of one of the Kings Garden leases. The Company filed a Response to Kings Garden’s Arbitration Demand, Affirmative Defenses and Counter-Claim on March 1, 2023 (the “Counter-Claim”). Kings Garden filed an answer to the Counter-Claim on March 15, 2023. In July 2023, the Company filed a motion for leave to amend its Counter-Claims. On August 4, 2023, the Company accepted an offer of judgment extended by Kings Garden under California Code of Civil Procedure Section 998, pursuant to which Kings Garden (i) vacated the remaining four properties it previously occupied in September 2023, paying the stipulated rent during its period of occupancy through September 20, 2023, and (ii) agreed to pay the Company damages and attorneys’ fees totaling approximately $6.0

million, including interest on the then-outstanding amount, on a fully amortizing schedule of approximately $193,000 per month over a three-year period. The offer of judgment included a mutual release.

Parallel Pennsylvania Litigation

On February 6, 2023, IIP-PA 8 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Goodblend Pennsylvania LLC, as tenant, and Parallel, as guarantor, in the Court of Common Pleas of Allegheny County, Pennsylvania, regarding the lease and related guaranty for one of the Company’s properties located in Pennsylvania. The lawsuit asserts claims for breach of contract by the tenant and guarantor and ejectment. Goodblend Pennsylvania LLC and Parallel filed preliminary objections to the lawsuit on March 3, 2023.  IIP-PA 8 LLC filed its response to Goodblend Pennsylvania LLC’s and Parallel’s preliminary objections on March 23, 2023. The Court issued an Order on June 13, 2023 denying Goodblend Pennsylvania LLC’s and Parallel’s preliminary objections and directing Goodblend Pennsylvania LLC and Parallel to file an answer to the complaint. On October 25, 2023, a consent order was executed by the Court which awarded possession of the property to IIP-PA 8 LLC on October 31, 2023 and damages in favor of IIP-PA 8 LLC in the amount of approximately $15.5 million.

Parallel Texas Litigation

On February 11, 2023, a subsidiary of Parallel defaulted on its obligations to pay rent under the lease at one of our properties in Texas that is under development. On February 23, 2023, IIP-TX 1 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Surterra San Marcos, LLC, as tenant, in the Justice Court of Hays County, Texas, regarding the lease, asserting claim for possession. In March 2023, a judgment for possession was entered in favor of IIP-TX 1 LLC, as well as monthly rental amounts due, and we regained possession of the property. On March 13, 2023, IIP-TX 1 LLC filed a subsequent lawsuit against Surterra San Marcos, LLC, Parallel and Sunstream Opportunities LP (“SAF Entity 1”) in the District Court of Hays County, Texas, regarding the same lease, asserting claims against Surterra San Marcos, LLC, Parallel and SAF Entity 1 for breach of contract, tortious interference with contract, unjust enrichment, fraud and fraudulent inducement, intentional failure to disclose and misrepresentations and conversion, and also requested the granting of a temporary injunction and the appointment of a receiver over the license(s) pertaining to the property’s operations as a regulated cannabis facility. The parties exchanged initial disclosures in September 2023, and are in the discovery phase.

Green Peak Michigan Litigation

On February 2, 2023, IIP-MI 1 LLC, as landlord and an indirect subsidiary of the Company, filed a lawsuit against Green Peak Industries, Inc. (“Green Peak”), as tenant, in 56-A District Court of the State of Michigan, regarding the lease for one of the Company’s properties located in Michigan, asserting claim for possession. On February 22, 2023, IIP-MI 1 LLC filed a subsequent lawsuit against Green Peak and Tropics LP (“SAF Entity 2”) in the Circuit Court of Eaton County, Michigan, regarding the same lease, asserting claims against Green Peak for breach of contract, unjust enrichment, and innocent misrepresentation, against SAF Entity 2 for tortious interference with contract, and against both Green Peak and SAF Entity 2 for civil conspiracy (the “Circuit Court Action”). On March 3, 2023, a stipulated order appointing a receiver over substantially all of Green Peak’s assets was entered in the Circuit Court of Ingham County, Michigan (the “Receivership Case”), pursuant to which the Company re-gained possession of one of the Company’s cultivation and processing properties, which is under redevelopment as of September 30, 2023, and two retail properties. As a result of the Receivership Case the claims asserted against Green Peak in the Circuit Court Action were stayed by order of the court and the claims against SAF Entity 2 were suspended by agreement of the parties pending the outcome of the Receivership Case. On September 28, 2023, a stipulation and order was entered in the Receivership Case, pursuant to which the Company is expected to re-gain possession of another retail property in Michigan on November 30, 2023, with the receiver paying contractually due rent through the last date of occupancy. On October 3, 2023, the court approved the sale of substantially all of Green Peak’s remaining assets in receivership to an affiliate of Green Peak’s senior secured lender, with the order approving the sale entered October 12, 2023. The leases for the remaining properties are expected to be assumed by the purchaser in connection with the closing of the sale.

We may, from time to time, be a party to other legal proceedings, which arise in the ordinary course of our business. Although the results of these proceedings, claims, inquiries, and investigations cannot be predicted with certainty, we do not believe that the final outcome of these matters is reasonably likely to have a material adverse effect on our business, financial condition, or results of operations. Regardless of final outcomes, however, any such proceedings, claims, inquiries, and investigations may nonetheless impose a significant burden on management and employees and may come with significant defense costs or unfavorable preliminary and interim rulings.

v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events  
Subsequent Events

12. Subsequent Events

On October 23, 2023, our Operating Partnership entered into a loan and security agreement (the “Loan Agreement”) with a federally regulated commercial bank, as lender and as agent for lenders that become party thereto from time to time. The Loan Agreement matures on October 23, 2026, and provides $30.0 million in aggregate commitments for secured revolving loans, the availability of which is based on a borrowing base consisting of real properties owned by subsidiaries (the “Subsidiary Guarantors”) of the Operating Partnership that satisfy eligibility criteria set forth in the Loan Agreement. The obligations of the Operating Partnership under the Loan Agreement are guaranteed by the Company and the Subsidiary Guarantors, and are secured by (i) operating accounts of the Operating Partnership into which lease payments under the real property included in the borrowing base are paid, (ii) the equity interest of the Subsidiary Guarantors, (iii) the real estate included in the borrowing base and the leases and rents thereunder, and (iv) all personal property of the Subsidiary Guarantors. Borrowings under the Loan Agreement bear interest at a variable rate based on the greater of the prime rate and an applicable margin based on deposits with the participating bank(s) and a stipulated interest rate. The Loan Agreement is subject to certain liquidity and operating covenants and includes customary representations and warranties, affirmative and negative covenants and events of default. The Loan Agreement also allows the Operating Partnership, subject to the satisfaction of certain conditions, to request additional revolving incremental loan commitments up to a specified amount. There were no amounts outstanding under the Loan Agreement as of November 2, 2023.

In October 2023, we amended our lease with a subsidiary of Goodness Growth at one of our New York properties, increasing the improvement allowance under the lease by $14.0 million to a total of approximately $67.4 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. In connection with the lease amendment, the tenant prepaid rent for the three month period commencing on November 1, 2023 and ending January 31, 2024.

v3.23.3
Summary of Significant Accounting Policies and Procedures (Policies)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies and Procedures  
Basis of Presentation

Basis of Presentation. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm’s review.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2023.

Reclassifications

Reclassification. We have combined $705.3 million of “Tenant improvements” as of December 31, 2022, which represented building improvements in which we are considered to be the accounting owner, with “Building and improvements” in our consolidated balance sheets to conform to the current period presentation as of September 30, 2023. There was no change to “Total real estate, at cost”.

Federal Income Taxes

Federal Income Taxes. We believe that we have operated our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Under the REIT operating structure, we are permitted to deduct dividends paid to our stockholders in determining our taxable income. Assuming our dividends equal or exceed our taxable net income, we generally will not be required to pay federal corporate income taxes on such income. The income taxes recorded on our condensed consolidated statements of income represent amounts paid for city and state income and franchise taxes and are included in general and administrative expenses in the accompanying condensed consolidated statements of income.

Use of Estimates

Use of Estimates. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions. The most significant estimates and assumptions made include determination of lease accounting, fair value of acquisition of real estate properties and valuation of stock-based compensation.

Reportable Segment

Reportable Segment. We are engaged in the business of providing real estate for the regulated cannabis industry. Our properties are similar in that they are leased to the state-licensed operators on a long-term triple-net basis, consist of improvements that are reusable and have similar economic characteristics. Our chief operating decision maker reviews financial information for our entire consolidated operations when making decisions related to assessing our operating performance. We have aggregated the properties into one reportable segment as the properties share similar long-term economic characteristics and have other similarities, including the fact that they are operated using consistent business strategies. The financial information disclosed herein represents all of the financial information related to our one reportable segment.

Acquisition of Real Estate Properties

Acquisition of Real Estate Properties. Our investment in real estate is recorded at historical cost, less accumulated depreciation. Upon acquisition of a property, the tangible and intangible assets acquired and liabilities assumed are initially measured based upon their relative fair values. We estimate the fair value of land by reviewing comparable sales within the same submarket and/or region. We estimate the fair value of buildings and improvements as if the property was vacant, taking into consideration current replacement costs and other relevant market rate information and may engage third-party valuation specialists. Acquisition costs are capitalized as incurred. All of our acquisitions to date were recorded as asset acquisitions.

The fair value of acquired in-place leases is derived based on our assessment of estimated lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased. The amounts recorded for acquired in-place leases are reflected as in-place lease intangible assets, net on our condensed consolidated balance sheets and are amortized on a straight-line basis as a component of depreciation and amortization expense over the remaining term of the applicable leases.

The fair value of the above-market component of an acquired in-place operating lease is based upon the present value (calculated using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining non-cancellable lease term and (ii) our estimate of the rents that would be paid using fair market rental rates and rent escalations at the date of acquisition measured over the remaining non-cancellable term of the lease. The amount recorded for one above-market operating lease is included in other assets, net on our condensed consolidated balance sheets and is amortized on a straight-line basis as a reduction of rental revenues over the remaining term of the applicable lease.

Sale of Real Estate

Sale of Real Estate. When a real estate asset is sold, we evaluate the provisions of ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”) to determine whether the asset is within the scope of ASC 610-20, including an evaluation of whether the asset being sold is a nonfinancial asset and whether the buyer has gained control of an asset within the scope of ASC 610-20. In assessing whether the buyer has gained control of the asset, we must determine whether the contract criteria in ASC 606, Revenue from Contracts with Customers (Topic 606) have been met, including 1) the parties to the contract have approved the contract and the contract has commercial substance, 2) we can identify each party’s rights regarding the asset to be transferred, 3) we can identify the payment terms for the asset to be transferred, and 4) it is probable that we will collect substantially all of the consideration to which we will be entitled in exchange for the asset to be transferred. If all of the contract criteria have been met, the carrying amount of the applicable asset is derecognized with a corresponding gain or loss from the sale recognized in our consolidated statements of income. If the contract criteria are not all met, the asset transferred is not derecognized and we continue to report the asset in our condensed consolidated balance sheet. See Note 6 “Investments in Real Estate - Property Disposition” for further information.

Cost Capitalization and Depreciation

Cost Capitalization and Depreciation. We capitalize costs associated with development and redevelopment activities and improvements when we are considered to be the accounting owner of the resulting assets. The development and redevelopment activities may be funded by us pursuant to the lease. We are generally considered the accounting owner for such improvements that are attached to or built into the premises, which are required under the lease to be surrendered to us upon the expiration or earlier termination of the lease. Typically, such improvements include, but are not limited to, ground up development, and enhanced HVAC, plumbing, electrical and other building systems.

Amounts capitalized are depreciated over estimated useful lives determined by management. We depreciate buildings and improvements based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. For the three months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $16.5 million and $15.7 million, respectively, and for the nine months ended September 30, 2023 and 2022, we recognized depreciation expense of approximately $49.5 million and $44.4 million, respectively. Depreciation expense relating to our real estate held for investment is included in depreciation and amortization expense in our condensed consolidated statements of income. We depreciate office equipment and furniture and fixtures over estimated useful lives ranging from three to seven years. We depreciate the leasehold improvements at our corporate office over the shorter of the estimated useful lives or the remaining lease term. Depreciation expense relating to our corporate assets is included in general and administrative expense in our condensed consolidated statements of income.

Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. Project costs that are clearly associated with the acquisition and development or redevelopment of a real estate project, for which we are the accounting owner, are capitalized as a cost of that project. Expenditures that meet one or more of the following criteria generally qualify for capitalization:

the expenditure provides benefit in future periods; and
the expenditure extends the useful life of the asset beyond our original estimates.

We define redevelopment properties as existing properties for which we expect to spend significant development and construction costs that are not reimbursements to tenants for improvements at the properties. When existing properties are determined to be redevelopment properties, the net carrying value of the buildings and improvements are transferred to construction in progress while the redevelopment activities are in process. During the nine months ended September 30, 2023, we reclassified the net carrying value of the buildings and improvements totaling approximately $51.2 million to construction in progress relating to an existing property that was placed into redevelopment. Costs capitalized to construction in progress related to redevelopment properties are transferred to buildings and improvements at historical cost of the properties as the redevelopment project or phases of projects are placed in service.

Provision for Impairment

Provision for Impairment. On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties.

Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the nine months ended September 30, 2023 and 2022.

Revenue Recognition

Revenue Recognition. Our leases are triple-net leases, an arrangement under which the tenant maintains the property while paying us rent. We account for our current leases as operating leases and record revenue for each of our properties on a cash basis due to the uncertain regulatory environment in the United States pertaining to the regulated cannabis industry, the limited operating history of certain tenants and the resulting uncertainty of collectability of lease payments from each tenant over the duration of the lease term. Contractually obligated reimbursements from tenants for recoverable real estate taxes, insurance and operating expenses are included in rental revenues in the period when such costs are reimbursed by the tenants. Contractually obligated real estate taxes that are paid directly by the tenant to the tax authorities are not reflected in our condensed consolidated financial statements.

For the three months ended September 30, 2023, rental revenue recognized included the application of approximately $2.2 million of security deposits for rent with three tenants in connection with lease amendments. For the nine months ended September 30, 2023, rental revenue recognized included the application of approximately $3.1 million of security deposits applied for rent with two tenants who were in default under their respective lease agreements and approximately $4.9 million of security deposits for rent with three tenants in connection with lease amendments.

Construction Loan

Construction Loan. In June 2021, we executed a construction loan agreement with a developer, pursuant to which we agreed to lend up to $18.5 million for the development of a regulated cannabis cultivation and processing facility in California. We have an option to purchase the property, and may execute a negotiated lease with an affiliate of the developer or with another third party, if we determine to exercise our purchase option. In February 2023, we amended the construction loan to provide for, among other things: (1) the additional capital commitment of the borrower into the project of $1.0 million; (2) our agreement to fund an additional $4.5 million into the project; (3) an increase in the interest rate effective April 1, 2023; (4) an extension of the loan term to December 31, 2023; and (5) the provision of additional collateral from the borrower for the loan. Interest on the loan continued to accrue through March 31, 2023, with monthly payment of interest having commenced April 1, 2023. As of September 30, 2023, we had funded approximately $21.6 million of the $23.0 million total commitment.

Cash and Cash Equivalents

Cash and Cash Equivalents. We consider all highly-liquid investments with original maturities of three months or less to be cash equivalents, which is comprised of short-term money market funds, obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of less than or equal to three months.

Restricted Cash

Restricted Cash. Restricted cash relates to cash held in escrow accounts for future draws for improvements for tenants in accordance with certain lease agreements.

Investments

Investments. Investments consist of obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of greater than three months. Investments are classified as held-to-maturity and stated at amortized cost.

Exchangeable Notes

Exchangeable Notes. In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models, and convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature, will no longer be allocated between debt and equity components. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. We adopted ASU 2020-06 on January 1, 2022 and recognized a cumulative-effect adjustment of approximately $728,000 to the opening balance of retained earnings and derecognized approximately $1.3 million of the remaining equity component relating to the outstanding principal balance of our Exchangeable Senior Notes (as defined below) at the date of adoption.

Deferred Financing Costs

Deferred Financing Costs. The deferred financing costs that are included as a reduction in the net book value of the related liability on our condensed consolidated balance sheets reflect issuance and other costs related to our debt obligations. These costs are amortized as non-cash interest expense using the effective interest method over the life of the related obligations.

Stock-Based Compensation

Stock-Based Compensation. Stock-based compensation for equity awards is based on the grant date fair value of the equity awards and is recognized over the requisite service or performance period. If awards are forfeited prior to vesting, we reverse any previously recognized expense related to such awards in the period during which the forfeiture occurs and reclassify any non-forfeitable dividends and dividend equivalents previously paid on these awards from retained earnings to compensation expense. Forfeitures are recognized as incurred. Certain equity awards are subject to vesting based upon the satisfaction of various market conditions. Forfeiture of share awards with market-based restrictions does not result in a reversal of previously recognized share-based compensation expense.

Lease Accounting

Lease Accounting. We elected the practical expedient not to separate certain non-lease components from the lease component if the timing and pattern of transfer are the same for the non-lease component and associated lease component, and the lease component would be classified as an operating lease if accounted for separately. We also elected the short-term lease exception for lessees for leases that are less than 12 months. As lessee, we recognized a liability to account for our future obligations and a corresponding right-of-use asset related to our corporate office lease. The lease liability was initially measured based on the present value of the future lease payments discounted using the estimated incremental borrowing rate of 7.25%, which was the interest rate that we estimate we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. In November 2021, we amended the lease to extend the term from April 2025 to January 2027 in connection with an expansion of the leased space which did not commence until February 2022. As a result of the lease amendment, we re-measured the lease liability relating to the existing lease space and measured the lease liability to the expansion space based on the present value of the respective future lease payments (excluding the extension option that we are not reasonably certain to exercise), discounted using the estimated incremental borrowing rate of 5.5%, which was the interest rate at that time that we estimate we would have had to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period.

The right-of-use asset is measured based on the corresponding lease liability. We did not incur any initial direct leasing costs or exchange any other consideration with the landlord prior to the commencement of the lease. Subsequently, the right-of-use asset is amortized on a straight-line basis during the lease term. For both the three months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $121,000, and for the nine months ended September 30, 2023 and 2022, we recognized office lease expense of approximately $364,000 and $344,000, respectively, which are included in general and administrative expenses in our condensed consolidated statements of income. For the nine months ended September 30, 2023 and 2022, amounts paid and classified as operating activities in our condensed consolidated statements of cash flows for the office lease were approximately $372,000 and $282,000, respectively.

As lessor, for each of our real estate transactions involving the leaseback of the related property to the seller or affiliates of the seller, we determine whether these transactions qualify as sale and leaseback transactions under the accounting guidance. For these transactions, we consider various inputs and assumptions including, but not necessarily limited to, lease terms, renewal options, discount rates, and other rights and provisions in the purchase and sale agreement, lease and other documentation to determine whether control has been transferred to the Company or remains with the lessee. A transaction involving a sale leaseback will be treated as a purchase of a real estate property if it is considered to transfer control of the underlying asset from the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control and will be classified as a sales-type lease if control of the underlying asset is transferred to the lessee. Otherwise, the lease is treated as an operating lease. These criteria also include estimates and assumptions regarding the fair value of the leased facilities, minimum lease payments, the economic useful life of the facilities, the existence of a purchase option, and certain other terms in the lease agreements. The lease accounting guidance requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant’s option. Substantially all of our leases continue to be classified as operating leases and we continue to record revenue for each of our properties on a cash basis. Our tenant reimbursable revenue and property expenses continue to be presented on a gross basis as rental revenues and as property expenses, respectively, on our condensed consolidated statements of income. Property taxes paid directly by the lessee to a third party continue to be excluded from our condensed consolidated financial statements.

Lease amendments are evaluated to determine if the modification grants the lessee an additional right-of-use not included in the original lease and if the lease payments increase commensurate with the standalone price of the additional right-of-use, adjusted for the circumstances of the particular contract. If both conditions are present, the lease amendment is accounted for as a new lease that is separate from the original lease.

Our leases generally contain options to extend the lease terms at the prevailing market rate or at the expiring rental rate at the time of expiration. Certain of our leases provide the lessee with a right of first refusal or right of first offer in the event we market the leased property for sale.

Concentration of Credit Risk

Concentration of Credit Risk. As of September 30, 2023, we owned 108 properties located in 19 states and leased to 29 tenants. The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates.

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2023 and 2022, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

15

%

Ascend Wellness Holdings, Inc. ("Ascend")

4

10

%

Green Thumb Industries, Inc. ("GTI")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

 

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

GTI

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

For the Three Months Ended

September 30, 2022

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

14

%

Parallel

4

10

%

Ascend

4

10

%

GTI

3

8

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2022

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

14

%

Parallel

4

10

%

Ascend

 

4

9

%

Kings Garden Inc. ("Kings Garden")(2)

6

7

%

Trulieve

 

6

7

%

(1)Commencing in November 2022, Parallel defaulted on its obligations to pay rent at one of our Pennsylvania properties. In February 2023, Parallel defaulted on its obligations to pay rent at one of our Texas properties, and we regained possession of that property in March 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information. Excluding security deposits applied for payment of rent for Parallel at one property in Pennsylvania and one property in Texas of approximately $1.8 million and $395,000, respectively, Parallel would have represented 6% of our total rental revenues for the nine months ended September 30, 2023.
(2)In July 2022, Kings Garden defaulted on its obligations to pay rent at all of the properties it leases with us, and pursuant to a confidential, conditional settlement agreement executed on September 11, 2022 between us and Kings Garden, we terminated the leases for two properties and regained possession of those properties, which continued to be in development or redevelopment as of September 30, 2023. Kings Garden paid the stipulated rent during its period of occupancy for the remaining four properties through September 20, 2023, and we regained possession of those properties in September 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

As of September 30, 2023, our largest property was located in New York and accounted for approximately 5.4% of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment as of September 30, 2023. As of December 31, 2022, none of our properties individually represented more than 5% of our net real estate held for investment.

We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2023, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.

v3.23.3
Summary of Significant Accounting Policies and Procedures (Tables)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies and Procedures  
Schedule of tenants in the company's portfolio that represented the largest percentage of total rental revenue for each period presented, including tenant reimbursements

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2023 and 2022, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

15

%

Ascend Wellness Holdings, Inc. ("Ascend")

4

10

%

Green Thumb Industries, Inc. ("GTI")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

 

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

GTI

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

For the Three Months Ended

September 30, 2022

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

14

%

Parallel

4

10

%

Ascend

4

10

%

GTI

3

8

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2022

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

14

%

Parallel

4

10

%

Ascend

 

4

9

%

Kings Garden Inc. ("Kings Garden")(2)

6

7

%

Trulieve

 

6

7

%

(1)Commencing in November 2022, Parallel defaulted on its obligations to pay rent at one of our Pennsylvania properties. In February 2023, Parallel defaulted on its obligations to pay rent at one of our Texas properties, and we regained possession of that property in March 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information. Excluding security deposits applied for payment of rent for Parallel at one property in Pennsylvania and one property in Texas of approximately $1.8 million and $395,000, respectively, Parallel would have represented 6% of our total rental revenues for the nine months ended September 30, 2023.
(2)In July 2022, Kings Garden defaulted on its obligations to pay rent at all of the properties it leases with us, and pursuant to a confidential, conditional settlement agreement executed on September 11, 2022 between us and Kings Garden, we terminated the leases for two properties and regained possession of those properties, which continued to be in development or redevelopment as of September 30, 2023. Kings Garden paid the stipulated rent during its period of occupancy for the remaining four properties through September 20, 2023, and we regained possession of those properties in September 2023. See Note 11 “Commitments and Contingencies — Litigation” to our condensed consolidated financial statements for more information.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

v3.23.3
Dividends (Tables)
9 Months Ended
Sep. 30, 2023
Dividends  
Schedule of dividends declared

The following table describes the dividends declared by the Company during the nine months ended September 30, 2023:

    

    

Amount

    

    

Dividend

    

Dividend

Declaration Date

Security Class

Per Share

Period Covered

Paid Date

Amount

 

(In thousands)

March 15, 2023

Common stock

$

1.80

January 1, 2023 to March 31, 2023

April 14, 2023

$

50,725

March 15, 2023

Series A preferred stock

$

0.5625

January 15, 2023 to April 14, 2023

April 14, 2023

$

338

June 15, 2023

Common stock

$

1.80

April 1, 2023 to June 30, 2023

July 14, 2023

$

50,742

June 15, 2023

Series A preferred stock

$

0.5625

April 15, 2023 to July 14, 2023

July 14, 2023

$

338

September 15, 2023

Common stock

$

1.80

July 1, 2023 to September 30, 2023

October 13, 2023

$

50,742

September 15, 2023

Series A preferred stock

$

0.5625

July 15, 2023 to October 14, 2023

October 13, 2023

$

338

v3.23.3
Investments in Real Estate (Tables)
9 Months Ended
Sep. 30, 2023
Schedule of real estate properties

The Company acquired the following properties during the nine months ended September 30, 2023 (dollars in thousands):

Rentable 

 Square

 Purchase

Transaction

Property

    

Market

    

Closing Date

    

Feet(1)

    

 Price

    

 Costs

    

Total

Susquehanna Street

 

Pennsylvania

February 15, 2023

 

58,000

$

15,000

$

26

$

15,026

Boltonfield Street

 

Ohio

March 3, 2023

 

157,000

 

20,100

 

29

 

20,129

(2)

Total

 

215,000

$

35,100

$

55

$

35,155

(3)

(1)Includes expected rentable square feet at completion of construction of certain properties.
(2)The tenant is expected to complete improvements at the property, for which we agreed to provide funding of up to $21.9 million.
(3)Approximately $2.6 million was allocated to land and approximately $32.6 million was allocated to building and improvements.

Schedule of future contractual minimum rent

Future contractual minimum rent (including base rent and property management fees) under the operating leases as of September 30, 2023 for future periods is summarized as follows (in thousands):

Year

    

Contractual Minimum Rent

2023 (three months ending December 31)

$

71,899

2024

296,878

2025

 

305,612

2026

 

314,670

2027

 

324,001

Thereafter

 

4,167,626

Total

$

5,480,686

Acquired In-Place Lease Intangible Assets  
Schedule of intangible assets and related accumulated amortization

In-place lease intangible assets and related accumulated amortization as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

In-place lease intangible assets

$

9,979

$

9,979

Accumulated amortization

 

 

(1,519)

 

(874)

In-place lease intangible assets, net

$

8,460

$

9,105

Schedule of estimated annual amortization

Year

    

Amount

2023 (three months ending December 31)

$

215

2024

 

860

2025

 

860

2026

 

860

2027

 

860

Thereafter

 

4,805

Total

$

8,460

Above-Market Lease  
Schedule of intangible assets and related accumulated amortization

The above-market lease and related accumulated amortization included in other assets, net on our condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 is as follows (in thousands):

    

September 30, 2023

    

December 31, 2022

Above-market lease

$

1,054

$

1,054

Accumulated amortization

 

 

(164)

 

(95)

Above-market lease, net

$

890

$

959

v3.23.3
Debt (Tables)
9 Months Ended
Sep. 30, 2023
Summary of principal payments on outstanding indebtedness

The following table summarizes the principal payments on our outstanding indebtedness as of September 30, 2023 (in thousands):

Payments Due

by Year

    

Amount

2023 (three months ending December 31)

$

2024

4,436

2025

2026

300,000

2027

Thereafter

Total

$

304,436

Exchangeable Senior Notes  
Schedule of interest expense

The following table details our interest expense related to the Exchangeable Senior Notes (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

Cash coupon

  

$

41

  

$

60

  

$

140

  

$

391

Amortization of issuance cost

  

9

  

12

  

29

  

83

Capitalized interest

(2)

(2)

Total interest expense

  

$

48

  

$

72

  

$

167

  

$

474

Schedule of carrying value

The following table details the carrying value of our Exchangeable Senior Notes (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

4,436

  

$

6,436

Unamortized issuance cost

  

 

(13)

  

(56)

Carrying value

  

$

4,423

  

$

6,380

Notes due 2026  
Schedule of interest expense

The following table details our interest expense related to the Notes due 2026 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2023

2022

    

2023

2022

Cash coupon

$

4,125

$

4,125

$

12,375

$

12,375

Amortization of issuance cost

 

335

316

992

934

Capitalized interest

 

(178)

(212)

Total interest expense

$

4,282

$

4,441

$

13,155

$

13,309

Schedule of carrying value

The following table details the carrying value of our Notes due 2026 (in thousands):

    

September 30, 2023

    

December 31, 2022

Principal amount

  

$

300,000

  

$

300,000

Unamortized issuance cost

  

 

(3,893)

  

(4,885)

Carrying value

  

$

296,107

  

$

295,115

v3.23.3
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Net Income Per Share  
Schedule of earnings per share, basic and diluted

Computations of net income per basic and diluted share (in thousands, except share and per share data) were as follows:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Net income

$

41,594

$

37,616

$

123,955

$

112,880

Preferred stock dividends

 

(338)

 

(338)

(1,014)

(1,014)

Distribution to participating securities

 

(372)

 

(213)

(1,106)

(622)

Net income attributable to common stockholders used to compute net income per share – basic

40,884

37,065

121,835

111,244

Dilutive effect of Exchangeable Senior Notes

50

72

169

474

Net income attributable to common stockholders used to compute net income per share – diluted

$

40,934

$

37,137

$

122,004

$

111,718

Weighted-average common shares outstanding:

Basic

 

27,983,004

 

27,938,568

27,971,544

27,144,953

Restricted stock and RSUs

206,919

118,567

193,503

115,445

Dilutive effect of Exchangeable Senior Notes

75,682

100,799

83,007

235,753

Diluted

 

28,265,605

 

28,157,934

28,248,054

27,496,151

Net income attributable to common stockholders per share:

Basic

$

1.46

$

1.33

$

4.36

$

4.10

Diluted

$

1.45

$

1.32

$

4.32

$

4.06

v3.23.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value of Financial Instruments  
Schedule of condensed financial statements

The following table presents the carrying value and approximate fair value of financial instruments at September 30, 2023 and December 31, 2022 (in thousands):

At September 30, 2023

At December 31, 2022

                                                                                                          

                                                                                                                         

                                                                                                

                                                                                                                                   

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Investments(1)

$

41,885

$

41,880

$

200,935

$

200,715

Investments as cash equivalents(2)

$

20,100

$

20,091

$

$

Exchangeable Senior Notes(3)

$

4,423

$

5,577

$

6,380

$

10,282

Notes due 2026(3)

$

296,107

$

268,611

$

295,115

$

264,234

Construction Loan(4)

$

21,556

$

26,362

$

18,021

$

20,167

(1)Investments consisting of obligations of the U.S. government with an original maturity at the time of purchase of greater than three months are classified as held-to-maturity and valued using Level 1 inputs.
(2)Investments as cash equivalents consisting of obligations of the U.S. government with an original maturity at the time of purchase of less than or equal to three months are classified as held-to-maturity and valued using Level 1 inputs.
(3)The fair value is determined based upon Level 2 inputs as the Exchangeable Senior Notes and Notes due 2026 were trading in the private market.
(4)The construction loan receivable is categorized as Level 3 and was valued using a yield analysis, which is typically performed for non-credit impaired loans. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. At September 30, 2023 and December 31, 2022, the expected market yield used to determine fair value was 25%. Changes in market yields may change the
fair value of the construction loan. Generally, an increase in market yields may result in a decrease in the fair value of the construction loan. Due to the inherent uncertainty of determining the fair value of a loan that does not have a readily available market value, the fair value of the construction loan may fluctuate from period to period. Additionally, the fair value of the construction loan may differ significantly from the value that would have been used had a readily available market existed for such loan and may differ materially from the value that the Company may ultimately realize.
v3.23.3
Common Stock Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2023
Restricted Shares  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the activity

A summary of the restricted stock activity under the 2016 Plan and related information for the nine months ended September 30, 2023 is included in the table below:

    

    

Weighted-

Unvested

Average

Restricted

Grant Date Fair

Stock

Value

Balance at December 31, 2022

 

34,026

$

181.08

Granted

 

35,565

$

110.88

Vested

 

(9,154)

$

187.00

Forfeited(1)

 

(5,596)

$

115.01

Balance at March 31, 2023

 

54,841

$

141.31

Granted

5,055

$

71.23

Vested

(2,811)

$

128.11

Balance at June 30, 2023

57,085

$

135.75

Granted

150

$

80.49

Vested

(150)

$

80.49

Forfeited(1)

(374)

$

135.84

Balance at September 30, 2023

56,711

$

135.75

(1)Shares that were forfeited to cover the employees’ tax withholding obligation upon vesting or employees’ cessation of employment.
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of the activity

The following table summarizes our RSU activity for the nine months ended September 30, 2023. RSUs are issued as part of the Innovative Industrial Properties, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows a select group of management and our non-employee directors to defer receiving certain of their cash and equity-based compensation. RSUs are subject to vesting conditions of the Deferred Compensation Plan and have the same economic rights as shares of restricted stock under the 2016 Plan:

    

    

Weighted-Average

Restricted

Grant Date Fair

Stock Units

Value

Balance at December 31, 2022

83,677

$

144.30

Granted

61,785

$

103.60

Balance at March 31, 2023

145,462

$

127.01

Granted

4,494

$

71.23

Balance at June 30, 2023

149,956

$

125.34

Granted

$

-

Balance at September 30, 2023

149,956

$

125.34

v3.23.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies  
Schedule of future contractual lease payments

Office Lease. The future contractual lease payments for our office lease and the reconciliation to the office lease liability reflected in other liabilities in our condensed consolidated balance sheet as of September 30, 2023 is presented in the table below (in thousands):

Year

    

Amount

2023 (three months ending December 31)

$

124

2024

 

511

2025

 

526

2026

 

543

2027

 

45

Total future contractual lease payments

 

1,749

Effect of discounting

 

(166)

Office lease liability

$

1,583

v3.23.3
Organization (Details)
Sep. 30, 2023
Iip Operating Partnership Lp  
Percentage Leased 100.00%
v3.23.3
Summary of Significant Accounting Policies and Procedures - Additional Information (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
tenant
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
tenant
segment
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Feb. 28, 2023
USD ($)
Dec. 31, 2021
USD ($)
Nov. 30, 2021
Jun. 30, 2021
USD ($)
Dec. 31, 2018
Tenant improvements         $ 705,300,000          
Number of Reportable Segments | segment     1              
Depreciation expense $ 16,500,000 $ 15,700,000 $ 49,500,000 $ 44,400,000            
Total investment in property 2,164,837,000   2,164,837,000   2,066,282,000          
Impairment loss     0 0            
Rental revenue recognized from security deposits applied for rent with tenants in default     3,100,000              
Rental revenue recognized from security deposits applied for rent with tenants with lease amendments 2,200,000   4,900,000              
Maximum construction loan agreed to lend                 $ 18,500,000  
Construction loan funded 21,556,000   21,556,000   $ 18,021,000          
Construction loan, total commitment amount $ 23,000,000.0   $ 23,000,000.0              
Lease, Practical Expedients, Package [true false]     true              
Incremental borrowing rate               5.50%   7.25%
Amounts paid and classified as operating activities for the office lease     $ 372,000 282,000            
Number of tenants who were in default | tenant     2              
Number of tenants for whom security deposits were applied | tenant 3   3              
Cannabis cultivation and processing facility, California                    
Additional capital commitment           $ 1,000,000.0        
Additional amount of construction loan           $ 4,500,000        
Adjustment | Accounting Standards Update 2020-06                    
Accumulated deficit             $ 728,000      
Equity Components             $ 1,300,000      
Geographic Concentration Risk | Net real estate held for investment                    
Concentration Risk, Threshold Percentage     5.00%   5.00%          
Geographic Concentration Risk | Net real estate held for investment | New York                    
Concentration Risk, Threshold Percentage     5.40%              
General and administrative expense                    
Office lease expense $ 121,000 $ 121,000 $ 364,000 $ 344,000            
Maximum                    
Cash, FDIC Insured Amount $ 250,000   $ 250,000              
Building and Improvements                    
Property, Plant and Equipment, Useful Life 40 years   40 years              
Office equipment and furniture and fixtures | Minimum                    
Property, Plant and Equipment, Useful Life 3 years   3 years              
Office equipment and furniture and fixtures | Maximum                    
Property, Plant and Equipment, Useful Life 7 years   7 years              
Construction in Progress | Kings Garden Lawsuit | Kings Garden. | Adjustment                    
Total investment in property $ 51,200,000   $ 51,200,000              
v3.23.3
Summary of Significant Accounting Policies and Procedures - Concentration of Credit Risk (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2023
lease
tenant
property
Sep. 30, 2022
tenant
lease
Sep. 30, 2023
USD ($)
tenant
property
lease
item
Sep. 30, 2022
lease
tenant
Concentration Risk        
Number of Properties | property 108   108  
Number of states in which properties are owned | item     19  
Number of tenants | tenant 29   29  
Number of properties lease terminated | property 2   2  
SH Parent, Inc. ("Parallel") | Pennsylvania | Parallel Pennsylvania Litigation        
Concentration Risk        
Number of Properties | property 1   1  
Rental revenue recognized from security deposits applied for rent | $     $ 1,800,000  
SH Parent, Inc. ("Parallel") | Texas | Parallel Texas Litigation        
Concentration Risk        
Number of Properties | property 1   1  
Rental revenue recognized from security deposits applied for rent | $     $ 395,000  
Kings Garden Inc.        
Concentration Risk        
Number of properties stipulated rent paid | property 4   4  
Rental revenues (including tenant reimbursements) | Customer concentration        
Concentration Risk        
Number of tenants | tenant 5 5 5 5
Rental revenues (including tenant reimbursements) | Customer concentration | PharmaCann Inc.        
Concentration Risk        
Number of Leases 11 11 11 11
Percentage of Rental Revenue 15.00% 14.00% 15.00% 14.00%
Rental revenues (including tenant reimbursements) | Customer concentration | Ascend Wellness Holdings, Inc.        
Concentration Risk        
Number of Leases 4 4 4 4
Percentage of Rental Revenue 10.00% 10.00% 10.00% 9.00%
Rental revenues (including tenant reimbursements) | Customer concentration | Green Thumb Industries, Inc.        
Concentration Risk        
Number of Leases 3 3 3  
Percentage of Rental Revenue 8.00% 8.00% 8.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | SH Parent, Inc. ("Parallel")        
Concentration Risk        
Number of Leases   4 4 4
Percentage of Rental Revenue   10.00% 7.00% 10.00%
Rental revenues (including tenant reimbursements) | Customer concentration | SH Parent, Inc. ("Parallel") | Parallel Pennsylvania Litigation        
Concentration Risk        
Percentage of Rental Revenue     6.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Curaleaf Holdings, Inc.        
Concentration Risk        
Number of Leases 8   8  
Percentage of Rental Revenue 7.00%   7.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Kings Garden Inc.        
Concentration Risk        
Number of Leases       6
Percentage of Rental Revenue       7.00%
Rental revenues (including tenant reimbursements) | Customer concentration | Trulieve        
Concentration Risk        
Number of Leases 6 6   6
Percentage of Rental Revenue 7.00% 7.00%   7.00%
v3.23.3
Common Stock (Details)
$ in Millions
1 Months Ended 9 Months Ended
Jan. 31, 2023
item
shares
Sep. 30, 2023
USD ($)
shares
Number of shares issued upon conversion   32,200
Outstanding principal amount | $   $ 2.0
At The Market Offerings    
Number of shares issued   0
Number of sales agents | item 4  
At The Market Offerings | Maximum    
Maximum number of common stock issuable 500,000,000.0  
v3.23.3
Preferred Stock (Details) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Preferred Stock, Shares Authorized 50,000,000 50,000,000
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Series A Preferred Stock    
Preferred Stock, Par or Stated Value Per Share $ 0.001  
Preferred Stock, Shares Issued 600,000 600,000
Preferred Stock, Shares Outstanding 600,000 600,000
Preferred Stock, Dividend Rate, Percentage 9.00% 9.00%
Preferred Stock, Redemption Price Per Share $ 25.00  
Preferred Stock, Voting Rights Holders of the Series A Preferred Stock generally have no voting rights except for limited voting rights if the Company fails to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.  
v3.23.3
Dividends (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Oct. 13, 2023
Sep. 15, 2023
Jul. 14, 2023
Jun. 15, 2023
Apr. 14, 2023
Mar. 15, 2023
Sep. 30, 2023
Sep. 30, 2022
Dividends declared per common share   $ 1.80   $ 1.80   $ 1.80    
Dividends declared per Series A preferred stock   $ 0.5625   $ 0.5625   $ 0.5625    
Dividend amount - Common stock     $ 50,742   $ 50,725   $ 151,969 $ 133,440
Dividend amount - Series A preferred stock     $ 338   $ 338   $ 1,014 $ 1,014
Subsequent event                
Dividend amount - Common stock $ 50,742              
Dividend amount - Series A preferred stock $ 338              
v3.23.3
Investments in Real Estate (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2023
USD ($)
ft²
Rentable Square Feet | ft² 215,000
Initial Purchase Price $ 35,100
Transaction Costs 55
Total 35,155
Land  
Total 2,600
Building and Improvements  
Total $ 32,600
Susquehanna Street  
Rentable Square Feet | ft² 58,000
Initial Purchase Price $ 15,000
Transaction Costs 26
Total $ 15,026
Boltonfield Street  
Rentable Square Feet | ft² 157,000
Initial Purchase Price $ 20,100
Transaction Costs 29
Total 20,129
Agreed funding for redevelopment of building $ 21,900
v3.23.3
Investments in Real Estate - Intangible assets and related accumulated amortization (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Acquired In-Place Lease Intangible Assets    
Investments in Real Estate    
Gross $ 9,979 $ 9,979
Accumulated amortization (1,519) (874)
Total 8,460 9,105
Above-Market Lease    
Investments in Real Estate    
Gross 1,054 1,054
Accumulated amortization (164) (95)
Total $ 890 $ 959
v3.23.3
Investments in Real Estate - Estimated annual amortization (Details) - Acquired In-Place Lease Intangible Assets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity    
2023 (three months ending December 31) $ 215  
2024 860  
2025 860  
2026 860  
2027 860  
Thereafter 4,805  
Total $ 8,460 $ 9,105
v3.23.3
Investments in Real Estate - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2023
Mar. 31, 2023
USD ($)
property
Feb. 28, 2023
USD ($)
Jan. 31, 2023
Sep. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
item
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Purchase Price         $ 35,100,000     $ 35,100,000    
Real estate property cost         111,100,000     111,100,000    
Tenant improvements and construction activities funded         129,500,000     129,500,000    
Interest payments         939,000     939,000    
4Front Ventures Corp.                    
Percentage of security deposit hold on base rent due from tenant 50.00%                  
Repayment period of tenant 12 months                  
Acquired In-Place Lease Intangible Assets                    
Initial value         8,460,000     8,460,000   $ 9,105,000
Amortization expense         215,000   $ 215,000 $ 645,000 $ 626,000  
Weighted-average amortization period (in years)               9 years 9 months 18 days    
Above-Market Lease                    
Initial value         $ 890,000     $ 890,000   $ 959,000
Amortization period (in years)         9 years 6 months     9 years 6 months    
Amortization expense         $ 23,000   $ 23,000 $ 69,000 $ 69,000  
Holistic | California Property                    
Base rent applied from the security deposits (in months)       8 months            
Holistic | Michigan Properties                    
Base rent applied from the security deposits (in months)       9 months            
Holistic | California, Maryland, Massachusetts, Michigan and Pennsylvania properties.                    
Percent of base rent which is applied from security deposits for lease payments       100.00%            
Payback of the security deposits (in months)       12 months            
Temescal MA | Massachusetts properties                    
Payback of the security deposits (in months)   12 months                
Calyx Peak MO [Member] | Missouri Property                    
Percent of base rent deferral under lease       100.00%            
Payback of the deferred rent (in months)       12 months            
PharmaCann | New York Properties                    
Increase amount of tenant improvement allowance     $ 15,000,000.0              
Tenant improvement allowance     93,500,000              
Medical Investor Holdings LLC | California Property                    
Real Estate Loans Receivable   $ 16,100,000       $ 16,100,000        
Extension Term           12 months        
Minimum Principal Balance Payment   $ 500,000       $ 500,000        
Number of Options to Extend | item           2        
Accumulated depreciation         1,500,000     1,500,000    
Number of properties sold | property   4                
Contracted sale price of properties disposed           $ 16,200,000        
Medical Investor Holdings LLC | Land | California Property                    
Gross carrying value         3,400,000     3,400,000    
Medical Investor Holdings LLC | Building and Improvements | California Property                    
Gross carrying value         $ 13,900,000     $ 13,900,000    
Ascend Wellness Holdings, Inc. | New Jersey properties                    
Increase amount of tenant improvement allowance     15,000,000.0              
Tenant improvement allowance     19,600,000              
Goodness Growth Holdings Inc. | New York Properties                    
Increase amount of tenant improvement allowance     4,000,000.0              
Tenant improvement allowance     $ 53,400,000              
v3.23.3
Investments in Real Estate - Future Contractual Minimum Rent (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Contractual Minimum Rent  
2023 (three months ending December 31) $ 71,899
2024 296,878
2025 305,612
2026 314,670
2027 324,001
Thereafter 4,167,626
Total $ 5,480,686
v3.23.3
Debt - Exchangeable Senior Notes - Additional Information (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
Principal amount   $ 304,436,000    
Number of shares issued upon conversion | shares   32,200    
Gain on exchange of debt   $ 22,000    
Threshold Limit of Convertible Debt for Issue of Shares   1,300,000    
Outstanding principal amount   2,000,000.0    
Exchange of Exchangeable Senior Notes $ 17,000 1,964,000 $ 26,682,000  
Additional Paid-In-Capital        
Exchange of Exchangeable Senior Notes $ 17,000 1,964,000 $ 26,682,000  
Exchangeable Senior Notes        
Principal amount   $ 4,436,000   $ 6,436,000
Interest rate   3.75%    
Number of shares issued upon conversion | shares 265 32,200 413,166  
Outstanding principal amount $ 17,000 $ 2,000,000.0 $ 26,900,000  
Loss on exchange of Exchangeable Senior Notes     125,000  
Exchange of Exchangeable Senior Notes $ 17,000   $ 26,700,000  
Exchangeable Senior Notes | Accounts payable and accrued expenses        
Accrued interest payable   $ 7,000   $ 70,000
Exchangeable Senior Notes | Common Stock        
Exchange rate   17.06090    
Amount converted   $ 1,000    
Exchange price | $ / shares   $ 58.61    
v3.23.3
Debt - Exchangeable Senior Notes - Interest expense (Details) - Exchangeable Senior Notes - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash coupon $ 41 $ 60 $ 140 $ 391
Amortization of issuance cost 9 12 29 83
Capitalized interest (2)   (2)  
Total interest expense $ 48 $ 72 $ 167 $ 474
v3.23.3
Debt - Exchangeable Senior Notes - Carrying value (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Principal amount $ 304,436  
Exchangeable Senior Notes    
Principal amount 4,436 $ 6,436
Unamortized issuance cost (13) (56)
Carrying value $ 4,423 $ 6,380
v3.23.3
Debt - Notes due 2026 (Details) - USD ($)
$ in Thousands
9 Months Ended
May 25, 2021
Sep. 30, 2023
Dec. 31, 2022
Principal amount   $ 304,436  
Notes due 2026      
Principal amount $ 300,000 $ 300,000 $ 300,000
Interest rate 5.50%    
Issuance costs $ 6,800    
Notes due 2026 | Minimum      
Debt instrument change in debt rating interest rate 6.00%    
Notes due 2026 | Maximum      
Debt instrument change in debt rating interest rate 6.50%    
Notes due 2026 | Redeemed Prior To February 25, 2026      
Percentage of principal amount redeemed   100.00%  
Notes due 2026 | Redeemed On Or After February 25, 2026      
Percentage of principal amount redeemed   100.00%  
Notes due 2026 | Accounts payable and accrued expenses      
Accrued interest payable   $ 6,200 $ 2,100
v3.23.3
Debt - Notes due 2026 - Interest expense (Details) - Notes due 2026 - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash coupon $ 4,125 $ 4,125 $ 12,375 $ 12,375
Amortization of issuance cost 335 316 992 934
Capitalized interest (178)   (212)  
Total interest expense $ 4,282 $ 4,441 $ 13,155 $ 13,309
v3.23.3
Debt - Notes due 2026 - Carrying value (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
May 25, 2021
Principal amount $ 304,436    
Notes due 2026      
Principal amount 300,000 $ 300,000 $ 300,000
Unamortized issuance cost (3,893) (4,885)  
Carrying value $ 296,107 $ 295,115  
v3.23.3
Debt - Principal Payments (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Debt  
2024 $ 4,436
2026 300,000
Total $ 304,436
v3.23.3
Net Income Per Share - Additional information (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dilutive effect of Exchangeable Senior Notes 75,682 100,799 83,007 235,753
PSUs        
Antidilutive securities excluded from computation 0 0 0 0
v3.23.3
Net Income Per Share - Computations of net income per basic and diluted share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Net Income Per Share        
Net income $ 41,594 $ 37,616 $ 123,955 $ 112,880
Preferred stock dividends (338) (338) (1,014) (1,014)
Distribution to participating securities (372) (213) (1,106) (622)
Net income attributable to common stockholders used to compute net income per share - basic 40,884 37,065 121,835 111,244
Dilutive effect of Exchangeable Senior Notes 50 72 169 474
Net income attributable to common stockholders used to compute net income per share - diluted $ 40,934 $ 37,137 $ 122,004 $ 111,718
Weighted-average common shares outstanding:        
Basic 27,983,004 27,938,568 27,971,544 27,144,953
Restricted stock and RSUs 206,919 118,567 193,503 115,445
Dilutive effect of Exchangeable Senior Notes 75,682 100,799 83,007 235,753
Diluted 28,265,605 28,157,934 28,248,054 27,496,151
Net income attributable to common stockholders per share:        
Basic $ 1.46 $ 1.33 $ 4.36 $ 4.10
Diluted (in dollars per share) $ 1.45 $ 1.32 $ 4.32 $ 4.06
v3.23.3
Fair Value of Financial Instruments (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Investments, Carrying Value $ 41,885 $ 200,935
Investments as cash equivalents, Carrying Value 20,100  
Exchangeable Senior Notes, Carrying Value 4,423 6,380
Notes due 2026, Carrying Value 296,107 295,115
Construction loan receivable 21,556 18,021
Investments, Fair Value 41,880 200,715
Investments as cash equivalents, Fair Value 20,091  
Exchangeable Senior Notes, Fair Value 5,577 10,282
Notes due 2026, Fair Value 268,611 264,234
Construction Loan, Fair Value $ 26,362 $ 20,167
Expected market yield    
Loan Receivable, Measurement Input 0.25 0.25
v3.23.3
Common Stock Incentive Plan - Additional Information (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Restricted Shares                
Unrecognized compensation cost     $ 5.2       $ 5.2  
Amortization period             1 year 9 months 18 days  
Fair value of restricted stock             $ 1.7  
Granted     150 5,055 35,565      
RSUs                
Unrecognized compensation cost     $ 7.3       $ 7.3  
Amortization period             1 year 10 months 24 days  
Granted       4,494 61,785      
PSUs                
Amortization period             1 year 2 months 12 days  
Granted 102,641 70,795            
Stock-based compensation expense     2.7     $ 8.0 $ 2.7 $ 8.0
Remaining unrecognized compensation     $ 9.3       $ 9.3  
2016 Plan                
Expiration term             10 years  
2016 Plan | Maximum                
Number of shares authorized     1,000,000       1,000,000  
v3.23.3
Common Stock Incentive Plan - Activity (Details) - $ / shares
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Restricted Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares, Beginning Balance 57,085 54,841 34,026
Granted 150 5,055 35,565
Vested (150) (2,811) (9,154)
Forfeited (374)   (5,596)
Shares, Ending Balance 56,711 57,085 54,841
Weighted-Average Grant Date Fair Value, Beginning Balance $ 135.75 $ 141.31 $ 181.08
Weighted-Average Grant Date Fair Value, Granted 80.49 71.23 110.88
Weighted-Average Grant Date Fair Value, Vested 80.49 128.11 187.00
Weighted-Average Grant Date Fair Value, Forfeited 135.84   115.01
Weighted-Average Grant Date Fair Value, Ending Balance $ 135.75 $ 135.75 $ 141.31
RSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares, Beginning Balance 149,956 145,462 83,677
Granted   4,494 61,785
Shares, Ending Balance 149,956 149,956 145,462
Weighted-Average Grant Date Fair Value, Beginning Balance $ 125.34 $ 127.01 $ 144.30
Weighted-Average Grant Date Fair Value, Granted   71.23 103.60
Weighted-Average Grant Date Fair Value, Ending Balance $ 125.34 $ 125.34 $ 127.01
v3.23.3
Commitments and Contingencies (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Commitments and Contingencies  
2023 (three months ending December 31) $ 124
2024 511
2025 526
2026 543
2027 45
Total future contractual lease payments 1,749
Effect of discounting (166)
Office lease liability $ 1,583
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities
v3.23.3
Commitments and Contingencies - Additional Information (Details)
3 Months Ended 6 Months Ended 9 Months Ended
Oct. 31, 2023
USD ($)
Aug. 16, 2023
item
Aug. 04, 2023
USD ($)
property
Sep. 30, 2023
USD ($)
item
property
Jun. 30, 2022
item
Sep. 30, 2023
USD ($)
item
property
Dec. 31, 2022
USD ($)
Jul. 31, 2022
lease
Other Commitments [Line Items]                
Number of Projects | item         2      
Construction in progress       $ 107,772,000   $ 107,772,000 $ 54,106,000  
Amended Class Action Lawsuit                
Other Commitments [Line Items]                
Amount accrued       0   0    
Derivative Action Lawsuit                
Other Commitments [Line Items]                
Amount accrued       0   0    
Kings Garden Lawsuit                
Other Commitments [Line Items]                
Number of leased properties | lease               6
Number of Projects | item   1            
Funds recovered       4,200,000   $ 19,800,000    
Remaining additional costs paid       $ 750,000        
Number of construction project under investigation | item       1   1    
Number of lease hold properties vacated | property     4          
Damages and attorneys' fees awarded     $ 6,000,000.0          
Amortization of litigation damages     $ 193,000          
Term of amortization of litigation damages     3 years          
Parallel Pennsylvania Litigation                
Other Commitments [Line Items]                
Damages and attorneys' fees awarded $ 15,500,000              
Green Peak Michigan Litigation                
Other Commitments [Line Items]                
Number of leases retail properties | property       2   2    
Kings Garden. | Kings Garden Lawsuit                
Other Commitments [Line Items]                
Construction in progress       $ 28,900,000   $ 28,900,000 $ 33,200,000  
Commitments related to improvement allowances                
Other Commitments [Line Items]                
Other Commitment       17,200,000   17,200,000    
Commitments related to construction loan                
Other Commitments [Line Items]                
Other Commitment       $ 1,400,000   $ 1,400,000    
v3.23.3
Subsequent Events (Details) - USD ($)
$ in Millions
1 Months Ended
Oct. 31, 2023
Feb. 28, 2023
Nov. 02, 2023
Oct. 23, 2023
Goodness Growth Holdings Inc. | New York Properties        
Subsequent Event [Line Items]        
Increase amount of tenant improvement allowance   $ 4.0    
Tenant improvement allowance   $ 53.4    
Subsequent Event        
Subsequent Event [Line Items]        
Aggregate commitments       $ 30.0
Outstanding amount     $ 0.0  
Subsequent Event | Goodness Growth Holdings Inc. | New York Properties        
Subsequent Event [Line Items]        
Increase amount of tenant improvement allowance $ 14.0      
Tenant improvement allowance $ 67.4      
Term of prepaid lease rent 3 months      
v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ 41,594 $ 37,616 $ 123,955 $ 112,880
v3.23.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false

Innovative Industrial Pr... (NYSE:IIPR)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Innovative Industrial Pr... Charts.
Innovative Industrial Pr... (NYSE:IIPR)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Innovative Industrial Pr... Charts.